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PREFACE 
 
To understand the role of food in acne, it‘s important to understand how the science of nutrition has 
changed. During much of the 20
th
 century, the nutritional challenge was the prevention of dietary 
deficiencies. This led to the establishment of essential nutrients and dietary guidelines for the purpose of 
preventing deficiencies and of supporting normal growth and maintenance. During the late 20
th
 and early 
21
st
 century, the societal abundance, which characterises most of the Western World, threw up new 
nutritional challenges. The concept of nutrition progressed from preventing dietary deficiencies to 
recommendations aimed at avoiding excessive consumption of some nutrients, after recognising their role in 
the aetiology of disease. Public awareness of the cause-and-effect relationship of the role of food in general 
health has caused an explosion in the scientific and mainstream literature, and the development of new 
nutritional concepts, such as functional foods to reduce the risk of disease and improve quality of life. This 
megatrend, actively popularised by mainstream media, and the dramatic changes in the attitudes of 
consumers, has fuelled an explosion in nutritional research.  
 
Given the logarithmic progression in the science of nutrition, there is merit in reassessing the role that diet 
plays in acne development. Forty years ago, at the time of the last diet and acne study, many authorities 
found the concept of food causing disease, when no metabolic or nutritional deficiency exists, difficult to 
comprehend. This reflects the consideration at the time of minimum dietary requirements as a means of 
defining nutritional guidelines. Fulton et al (1969) stated that ―if a food can really alter a disease..[this] 
finding would set into motion a wholesale attack on the effects of foods on normal physiologic functions.‖ 
This statement highlights a prinipal difference between the science of nutrition in 1969 and that of today. 
Since the advent of functional foods, modern-day nutritional research is largely directed towards 
understanding how the food we eat relates to health or particular pathologic processes. Nutrition has come to 
the fore of mainstream modern medicine and doctors are being asked now more than ever for unbiased 
information on the effects of certain diets, foods, supplements and numerous other dietary elements on 
health and disease. 
 
While progress has been made over the past 40 years in the nutritional field, it is distressing to realise how 
little our understanding of the relationship of acne to foods has changed. There are surprisingly few studies 
that examine the role of diet in acne development. There are no meta-analyses, randomised controlled 
clinical studies, or well-designed scientific trials that follow evidence-based guidelines for providing solid 
proof in dealing with this issue. Despite the lack of hard evidence, the current consensus amongst most of 
the medical profession is that diet did not cause pimples. In the popular press, article after article lists ―acne 
is caused by diet‖ as ―Myth #1‖. However, few doctors feel that they can argue fervently on the issue (Nash, 
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2003) and many are quite surprised at the poor quality of the studies on which this myth is based (Dr Anne 
Howard, personal communication). 
 
The following thesis reconsiders the diet and acne connection, and opens a new chapter for an understanding 
of nutrition on skin health. According to Yudkin (1953), there are three criteria by which one tests the 
hypothesis that a dietary component is implicated in the causation of disease. ―Firstly, there should be 
evidence that the diet of persons with the disease differs significantly from that of persons without the 
disease. Secondly, the symptoms and signs should be those that are known to be, or plausibly suspected of 
being, caused by dietary imbalance. Thirdly, correction of the dietary imbalance should result in correction 
of the signs and symptoms.‖ Although these fundamental principles should be simple to apply, the major 
limitation 50 years ago was a poor understanding of the cause and exacerbation of acne. During the past 30 
years, significant advances have been made in the area of dermatology, subsequently acne has begun to be 
characterised at each stage of the disease process. A greater understanding of the disease process has 
enabled a more mechanistic and pathophysiological approach to understanding the role that diet plays in 
acne development.  
 
Recent studies on the variation of acne prevalence worldwide have prompted researchers to question the 
natural development of the disease. In 1969, Fulton et al stated that ―it would be remarkable if skin functions 
were easily influenced by the vagaries of the diverse diets which have evolved in human populations.‖ 
Today, however, nutritionists are increasingly convinced that dietary habits have significantly contributed to 
the proliferation of several chronic disease states, such as diabetes and cardiovascular disease, in Western 
countries. So, perhaps, what was once deemed remarkable in 1969 is now comprehensible in 2008. There is 
now also compeling evidence from epidemiological studies to suggest a potential role of diet in acne 
development. Ultimately, however, only experimental and clinical studies can confirm the biological 
consequences of dietary choices. This thesis provides for the first time clinical evidence of a cause-and-
effect relationship between diet and acne and hopefully will provide greater insight into the potential 
underlying mechanisms involved.  
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Acne and the Western diet 
An examination of the potential mechanisms involved 
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CHAPTER ONE 2 
1.1 ABSTRACT 
In Western civilisations, acne is a common skin disease affecting the majority of the adolescent 
population. Despite its high prevalence in the West, acne incidence is considerably lower in non-
Westernised societies and prevalence rates have been shown to increase when a previously unaffected 
society adopts a Western lifestyle. These observations urge further examination of the lifestyle factors 
that may influence the pathological mechanisms involved in acne. Among the possible lifestyle factors 
(eg. diet, physical activity, climate, stress, sun exposure), diet is a likely contender based on 
observational evidence. This paper explores the possible diet-acne connection by examining factors 
that differentiate diets of non-Westernised societies from those of the West. 
Nutritional research has revealed that non-Westernised societies consume fewer high glycaemic index 
carbohydrates, dairy foods and have lower intakes of omega-6 polyunsaturated oils than Westernised 
societies. These dietary factors may affect the development of acne through their influence on 
mediators such as androgens, sex-hormone binding globulin, insulin-like growth factor (IGF)-I, IGF-
binding proteins and inflammatory leukotrienes and prostaglandins. Together, these may affect several 
aspects of the disease process including sebum production, desquamation of keratinocytes and the 
surrounding inflammatory response. Consequently, this review proposes that Western diets may play a 
multifactorial role in the pathogenesis of acne. 
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1.2 INTRODUCTION 
1.2.1 Acne vulgaris: Definition and pathophysiology 
Acne vulgaris is a complex disorder of the pilosebaceous unit, which is comprised of sebum-producing 
sebaceous glands, a keratinocyte-lined follicular canal and a hair follicle. Acne is thought to arise from 
the interplay of four pathological factors: (i) increased growth and abnormal differentiation of 
follicular keratinocytes which obstruct the follicle opening; (ii) increased sebum production in 
response to androgen hormone stimulation; (iii) increased bacterial colonisation by Propionibacterium 
acnes (P.acnes), and (iv) the host immune response due to the increased numbers of bacteria and 
rupturing of the follicular wall (Brown and Shalita, 1998; Thiboutot, 2000; Gollnick, 2001). These 
events can lead to the formation of non-inflammatory lesions and /or inflammatory papules, pustules 
and nodules.  
 
1.2.2 Acne prevalence and factors affecting acne incidence rates 
In Western civilisations, acne is widespread with prevalence rates ranging between 70-87% for 
adolescents (Kilkenny et al., 1997; Dreno and Poli, 2003). Following puberty, acne prevalence 
decreases with age, with only 8% of adults aged 25-34yr and 3% of those aged 35-44yr affected 
(Bergfeld, 1996). Acne prevalence also varies between the sexes, as the disease is more common and 
severe in males (Stathakis et al., 1997). However, women are more likely to have acne persist into 
adulthood, with reports indicating as many as 12% of women over 25yr are affected (Goulden et al., 
1997; Goulden et al., 1999b).  
 
Other factors can influence the incidence of acne in various subpopulations. Variations in acne 
prevalence exist according to genetics (family, ethnicity, gender), socioeconomic status and life 
settings such as urban vs. rural (Lehmann et al., 2001). In a multi-ethnic study in the USA, acne 
prevalence was highest in Hispanics (79.2%), while similar rates were reported amongst African 
Americans (59.9%) and Asian subpopulations (63.2%) (Taylor et al., 2002). These findings, together 
with observations of the concordance of acne in monozygotic twins, further highlight that acne may 
have a genetic component (Walton et al., 1988; Goulden et al., 1999a). However, acne prevalence in 
Kenya (Ormsby and Montgomery, 1954), Zambia (Ratnam and Jayaraju, 1979) and Peru (Freyre et 
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al., 1998) is reportedly lower than in the black (Wilkins and Voorhees, 1970; Taylor et al., 2002) and 
Hispanic (Taylor et al., 2002) populations of Western countries, suggesting that environmental factors 
play a role. Furthermore, a recent Turkish study suggested that socioeconomic status may be a factor, 
after acne was more frequently observed in children of affluent communities (Inanir et al., 2002). 
Given the evidence from these studies, it is plausible to suspect that acne may develop in genetically 
predisposed individuals in response to environmental triggers. The environmental factors responsible 
for the onset of acne are unclear, however the impact of diet should be further explored. 
 
1.3 DIET AND ACNE – EXPLORING THE LINK 
During the last century, much controversy has surrounded the subject of diet in acne management. In 
the early 1950s, major dermatology textbooks recommended dietary modifications in the treatment of 
acne (Sulzberger and Baer, 1948; Belsario, 1951). Most advised against the excessive consumption of 
fat and carbohydrates, targeting foods such as chocolates, sweets, and carbonated beverages 
(Sulzberger and Baer, 1948; Belsario, 1951). However, apart from anecdotal accounts and case 
reports, little evidence could support the removal of such items from the diet (Cornbleet and Gigli, 
1961; Rasmussen, 1977). Twenty years later, dietary advice was removed from standard texts and the 
consensus has since been that diet plays no role in the development of acne.  
 
The most frequently cited reference dissociating diet and acne was the study by Fulton et al (1969), 
which has since been widely criticised for its design and mode of evaluating acne (Mackie and 
Mackie, 1974; Rasmussen, 1977; Cordain, 2003; Treloar, 2003). This study compared the effects of a 
chocolate versus a placebo bar in a crossover double-blind study (Fulton et al., 1969). After examining 
the data, the authors concluded that ―ingestion of high amounts of chocolate did not materially affect 
the course of acne vulgaris‖ (Fulton et al., 1969). However, a review of this work, found no real 
difference in the lipid and sugar contents of the two bars (Mackie and Mackie, 1974). Furthermore, the 
fatty acid composition of the hydrogenated fat in the placebo was very similar to that of cocoa butter 
(Mackie and Mackie, 1974). The authors described the chocolate study as ―incorrectly controlled‖, 
stating that the results were ―not valid‖.   
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Two years later, a study involving US college students set out to examine whether certain foods 
aggravate or worsen acne. Twenty-seven students consumed the culprit foods everyday for a week and 
returned daily to an outpatient clinic to be examined. No major flares of acne were observed. 
However, if aetiological mechanisms are to be suspected, it is unlikely that they would produce a 
clinical response given the study‘s short-duration. Recently, Treloar (2003) also questioned the 
validity of the study design, the small sample size and the absence of baseline dietary information.  
 
There is no compelling scientific evidence to indicate that individual foods cause acne, and the 
established medical view is that ―diet plays no role in acne treatment in most patients‖ (Kaminester, 
1978). However, this advice is based upon these poorly controlled studies which focus on individual 
foods and fail to consider the influence of other dietary factors. No food has been identified as single 
cause of other Western diseases, such as diabetes, atherosclerosis and cardiovascular diseases, which 
are now accepted as nutritionally-related disorders. In fact, for many years opponents disregarded diet 
as a causative factor in heart disease, as dietary histories failed to predict serum cholesterol levels or 
coronary heart disease mortality (Kannel and Gordon, 1970; Nichols et al., 1976; Rosenberg and Kirk, 
1981). However, characterising the role of various dietary factors (eg. saturated fat, glycaemic index 
and fibre) and their physiological effects has since increased our understanding of their impact on 
cardiovascular disease health (Reaven, 1995; Kris-Etherton et al., 2002; Ludwig, 2002; Cordain et al., 
2005). When one compares the wealth of literature on the ‗diet-heart‘ theory with that of the acne, it is 
clear the nutritional research into acne is still very much in its infancy. 
 
1.3.1 Nutrition and diseases of the West 
In most Western countries, diet-related chronic diseases represent the single largest cause of morbidity 
and mortality. As diseases such as type 2 diabetes, cardiovascular disease and obesity reach epidemic 
proportions in Western nations, they remain rare in non-industrialised or less Westernised 
communities (Eaton et al., 1988; Lindeberg et al., 2003b; O'Keefe and Cordain, 2004). Extensive 
pathophysiologic research has identified many environmental and dietary factors that are influential in 
disease aetiology, including caloric intake, tobacco use, physical inactivity, glycaemic load, fibre 
intake, fatty acid composition, macronutrient composition and salt intake (Eaton et al., 1988; Cordain 
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et al., 2005). Altogether, these diet and lifestyle factors along with genetic susceptibility may provide 
a complex interaction in the pathophysiology of Western disease. Therefore, from our current 
understanding of nutrition it is unlikely that acne would arise from the excessive consumption of 
single foods, but rather a complex interaction of many dietary/lifestyle factors as do other non-
communicatable diseases. 
 
It has recently been proposed that diets consumed by non-Westernised societies may serve as models 
for protection against acne. Researchers have previously explored the diet-acne connection by 
reporting the emergence of acne in Eskimos of Northern America following the adoption of a Western 
lifestyle (Schaefer, 1971; Bendiner, 1974). Acne was virtually absent among the Eskimo youth as they 
continued to maintain their hunter-gatherer lifestyle (Schaefer, 1971; Bendiner, 1974). The diet of 
Eskimos in earlier times was based almost entirely on animal protein and fat, with land and marine 
animals constituting 80-100% of their food intake (Nestle, 1999). However, when they urbanised and 
were exposed to a high carbohydrate diet, acne became a common and sometimes severe problem. 
Although the primary determinant for the increased acne incidence is unknown, the Eskimos 
reportedly blamed the increased sugar consumption for the appearance of acne (Schaefer, 1971). In 
addition to acne, other common Western diseases also emerged, including dental caries, obesity, 
diabetes and heart disease (Schaefer, 1971; Bendiner, 1974).  
 
Cordain et al (2001) recently proposed that freedom from acne was related to the differences in the 
digestibility of carbohydrate in the diet. This concept is supported in their observations of the Ache‘ 
hunter-gatherers of Paraguay and the Kitavan subsistence horticulturists of Papua New Guinea. In over 
1300 subjects (aged 15-25yr), not a single case of acne was reported. The Kitavan and Ache societies 
ate foods such as low glycaemic index (GI) tubers, fruits, fish and coconut and locally cultivated foods 
(sweet manioc, peanuts, maize and rice) (Cordain et al., 2002). They were also more physically active 
than their Western counterparts and did not show any signs or symptoms of other chronic Western 
diseases, such as diabetes and/or cardiovascular disease (Lindeberg et al., 1999). The authors attribute 
the absence of acne to environmental factors, mainly local diets, which are devoid of high GI 
carbohydrates. They also argued that genetic factors are not wholly responsible for the observed 
CHAPTER ONE 7 
 
 
differences, as other South American Indians and Pacific Islanders, who share similar ethnic 
backgrounds, have higher levels of acne when consuming a Western diet (Cordain et al., 2002).  
 
Epidemiologists have defined the primary cause of disease, as not one in whose presence disease will 
always occur, but as one in whose absence disease will not occur (Rosenberg and Kirk, 1981). In line 
with this concept, Cordain et al (2001) attributed the absence of acne to a diet devoid of high GI 
carbohydrates. However, there are many factors that dissociate traditional human diets from those of 
the Western civilisations. Consequently, this review attempts to identify dietary elements that are 
pervasive in Western societies, but remain rare or unfamiliar to traditional societies.  
 
1.3.2 Glycaemic index and glycaemic load 
Cordain et al (2001) observed that the carbohydrates eaten by the Ache and Kitavan societies were 
uniformly low in GI, which is a relative scale used to determine the blood glucose-raising potential for 
a given sample of food containing 50g of available carbohydrate (Jenkins et al., 2002). By definition, 
high GI carbohydrates are rapidly digested, producing rapid, high concentrations of blood glucose and 
increasing insulin demand. In contrast, low GI carbohydrates are slowly digested and absorbed during 
the postprandial period. It is thought that the use of low GI foods in traditional cultures may play a 
protective role against Western disease. This notion is supported by the observed high rates of type 2 
diabetes in the Pima Indians and Australian aborigines for whom the dietary transition to high GI 
foods has been a fairly recent phenomenon (Thorburn et al., 1987; Boyce and Swinburn, 1993; 
Colagiuri and Brand-Miller, 2002).  
 
A unifying feature of traditional diets is that they are naturally low in glycaemic load (GL). As the GI 
can only be used to compare foods of equal carbohydrate content, the GL was developed to 
characterise the glycaemic effect of meals or diets of differing macronutrient composition. The GL 
takes both the quantity and quality of carbohydrate into consideration and is calculated as GI  
carbohydrate content per serve. The Eskimo‘s diet, which was traditionally high in protein and fat with 
minimal carbohydrate, would have been low in GL due to the limited availability of carbohydrate 
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(Schaefer, 1971). Conversely, the Ache and Kitavan diets were high in carbohydrate (>60% total 
energy), but low in GL due to exclusive consumption of low GI foods.  
 
There is suggestive evidence that the GL of Western diets has increased over recent years. Studies of 
dietary trends between 1989-1996 and 1971-2000 in the US indicate that carbohydrate intake has 
increased (Cavadini et al., 2000; Wright et al., 2004). The increase in carbohydrate consumption is 
thought to be a consequence of dietary recommendations to decrease dietary fat (Slyper, 2004). 
Several studies have demonstrated that a reduction in dietary fat is invariably associated with 
increased consumption of simple sugars (Gibney, 1990; Nicklas et al., 1992). Slyper (2004) also 
suggested that the overall dietary GI has increased in children‘s diet over the last few decades. There 
have been significant increases in the consumption of high GI foods, such as ready-to-eat cereals 
(Nicklas et al., 1998), potatoes (Cavadini et al., 2000), soft drinks (Troiano et al., 2000), and salty 
snacks (Nielsen et al., 2002), with considerably more foods being consumed outside the home 
(Nielsen et al., 2002). A high carbohydrate diet, based on rapidly digestible carbohydrates, would 
repeatedly expose individuals to acute elevations in blood glucose and insulin. Cordain et al (2001) 
proposed that diet-induced hyperinsulinaemia may elicit an endocrine response that simultaneously 
promotes follicular epithelial growth and enhanced sebaceous gland activity – two factors responsible 
for acne proliferation. Therefore, it is possible that a high dietary GL may account for higher 
prevalence of acne in Western societies. 
 
1.3.3 Essential fatty acids  
There is evidence to suggest that essential polyunsaturated fatty acids (PUFA) also play a role in acne 
pathogenesis (Logon, 2003). Of particular importance is the dietary balance of two series of PUFA: 
the omega-6 (which are generally proinflammatory) and the omega-3 fatty acids (which are anti-
inflammatory with several intrinsic cardioprotective effects). In Western diets, the ratio of omega-
6/omega-3 fatty acids is generally high (of the order 20:1), due to a high intake of vegetable oils and 
consumption of grain-fed livestock (Cordain et al., 2005). High intakes of omega-6 is known to 
increase levels of lipid inflammatory mediators, such as leukotrienes and prostaglandins, and this can 
have adverse effects on skin disorders (Horrobin, 2000; James et al., 2000). Lindeberg et al (2003a) 
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previously described the lower intake ratio of omega-6/omega-3 PUFA in the Kitavan population 
compared with Western populations and a low intake ratio (approximately 2:1) is also a characteristic 
feature of hunter-gatherer societies such as the Ache‘ population (Simopoulos, 1999). Consequently, 
the lower dietary ratio of omega-6/omega-3 PUFA may also help to explain the absence of acne in 
traditional societies.  
 
1.3.4 Dairy intake 
Another distinguishing feature of traditional diets is the absence of dairy foods (Cordain, 2003). A 
recent retrospective evaluation of dairy intake revealed a positive association between milk intake 
(total and skim) and physician-diagnosed severe acne (Adebamowo et al., 2005). The authors suggest 
that hormonal constituents of milk (estrogens, androgen precursors and IGF-I) are present in sufficient 
quantities to exert biological effects on the hormone-sensitive pilosebaceous units. However, whether 
IGF-I can retain its bioactivity and be protected from proteolysis in the gut is still uncertain. The 
intestinal absorption of milk-borne IGF-I is negligible in animals, however no such trials have been 
demonstrated in humans (Burrin, 1997; Donovan et al., 1997). Furthermore, androgen intake from 
milk is very low (0.06% of circulating testosterone is from milk) and these estimated intakes could be 
further reduced by androgen metabolism in the liver (Adebamowo et al., 2005). However, another 
possible explanation is the highly insulinotropic nature of dairy products (Holt et al., 1997; Liljeberg 
Elmståhl and Björck, 2001; Östman et al., 2001). Dairy products have a 3- to 6- fold greater insulin 
response compared with foods with similar GI values (Östman et al., 2001). Therefore, it is possible 
that the absence of dairy foods in traditional societies may also play a role in the negligible acne seen 
in these societies. 
 
1.4 INSULIN RESISTANCE AND HYPERINSULINAEMIA 
An important factor differentiating diets of more traditional societies from that of the West is that 
several Western dietary components (GI, carbohydrate intake, dairy foods) have the potential to lead 
to postprandial hyperinsulinaemia. However, hyperinsulinaemia can also be a function of the body‘s 
reduced sensitivity to plasma insulin. When peripheral tissues become resistant to the insulin-mediated 
uptake of glucose, clinically defined insulin resistance occurs. Hyperinsulinaemia is commonly 
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coupled with insulin resistance, as more insulin is required to overcome tissue insensitivity so one can 
remain in a euglycaemic state (Livingstone and Collison, 2002). The development of impaired glucose 
tolerance or type 2 diabetes marks a failure of the pancreas to maintain euglycaemia and blood glucose 
begins to rise in a pathological fashion (Cordain et al., 2003). Several factors are known to influence 
insulin resistance including age, physical fitness, obesity, genetics and foetal or infant malnutrition 
(Liese et al., 1998; Reaven, 1998).  
 
Colagiuri and Brand Miller (2002) hypothesised that insulin resistance may have provided survival 
and reproductive advantages to our ancestors who were genetically adapted to a carnivorous-type diet. 
In their natural environment, it is thought that insulin resistance would facilitate the deposition of food 
energy as body fat in preparation for times of food scarcity (―thrifty genotype‖) (Neel, 1962). Insulin 
resistance would not have resulted in compensatory hyperinsulinaemia with the consumption of a high 
protein, low carbohydrate diet (Colagiuri and Brand-Miller, 2002). Although the introduction of 
agriculture over the last 10,000 years has caused a progressive and rapid dietary replacement of 
protein with carbohydrate, these carbohydrates were mostly low in GI (Colagiuri and Brand-Miller, 
2002). The advent of milling processes to refine cereals with the industrial revolution made starch 
more digestible, increasing the postprandial glucose and insulin responses 2-3 fold compared to coarse 
or unrefined grains (Brand et al., 1985; Heaton et al., 1988; Colagiuri and Brand-Miller, 2002). The 
consequence of this last dietary transition was that insulin resistance became associated with 
significant hyperinsulinaemia, a combination which plays a role in several chronic disease states 
(Reaven, 1998). 
 
High GL load diets have been implicated in the deterioration of insulin sensitivity and the decline in β-
cell function which are critical to the development of type 2 diabetes (Brand-Miller, 2004). Several 
epidemiological and prospective studies have demonstrated an association of type 2 diabetes with high 
GL diets (Salmeron et al., 1997a; Salmeron et al., 1997b; Schulze et al., 2004). However, examining 
the effect of diet on insulin resistance is difficult because many other factors influence insulin action 
and it often goes undiagnosed until it reaches the advanced diabetic stage. An important principle in 
endocrinology is that of receptor down-regulation. A diet which persistently elevates insulin 
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concentrations may be expected to downregulate insulin receptors, thereby resulting in insulin 
resistance (Virkamaki et al., 1999). Feeding rats a high GL diet (high in glucose or amylopectin) has 
been shown to induce rapid and severe insulin resistance when compared to a low GL diet (high in 
amylose) (Byrnes et al., 1994; Higgins et al., 1996). Furthermore, evidence suggests that high GI 
foods may also affect insulin resistance through pathophysiologic mechanisms related to increases in 
free fatty acids (Boden et al., 1991; Piatti et al., 1991) and other obesity-related factors (eg. 
hyperphagia and fuel partitioning) (Brand-Miller et al., 2002). 
 
1.4.1 Metabolic syndrome 
Insulin resistance and its compensatory hyperinsulinaemia are central to a number of metabolic 
abnormalities which are collectively termed ‗metabolic syndrome‘ (Reaven, 1998). This syndrome is 
characterised by conditions of disturbed glucose and insulin metabolism, obesity, intra-abdominal fat, 
mild dyslipidaemia, hypertension and the subsequent development of type 2 diabetes and/or 
cardiovascular disease. However, the clinical consequences extend far beyond the realm of risk factors 
associated with type 2 diabetes and cardiovascular disease. Other maladies include cutaneous 
papillomas (skin tags), ancanthosis nigricans, myopia, polycystic ovarian syndrome and certain 
cancers (breast, colon and prostate) (Cordain et al., 2003). Cordain et al. (2003a) recently proposed 
that insulin resistance may also play an underlying role in acne pathogenesis. 
 
1.4.2 Evidence of the association between insulin resistance and acne vulgaris 
The link between acne and insulin resistance is not entirely unfamiliar, as acne is a clinical feature of 
polycystic ovarian syndrome (PCOS), a condition which affects women and is associated with insulin 
resistance, hyperinsulinaemia and hyperandrogenism (Falsetti et al., 2002). Treatments for PCOS now 
includes insulin-sensitising drugs, which improve insulin sensitivity, restore fertility and alleviate acne 
(Kolodziejczyk et al., 2000; Harborne et al., 2003). Pharmacologic approaches to slow down 
carbohydrate absorption, notably with the use of –glucosidase inhibitors, have also demonstrated 
significant improvements in acne in PCOS (Ciotta et al., 2001). This tends to suggest that reducing the 
rate of carbohydrate absorption per se may help to ameliorate acne. However, whether the 
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consumption of natural unrefined, slow-release carbohydrates can achieve the same outcome remains 
unknown. 
Disturbances in glucose metabolism were traditionally thought to be associated with acne. Numerous 
studies explored the relationship between fasting hyperglycemia and acne (Levin and Kahn, 1922; 
McGlasson, 1923; Strickler and Adams, 1932), however support for this relationship was inconsistent. 
Likewise, the results from glucose tolerance tests tended to be variable, often with unexplained 
variations from normal (Rost, 1932; Cornbleet and Gigli, 1961) to borderline (Greenbaum, 1930) to 
reduced tolerance (Semon and Herrmann, 1961). However, these studies looked at glucose 
concentrations at specific time points without any reference to insulin. This could have been a 
significant limitation as glucose tolerance is, in part, determined by sensitivity of peripheral tissues to 
insulin. This is supported by a more recent study which found the glucose response profile to be 
similar in acne patients and non-acne sufferers, however the total insulin response (Figure 1) was 
significantly greater in acne patients (Aizawa and Niimura, 1996). The authors observed that the 
relationship between acne and hyperinsulinaemia was independent of obesity and menstrual 
irregularities. 
  
 
13 
 
Figure 1.1.  Mean insulin and glucose concentrations during a 75g OGTT in women with postadolescent acne versus controls without acne.  Controls were 
matched for BMI and age and acne sufferers were otherwise healthy with no menstrual irregularities (Adapted from Aizawa and Niimura, 1996). 
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1.5 CHANGES IN THE HORMONAL MILIEU OF PUBERTY 
Acne is a complex disease due to the interplay of hormones that control the pilosebaceous unit, with 
the pituitary as the driving factor due to its influence on androgen production and hence sebum 
production. However, it is unlikely that androgens are operating alone. For although the androgen 
dependency of sebaceous glands is unequivocal, most acne patients have normal concentrations of 
plasma androgens (Lucky et al., 1997). Furthermore, it is not known why acne typically subsides in 
the late teenage years, when androgen levels remain stable throughout adulthood (Rosenfield et al., 
2000). The evolution of acne more closely resembles the transient changes in insulin-stimulated 
glucose metabolism during puberty.  
 
1.5.1 Insulin resistance of puberty  
This pattern of pubertal development is normally associated with a transient increase in insulin 
resistance, with insulin stimulated glucose uptake decreased compared with adults and prepubertal 
children (Bloch et al., 1987; Moran et al., 1999). Previous studies using the euglycaemic insulin clamp 
have shown that the pattern of increasing insulin resistance begins during early puberty and increases 
across all Tanner stages (Amiel et al., 1986; Moran et al., 1999). According to cross-sectional 
observations, acne begins about the same time as the gradual increase in plasma insulin, the 
preadolescent rise in body mass index (BMI), and the increase in IGF-I serum levels (Caprio et al., 
1989; Smith et al., 1989). Although causality has not been proven, there is indirect evidence to suggest 
that these metabolic changes during puberty may exaggerate factors involved in acne development. 
 
The mechanism behind the metabolic deterioration in glucose control is unclear. Some studies suggest 
that the observed increase in body fat during puberty may contribute to the decrease in insulin 
sensitivity (Bloch et al., 1987; Hoffman et al., 2000). However, body fat increases occur prior to and 
post puberty, whereas the fall in insulin sensitivity is transient (Goran and Gower, 2001). Furthermore, 
other studies have shown that the relative fall in insulin sensitivity is not associated with changes in 
body fat (Moran et al., 1999). Alternatively, pubertal insulin resistance may be driven by transient 
changes in growth hormone levels during puberty. Growth hormone (GH) pulse amplitude is highest 
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during mid-late puberty, reflecting an inverse relationship with pubertal changes in insulin sensitivity 
(Amiel et al., 1986; Moran et al., 2002). This increase in GH may contribute to insulin resistance via 
GH‘s effect on increasing lipolysis and free fatty acid concentrations (Goran and Gower, 2001). This 
is further supported by the fact that GH-deficient children have higher insulin sensitivities (Merimee et 
al., 1967) and as GH treatment in GH-deficient adults results in the development of peripheral insulin 
resistance (Bramnert et al., 2003). 
1.5.2 Pubertal insulin resistance facilitates the effects of IGF-I 
The observed pubertal change in insulin sensitivity may facilitate the growth promoting effects of the 
insulin-like growth factor (IGF) system. IGF-I plays an important role in stimulating cell proliferation 
and differentiation in a variety of tissues, as well as inhibiting cell apoptosis (Kaaks et al., 2000). 
Serum IGF-I levels increase with advancing puberty and are associated with linear growth during this 
period (Rosen, 1999; Juul, 2003). GH, insulin and nutritional status (eg.caloric deprivation or excess) 
can all influence IGF-I production. GH stimulates the hepatic secretion of IGF-I and insulin enhances 
production by up-regulating GH receptor numbers (Lewitt, 1994; Thissen et al., 1994). Nutritional 
status is also a critical regulator of IGF-I, as caloric restriction substantially lowers IGF-I levels 
(Thissen et al., 1994; Giovannucci et al., 2003). Although GH levels are increased during fasting, 
IGF-I secretion is reduced due to hepatic GH resistance (Merimee et al., 1982). Caloric excess may 
increase IGF-I, but the effect of over-consumption is not nearly as strong as caloric restriction 
(Thissen et al., 1994). 
Insulin is also able to modulate the physiological effects of IGF-I through its influence on IGF-binding 
proteins (IGFBPs). The actions of IGFBPs can oppose those of IGF-I by binding to IGF-I, thus 
reducing its biological activity. IGFBP-1 plays an integral role in controlling free IGF- I and studies 
have shown that IGFBP-1 is a potent inhibitor of IGF-I effects in vivo (Clemmons, 1997). IGFBP-1 
concentrations decrease during puberty and follow a close negative association with the rise in insulin 
resistance (Ibáñez et al., 1997; Moran et al., 2002). Insulin is the principle determinant of plasma 
IGFBP-1 levels and postprandial insulin can dramatically inhibit hepatic production of IGFBP-1 
(Powell et al., 1991). Conditions associated with elevated IGFBP-1 levels include the fasting state 
CHAPTER ONE 16 
 
 
(Cotterill et al., 1993), exercise (Suikkari et al., 1989) and poorly controlled insulin-dependent 
diabetes mellitus (Batch et al., 1991). Travers et al. (1998) found an inverse relationship between 
IGFBP-1 levels and BMI in early pubertal children and suggested that this is most likely due to the 
positive association between BMI and insulin resistance (Travers et al., 1998).  
 
1.5.3 Insulin and IGF-I modulate androgenic activity  
Insulin and IGF-I have been implicated in reproductive development through the activation of the 
hypothalamic-pituitary-gonadal axis (Burcelin et al., 2003; Daftary and Gore, 2003). Homeostatic 
mechanisms related to sex steroid concentrations control the hypothalamic-pituitary-gonadal system 
through negative feedback. However, in cases of hyperinsulinaemia (eg. PCOS), there is exaggerated 
secretion of the gonadotropin, luteinizing hormone, suggesting an underlying hypothalamic defect and 
abnormal feedback sensitivity (Dunaif, 1997). Insulin resistance and hyperinsulinaemia may play a 
role in the genesis of this syndrome either through the direct effects of insulin or through insulin‘s 
ability to promote free IGF-I (Franks, 2002). IGF-I can increase gonadotropin releasing hormone 
(GnRH) mRNA expression (Zhen et al., 1997) and the maturation of GnRH-expressing neuronal cells 
of the hypothalamus (Olson et al., 1995), which may affect luteinizing hormone secretion from the 
pituitary. Insulin can also stimulate the secretion and expression of GnRH by hypothalamic neurons in 
culture (Burcelin et al., 2003). Burcelin et al. (2003) noted that peripheral administration of insulin 
and the resultant hyperinsulinaemic state stimulated reproductive activity in intact peripubertal 
animals, (Burcelin et al., 2003). Furthermore, improvements in insulin sensitivity with weight loss in 
overweight infertile women can decrease luteinizing hormone secretion and serum androgen 
concentrations (Burcelin et al., 2003).   
 
Insulin and IGF-I can also play a role in the tempo of the pubertal development through augmenting 
the bioavailability of sex steroids. During puberty, androgen levels rise, with testosterone being the 
biologically important extracellular androgen. Testosterone bioavailability is dependent on the serum 
concentration of the high-affinity binding protein known as sex-hormone binding globulin (SHBG) 
(Franks, 2003). Only free testosterone is biologically available to enter target tissues. Traditionally, 
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sex steroids were thought to be the major regulators of SHBG, but recent data suggest that nutritional 
factors, mediated by insulin, are more important in determining SHBG levels (Anderson, 1974; 
Franks, 2003). During puberty, hepatic production of SHBG declines simultaneously with the fall in 
insulin sensitivity (Holly et al., 1989). Girls who experience early menarche have significantly lower 
SHBG levels from 10-15.9yr compared to girls with later menarche (Holly et al., 1989). During 
puberty, serum SHBG concentrations are negatively associated with height and the degree of obesity 
(Holly et al., 1989). IGF-I also inhibits SHBG secretion (Singh et al., 1990; Crave et al., 1995), which 
coincides with the inverse association of total IGF-I and SHBG during puberty. However, SHBG 
levels are more closely associated with IGFBP-I, suggesting that a common mechanism regulates both 
binding proteins. Low levels of SHBG are associated with conditions of insulin resistance including 
obesity (Crave et al., 1995) and PCOS (Vermeulen et al., 1996) and similar observations have been 
made for IGFBP-1 (Thierry Van Dessel et al., 1999). 
 
Insulin resistance is also an underlying feature of premature adrenarche, a condition which is 
predictive of later onset of acne (Miller et al., 1996). Adrenarche refers to the pre-pubertal rise in the 
secretion of the adrenal steroids, DHEA, DHEA-S and androstenedione (Saenger and Dimartino-
Nardi, 2001). Premature adrenarche is associated with higher levels of adrenal androgens than 
expected for age and is clinically diagnosed as having pubic hair at <8yr (Ibáñez et al., 2000). Insulin 
resistance and hyperinsulinaemia are commonly associated with premature adrenarche (Oppenheimer 
et al., 1995; Vuguin et al., 2001; Denburg et al., 2002), which suggests that insulin has an important 
role in normal adrenarche. Insulin and IGF-I receptors have been identified in the adrenal cortex and 
both can stimulate adrenal androgen production in human adrenocortical cells in vitro (Endoh et al., 
1996; Fottner et al., 1998). Therefore, it is possible that insulin and IGF-I may act as nutritional 
signals in the modulation of adrenal androgen production in vivo. 
 
As dietary trends of adolescents continue to favour high glycaemic foods, the fall in insulin sensitivity 
during puberty could predispose individuals to significant hyperinsulinaemia. This, in turn, can affect 
a multitude of hormonal changes (Figure 1.2) that occur prior to and during puberty: (i) sex steroid 
production, by amplifying GnRH; (ii) SHBG production by the liver; (iii) adrenal androgen 
CHAPTER ONE 18 
 
 
production; (iv) circulating IGF-I levels; and (iv) IGFBP-1 production. These shifts in endocrine 
systems may provide the hormonal stimuli for events leading to the development of acne. 
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Figure 1.2: The combined effect of a high GL diet and pubertal insulin resistance on endocrine 
systems. As dietary trends of adolescents continue to favour high glycaemic foods, the fall in insulin 
sensitivity during puberty may be accompanied by significant hyperinsulinaemia. This may be 
facilitated by GH‘s effect on insulin sensitivity during puberty. The subsequent increase in plasma 
insulin levels may in turn encourage the growth promoting effects of the IGF-I by decreasing levels of 
IGFBP-1. Moreover, insulin may stimulate androgenic effects of sex hormones by decreasing SHBG 
levels and increasing sex steroid production through an increase in GnRH.
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1.6 EXPLORING THE LINK BETWEEN NUTRITIONAL FACTORS AND ACNE 
PATHOGENESIS 
Over the past thirty years, clinical research has characterised many of the physiological processes and 
immunological reactions involved at each stage of acne development. A better understanding of the 
disease at the biochemical level has helped to elucidate a possible role of nutritionally-related factors 
in acne aetiology. For example, there is now extensive clinical and experimental evidence to suggest 
that sex steroids and insulin interact in their actions on tissues. As discussed previously, insulin can 
also affect the changing hormonal milieu of puberty. Therefore, insulin may play a direct or indirect 
(via endocrine systems) role in the underlying molecular and non-inflammatory mechanisms involved 
in acne development. Furthermore, other nutritional factors (eg. proinflammatory fatty acids) may also 
influence the secondary inflammatory mechanisms that lead to the presentation of inflammatory acne. 
The following section attempts to illustrate how these nutritionally-related factors could play a role at 
each stage of the disease process.  
 
1.7 SEBACEOUS GLAND DEVELOPMENT AND SEBUM PRODUCTION  
The initial phase in the pathogenesis of acne is the androgen-induced enlargement of the sebaceous 
glands and increased production of sebum (Toyoda and Morohashi, 2001). Androgens are the major 
sebotrophic hormones and sebaceous glands are very sensitive to androgens whereas estrogens exhibit 
an inhibitory effect (Toyoda and Morohashi, 2001). Hormonal control of sebaceous gland function is 
complex and various factors influence sebaceous gland function such as androgen production, 
androgen bioavailabilty, peripheral androgen utilisation, or androgen receptor sensitivity (Figure 1.3). 
Furthermore, sebocyte proliferation and differentiation is also influenced by GH, IGF-I, and insulin 
(Shaw, 2002). 
  
 
Figure 1.3: Important factors in cell proliferation and differentiation of sebocytes. Several biochemical factors are important for the proliferation and 
differentiation of sebocytes. Sebocyte growth is stimulated by androgens, IGF-I and insulin whereas differentiation is influenced by androgens, GH, insulin and fatty 
acids. Abnormal expression of one or more of these factors could lead to the development of sebaceous hypertrophy associated with acne.  
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1.7.1 Androgen production and bioavailability 
Androgens, such as dehydroepiandrosterone (DHEA), androstenedione (A-dione) and testosterone, 
have a stimulatory effect on sebocyte differentiation and sebum production (Diamond et al., 1996; 
Brown and Shalita, 1998; Fritsch et al., 2001). However, patients with acne do not typically exhibit 
elevated serum levels of androgens (Gollnick et al., 2003). Although elevated serum androgens 
correlate with cystic acne, androgen levels are normal in mild-moderate cases (Marynick et al., 1983; 
Levell et al., 1989). The principal androgen to exert biological effects is testosterone which may be 
locally converted to the more active 5 -dihydrotestosterone (DHT) by 5 -reductase (Gollnick, 2003). 
Acne has been shown to correlate better with serum levels of bioavailable testosterone, rather than to 
total testosterone. Patients with acne frequently demonstrate lower levels of SHBG and higher levels 
of free testosterone compared with controls (Olind et al., 1982; Marynick et al., 1983; Slayden et al., 
2001). It is thought that high testosterone levels, coupled with low SHBG levels, during puberty 
produces a maximum stimulatory effect on the sebaceous glands (Olind et al., 1982). However post-
puberty, in later teenage years, SHBG increases and testosterone levels plateau followed by general 
acne improvement (Olind et al., 1982). 
 
1.7.2 End-organ androgen metabolism 
The peripheral conversion of androgen precursors to active androgens may also play a role in acne 
development. Androstenedione and DHEA-S are androgenic by means of their conversion to 
testosterone or DHT and sebocytes express all the steroidogenic enzymes required for their conversion 
(Figure 1.4) (Labrie et al., 2000; Chen et al., 2002). The androgenic precursors traverse the cell 
membrane of sebocytes where they can be converted to active androgens prior to binding to the 
androgen receptor (Barth and Clark, 2003). Although DHEA does not possess any intrinsic androgenic 
activity, plasma levels provide a large reservoir of substrate for its conversion in the peripheral 
intracrine tissues (i.e. sebaceous glands, hair follicles and sweat glands) (Labrie et al., 2000). The term 
‗intracrinology‘ has been used to describe the process where action and synthesis occur within the 
same peripheral cell (Labrie, 1991). The intracrine actions of DHEA can increase sebum output, acne 
and/or some hair growth following the topical application or oral administration of DHEA (Diamond 
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et al., 1996; Morales et al., 1998). Furthermore, lowering of elevated DHEA-S levels in patients with 
cystic acne results in remission of acne in most instances (Morales et al., 1998).    
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Figure 1.4: Pathways of cutaneous androgen metabolism in the sebaceous glands. Schematic 
representation illustrating the steroidogenic enzymes involved in the intracrine pathways. Weak 
androgens, such as DHEA-S, may be metabolised to form active hormones (testosterone and DHT), 
which exert their action in the same cells where synthesis took place (Adapted from Chen et al, 2002). 
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1.7.3 Growth hormone 
Studies using the rodent preputial gland, which is comprised primarily of sebocytes, suggest that GH 
works in combination with androgens to stimulate gland activity (Laurent et al., 1992). When 
castrated rats were given testosterone, the preputial glands became larger, but this effect was lost in 
hypopituitary-castrated rats, where GH production was limited (Ebling, 1957). The response to 
testosterone could only be fully restored when bovine GH was administered (Ebling et al., 1975). This 
suggests that testosterone requires the presence of GH to exert its stimulatory effect. Furthermore, GH 
can stimulate sebocyte differentiation in a dose dependent fashion (Deplewski and Rosenfield, 1999). 
In humans, excess sebum output is a characteristic feature of acromegaly, a condition of elevated GH 
levels (Burton et al., 1972). In contrast, individuals who are GH deficient have extremely low sebum 
secretion rates (Goolamali et al., 1973). 
1.7.4 Insulin like Growth Factor (IGF-I) and androgenic activity 
IGF-I is a potent stimulator of sebocyte proliferation in vitro, but with little effect on sebocyte 
differentiation (Deplewski and Rosenfield, 1999). It has been localised in the highly mitotic basal cells 
of sebaceous preputial glands, with labelled IGF-I being detected in the periphery of the gland 
(Hansson et al., 1988). Serum levels of IGF-I in women with postadolescent acne have been shown to 
be significantly higher than those of controls (Aizawa and Niimura, 1995). It is proposed that IGF-1 
may mediate some of the androgen effects on sebaceous glands by up-regulating enzymes responsible 
for local androgen metabolism (Horton et al., 1993). IGF-I has been shown to stimulate 5 -reductase 
activity (Horton et al., 1993), but other groups were unable to confirm this association (Dykstra et al., 
1993). 
1.7.5 Insulin and sebocyte differentiation 
The effects of DHT and GH on sebocyte differentiation are severely attenuated when insulin is not 
present (Deplewski and Rosenfield, 1999). Insulin‘s potentiating affect on GH-induced sebocyte 
differentiation in vitro has been shown to be dose-related (Deplewski and Rosenfield, 1999). High 
doses of insulin are also capable of stimulating sebocyte proliferation in vitro. However, the authors 
proposed that insulin was acting as a surrogate for IGF-I at the observed supraphysiological dose 
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(Deplewski and Rosenfield, 1999). Both insulin and IGF-I may bind to either receptor, but with 
reduced affinity (Ullrich et al., 1986). 
 
A role of insulin in sebaceous gland lipid metabolism has been suggested following the phenotypic 
characterisation of skin of streptozotocin-induced diabetic mice (Sakai et al., 2003). The diabetic mice 
exhibited a significant relative decrease in triglyceride content of the stratum corneum, together with 
an increase in wax/cholesterol esters, thus indicating changes in the lipid metabolism of sebaceous 
glands (Sakai et al., 2003). Insulin is a known regulator of lipid biosynthetic enzymes and is required 
for normal differentiation of adipocytes (Geloen et al., 1989). Adipocyte differentiation bears many 
similarities to sebocyte differentiation in vitro, suggesting that insulin plays a similar role in sebaceous 
lipogenesis (Jensen et al., 1989).   
 
1.8 FOLLICULAR DESQUAMATION AND FACTORS AFFECTING ABNORMAL 
KERATINISATION 
The second important factor in acne development is follicular hyperkeratinisation and the subsequent 
obstruction of sebaceous follicles (Toyoda and Morohashi, 2001). A precursor acne lesion, otherwise 
known as a microcomedone, forms due to abnormalities in the desquamation of ductal keratinocytes. 
The follicle wall of a microcomedone is characterised by a thicker cornified layer, comprised of 
compacted keratinised cells, which appear larger than cells found in normal follicles (Knutson, 1974). 
This altered morphology suggests hyperproliferation of ductal corneocytes/keratinocytes and perhaps a 
premature terminal keratinisation process. Several markers of proliferation (ie. 3H-thymidine labelling 
and keratins 6 and 16) are increased in comedones compared to normal follicles (Hughes et al., 1996). 
Several factors are thought to be involved in the process of comedogenesis, including sebaceous lipid 
composition, androgen concentrations, local cytokine production and the follicular bacterial 
population. Furthermore, histochemical studies have also shown that insulin and IGF-I and their 
receptors play fundamental roles in skin physiology. 
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1.8.1 Insulin and keratinocyte proliferation 
Several lines of evidence suggest an active role of insulin in skin physiology. Extracellular lipids of 
the stratum corneum create the epidermal water barrier, a hydrophobic seal between the internal milieu 
and the outside environment (Rosenfield et al., 2000). The epidermal barrier is vital for normal skin 
functioning and consists of a mixture of lipids that are synthesised in keratinocytes from two-carbon 
units (acetyl-CoA) sourced from carbohydrate catabolism (Elias, 1983; Swope et al., 2001). 
Carbohydrate uptake is regulated primarily by extracellular insulin, which is delivered from the 
plasma in vivo.  
 
Insulin is also an essential component for the growth and maturation of cultured skin substitutes which 
are used as  adjunctive therapy for skin wounds (Swope et al., 2001). In the presence of epidermal 
growth factor, insulin can stimulate the formation of several epithelial layers in culture, producing a 
stratum corneum similar to that of normal skin (Swope et al., 2001). Higher concentrations of insulin 
can sustain keratinocyte proliferation for an extended period of time in vitro and it is thought that the 
glucose supply may be rate limiting to the stimulation of mitosis (Swope et al., 2001).  
 
Insulin resistance and its compensatory hyperinsulinaemia are frequently associated with proliferative 
tissue abnormalities of the skin (ie. acanthosis nigricans, skin tags). Insulin may be involved in the 
pathogenesis of these skin abnormalities despite resistance to its metabolic effects via the insulin 
receptor (Geffner and Golde, 1988). It is thought that these growth abnormalities may be due to 
insulin‘s ability to bind to the IGF-I receptor at high concentrations (Kahn et al., 1976; Geffner and 
Golde, 1988; Neely et al., 1991). Insulin can act as a surrogate for IGF-I as it has approximately 50% 
amino acid homology to the IGFs (Jones and Clemmons, 1995). Increased phosphorylation of the IGF- 
receptor occurs in proliferating and differentiating keratinocytes isolated from IR-KO mice compared 
with wild type mice (Wertheimer et al., 2001). This suggests activation of the IGF-I receptor is 
increased to compensate for the lack of insulin receptor signalling.  
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1.8.2 Insulin like Growth factor (IGF-I) and keratinocyte proliferation 
IGF-I is required to maintain structural and functional integrity of the skin, although its role is not 
completely understood. IGF-I appears to direct its effects towards cell mitogenesis and is necessary for 
basal proliferation of keratinocytes (Rudman et al., 1997). The major source of circulating IGF-I is the 
liver, but IGF-I may also be produced by many cell types of the skin (eg. dermal fibroblasts, epidermal 
melanocytes and differentiated keratinocytes)(Tavakkol et al., 1992; Rudman et al., 1997). It is 
thought that IGF-I may serve as an autocrine/paracrine regulator of local tissue events. IGF-I receptors 
are expressed in basal epidermal keratinocytes, as well as in undifferentiated epithelial cells of the 
follicular infundibulum, sebaceous glands and the hair matrix (Hodak et al., 1996). However, IGF-I 
receptor expression has been shown to extend beyond the basal layer in hyperproliferative skin 
disorders (Hodak et al., 1996).  
 
Excessive IGF-I production has been linked to hyperproliferative skin conditions such as skin tags, 
coarsening of facial features and acanthosis nigricans, similar to elevated insulin levels (Barkan et al., 
1988). Eming et al. (1996) showed that when human keratinocytes, genetically modified to 
overexpress IGF-I, were grafted onto athymic mice, hyperkeratosis and epidermal hyperplasia was 
observed (Eming et al., 1996). Several days after grafting, epidermal structures were several cell 
layers thick and the cornified layer did not exfoliate, indicating that the thickness of the stratum 
corneum increased over time (Eming et al., 1996). The modified epithelia showed increases in the 
expression of the proliferation markers (keratin 16 and  Ki-67) (Eming et al., 1996). IGF-I receptor 
knock-out mice show an abnormally thin and translucent epidermis with a reduced number of hair 
follicles (Liu et al., 1993). Furthermore, IGF-I levels are decreased in the basal keratinocyte layer of 
sampled diabetic skin and that this could result in diminished proliferative activity of the keratinocytes 
(Blakytny et al., 2000). 
 
1.8.3 Androgens 
Androgens may also play a role in the follicular hyperkeratinisation seen in acne. Steroidogenic 
enzymes have been demonstrated in keratinocytes in vitro, thus indicating that these cells can produce 
active androgens via intracrine androgen metabolism (Gingras et al., 2003). Furthermore, 5 -
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reductase activity is different in various anatomical areas of the skin, with infundibulum keratinocytes 
demonstrating greater 5 -reductase activity than the interfollicular epidermis (Thiboutot et al., 1997). 
Comedonal acne correlates with DHEA-S levels before the onset of puberty (Lucky et al., 1994; 
Lucky et al., 1997), which suggests that the intracrine conversion of DHEA-S may be an important 
factor in follicular keratinisation.  
 
1.8.4 Lipids 
The prepubertal increase in sebum production is associated with significant changes in sebum 
composition (Stewart, 1992). Therefore, the critical factor may not be the amount of sebum, but rather 
the sebum composition. It has been suggested that follicles which are prone to acne have a relatively 
low concentration of linoleic acid. An examination of polar lipids from comedones revealed that acyl 
ceramides contain only 6% linoleate among the esterified fatty acids, compared with 45% in normal 
human epidermis (Wertz et al., 1985). Furthermore, levels of linoleic acid normalise following 
treatment with oral isotretinoin or oral antiandrogens (Stewart et al., 1986). It has been suggested that 
these changes may be due to dilutional effect of increasing lipid synthesis per sebocyte (Downing et 
al., 1986). For example, the essential fatty acids, which are derived from the diet, may be diluted in the 
sebum of more active glands, compared to the less active glands. It is suggested that the resultant 
linoleate-deficient sebum bathes the follicular keratinocytes, resulting in disturbed keratinisation of the 
infundibulum and the formation of comedones (Downing et al., 1987).  
 
1.9 BACTERIAL COLONISATION 
Bacterial colonisation of the sebaceous follicle with Propionibacterium acnes (P.acnes), is considered 
to be a major causative factor in the formation of inflammatory lesions. This anaerobic diphtheroid, 
increases by several orders of magnitude when sebaceous follicles become functionally blocked (Eady 
and Bojar, 2001). Therefore, P.acnes colonisation plays a secondary role in acne pathogenesis, as 
significant microbial involvement occurs only after sebum production has increased and comedone 
formation has become established (Bojar and Holland, 2004). P.acnes hydrolyses sebaceous 
triglycerides, consuming the glycerol fraction, while the liberated free fatty acids can have pro-
inflammatory effects (Webster, 2002). The free fatty acids act as irritants and other chemotactic 
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factors released by bacteria can cause further damage and rupture of the follicular wall (Toyoda and 
Morohashi, 2001). Traditionally, antibiotics were used as a first-line therapy for acne, however 
increasing resistance of P.acnes in acne patients and the increasing pool of resistant organisms 
(including Staphylococcus aureus) has since limited their use (Gollnick et al., 2003).  
 
1.10 INFLAMMATION  
The final pathogenic event in acne is the inflammatory reaction, which is triggered by a variety of 
pathological events. Inflamed lesions develop when comedones rupture and extrude their contents into 
the surrounding dermis. Bacteria can contribute to the inflammation by producing cytokines in a 
variety of different ways. Firstly, accumulation of the fatty acid waste products may promote the 
release of interleukin (IL) -1  and tumour growth factor-  from keratinocytes lining the follicle wall 
(Downie et al., 2002). Secondly, P.acnes and its cellular constituents may promote inflammation 
through the classical (involving antibodies) and alternative (naïve host) complement activation 
pathways, thus provoking the release of inflammatory cytokines (tumour necrosis factor (TNF)-  and 
interferon (IFN)- ) (Downie et al., 2002). And finally, P.acnes binds to the toll-like receptor on 
monocytes and neutrophils, leading to the production of multiple cytokines including IL-8, IL-12, and 
TNF- . Hypersensitivity of the host immune response to P.acnes may also explain why some 
individuals are more prone to developing severe inflammatory acne.    
 
A role for lipoxygenases in the pathogenesis of acne has recently provided evidence for a link between 
a dietary intake of pro-inflammatory omega-6 fatty acids and acne. A high omega-6/omega-3 dietary 
ratio can shift the eicosanoid balance in favour of metabolic products from arachidonic acid, 
specifically prostaglandins, thromboxanes and leukotrienes. Several metabolites of arachidonic acid 
(20:4n6), such as prostaglandin E2 (PGE2 ) 12-hydroytetraenoic acid and leukotriene B4 (LTB4) are 
increased in cutaneous disorders, such as psoriasis and atopic dermatitis, and it has been suggested that 
these metabolites may be involved in disease pathogenesis through their pro-inflammatory effects 
(Bjørneboe et al., 1988; Ziboh, 1989; Boelsma et al., 2001). In acne, LTB4 has been shown to induce 
recruitment and activation of neutrophils, monocytes and eosinophils (Zouboulis, 2001). Moreover, 
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LTB4 has been shown to provoke the release of a number of pro-inflammatory cytokines. Treatment of 
acne with an anti-inflammatory agent, which specifically blocks the formation of LTB4, has been 
shown to reduce inflammatory acne by approximately 70% (Zouboulis et al., 2001). These patients 
also showed a decrease in total serum lipids, especially of pro-inflammatory lipids and this reduction 
was found to be directly correlated with the improvement of inflammatory lesions (Zouboulis et al., 
2001). Therefore, dietary supplementation with omega-3 fatty acids may help to decrease 
inflammatory acne through a reduction in the formation of LTB4. 
 
1.11 CONCLUSIONS 
Current scientific opinion generally views diet as one of the many myths associated with acne. 
However, there is little experimental evidence in support of this widely held view. Furthermore, this 
view is based on a limited number of poorly controlled small studies which focused on individual 
foods and failed to examine the diet in its entirety. Given that acne involves of a complex etiology of 
several factors, it seems unlikely that one food could be responsible for its clinical manifestation. 
From our current understanding of nutrition, no single dietary element has been shown to be the cause 
of any other chronic disease. Evidence now suggests that virtually all Western lifestyle diseases have 
multifactorial dietary elements that underlie their etiology, and acne is unlikely to be an exception. 
 
The diets of traditional societies have provided us with some insights into the possible origins of this 
commonplace disorder. Insulinotrophic dietary factors are pervasive in Western societies, but not in 
traditional cultures, and this may explain the absence of acne in these societies. Puberty is normally 
associated with a transient decrease in insulin sensitivity and as modern dietary trends, particularly 
amongst adolescents, favour high GI foods, this fall in insulin sensitivity may be accompanied by 
significant hyperinsulinaemia. This may accentuate the normal endocrine changes of puberty and play 
an underlying role in acne pathogenesis. Insulin has been shown to affect several aspects of puberty, 
including: sex steroid production, by amplifying GnRH secretion; SHBG production by the liver; 
adrenal androgen production; circulating IGF-I levels and IGFBP-1 production. Although causality 
has not been proven, the evidence is highly suggestive that these nutritionally-related factors may be 
involved in the underlying molecular and non-inflammatory mechanisms that lead to comedone 
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formation. Furthermore, the fatty acid composition of the diet may also influence the secondary 
inflammatory mechanisms that lead to the presentation of inflammatory lesions.  
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2.1 ABSTRACT 
Background: Observational evidence suggests that dietary glycaemic load may be one environmental 
factor contributing to the variation in acne prevalence worldwide. 
Objective:  To investigate the effect of a low glycaemic load (LGL) diet on endocrine aspects of acne 
vulgaris. 
Methods:  Twelve male acne sufferers (17.0 ± 0.4 yr) completed a parallel, controlled feeding trial 
involving a 7 day admission to a housing facility. Subjects consumed either a LGL diet (n=7; 25% 
energy from protein and 45% from carbohydrates) or a high glycaemic load (HGL) diet (n=5; 15% 
energy from protein, 55% energy from carbohydrate). Study outcomes included changes in the 
homeostasis model of insulin resistance (HOMA-IR), sex hormone binding globulin (SHBG), free 
androgen index (FAI), insulin-like growth factor-I (IGF-I) and its binding proteins (IGFBP-I and 
IGFBP-3).  
Results:  Changes in HOMA-IR were significantly different between groups at day 7 (-0.57 for LGL 
vs 0.14 for HGL, P=0.03). SHBG levels decreased significantly from baseline in the HGL group 
(P=0.03), while IGFBP-I and IGFBP-3 significantly increased (P=0.03 and P=0.03, respectively) in 
the LGL group.  
Conclusion:  These results suggest that increases in dietary glycaemic load may augment the 
biological activity of sex hormones and IGF-I, suggesting that HGL diets may aggravate potential 
factors involved in acne development.  
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2.2 INTRODUCTION 
Acne pathogenesis is complex, with strong evidence supporting the involvement of increased sebum 
production, abnormal differentiation of skin keratinocytes, bacterial colonisation and inflammation 
(Thiboutot, 1997). Although scientific research has clarified many of the histological and 
immunological processes that characterise acne, the fundamental cause of the disease remains 
unknown. Experimental evidence has shown that androgen hormones are essential for acne 
development (Ebling, 1957; Pochi et al., 1962); however the relationship between acne severity and 
circulating androgen levels has been difficult to prove. Variations in the clinical response to androgens 
suggests that acne development may also be affected by androgen bioavailability, androgenic 
precursors, and androgen receptor sensitivity (Shaw, 2002). Furthermore, acne development can also 
be influenced by other biological factors, including growth hormone, insulin-like growth factor (IGF-
I), and insulin (Shaw, 2002). 
 
It is possible that the expression of acne may be affected by endocrine changes which are closely 
related to the pubertal rise in insulin resistance. The insulin response to glucose loads is increased 
during normal puberty and adolescence, and insulin sensitivity is decreased compared with adults and 
prepubertal children (Bloch et al., 1987; Moran et al., 1999). Insulin can affect the entire androgen 
axis: the pituitary, where it acts as a gonadotrophin amplifier (Adashi et al., 1981); the gonads where 
is stimulates androgen synthesis (Barbieri et al., 1988; Bebakar et al., 1990); the adrenal glands, where 
it stimulates production of androgenic precursors (Kristiansen et al., 1997); and the liver, where it 
inhibits sex hormone binding globulin (SHBG) production (Holly et al., 1989). Insulin can also have 
direct effects on sebum production (Deplewski and Rosenfield, 1999), and can amplify the growth 
promoting effects of IGF-I by inhibiting the production of IGF binding protein-1 (IGFBP-1) (Holly et 
al., 1989). Therefore, it is possible that underlying changes in insulin metabolism may potentiate 
multiple factors involved in acne development. 
 
Strong support for a link between acne and insulin resistance can be found in the high prevalence of 
acne in women with polycystic ovary syndrome (PCOS), a condition associated with insulin 
resistance, hyperinsulinaemia and hyperandrogenism (Dunaif et al., 1989; Franks, 2003). Evidence is 
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accumulating that Western dietary habits contribute to this high risk hormonal profile (Carmina et al., 
2006), but the efficacy of dietary change in altering hormone levels has not been sufficiently 
investigated (Marsh and Brand-Miller, 2005). Treatments for PCOS now includes insulin-sensitising 
drugs or carbohydrate digestion inhibitors, which improve insulin sensitivity, restore fertility and 
alleviate acne (Ciotta et al., 2001; Kazerooni and Dehghan-Kooshkghazi, 2003). 
 
Dietary glycaemic load may be one environmental factor linking acne and hyperinsulinaemia. The 
glycaemic load may be interpreted as a measure of the blood glucose and insulin-raising potential of a 
meal or diet (Brand-Miller et al., 2003). Unlike the glycaemic index (GI), which classifies the 
glycaemic response of carbohydrates on a gram-for-gram basis, the glycaemic load also takes into 
consideration the amount of carbohydrate consumed and is defined as the product of the GI and the 
carbohydrate content. Cordain et al (2001) recently proposed that a high glycaemic load Western diet 
may frequently expose adolescents to significant hyperinsulinaemia and a hormonal cascade that 
favours increased keratinocyte growth and androgen-mediated sebum production (Cordain et al., 
2002). This is supported by the observed low rates of acne among cultures existing on low glycaemic 
load (LGL) traditional diets, comprised of minimally processed plant foods or low amounts of 
carbohydrate (Verhagen et al., 1968; Schaefer, 1971; Cordain et al., 2002). Furthermore, when these 
societies urbanise and become exposed to a high glycaemic load (HGL) diet, acne becomes a common 
and sometimes severe problem (Schaefer, 1971). However, it remains unknown whether reducing 
dietary glycaemic load can alter clinical or endocrine aspects of acne. Therefore, in a controlled 
feeding trial, we investigated the short term effects of altering the dietary glycaemic load on endocrine 
variables associated with acne and insulin resistance. 
 
2.3 METHODS 
2.3.1 Study design  
The experimental protocol followed a parallel, non-randomised feeding trial involving a 7 day 
admission to a temporarily-assigned research facility at Ballarat University (Ballarat, Victoria, 
Australia). The research facility consisted of two separate dormitories, each offering a fully equipped 
kitchen, dining area and accommodation for the overnight housing of subjects. In a well-controlled 
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feeding environment, seven subjects consumed a LGL diet and five consumed a HGL diet for a period 
of 7 days. To ensure optimal control of dietary interventions, subjects were housed and fed in separate 
wards according to their dietary group allocation. At days 0 and 7, a venous blood sample was taken 
after an overnight fast. In addition, capillary blood samples were obtained on day 3 every hour for the 
measurement of blood glucose responses to meals.  
 
The primary endpoints of this study were changes in insulin sensitivity and hormonal markers of acne. 
This study was approved by the Human Ethics Committee of RMIT University and all subjects and 
guardians (if aged <18years) gave informed consent to participate in the study. 
 
2.3.2 Study subjects 
Twelve young males (aged 15-20yr) with mild-moderate acne were recruited from primary care 
physicians, dermatologists and newspaper advertisements. Participants were classified as having acne 
based on self-reported history of persistent acne (acne present on most days for the past 6 months). As 
several patients were recruited from specialists, this study was bound by a duty-of-care to provide non-
harmful treatments to patients seeking medical treatment. It was considered unethical to place referred 
patients on an intervention that could potentially harm or worsen acne severity. For this reason, 
subjects exhibiting milder forms of the disease, who were not actively seeking treatment, were 
recruited as controls. This research was intended as a pilot study for the design of a larger, randomised 
dietary intervention trial. 
 
2.3.3 Dietary intervention 
Dietary glycaemic load was manipulated by means of modification to the amount and type of 
carbohydrate. The LGL diet was achieved by means of a reduction in the amount of carbohydrate and 
by utilising carbohydrates with a lower GI. To maintain energy intakes, the percentage of lost energy 
from carbohydrates was replaced with energy from protein. In contrast, the HGL diet supplied more 
energy from carbohydrates and less from protein, and included foods with a higher GI. The target 
macronutrient composition of the LGL diet was 25% energy from protein, 45% energy from 
carbohydrates and 30% energy from fats and that of the HGL diet was 15% energy from protein, 55% 
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energy from carbohydrates, and 30% energy from fats. For the average subject (age 17, height 177cm, 
weight 69kg), a 7 day menu plan was calculated to meet each diet‘s target macronutrient composition, 
as well as matching for energy (1.16MJ) and the composition of dietary fats (saturated 8%, 
polyunsaturated 7%, monounsaturated 13%) between groups. Main meals were prepared and served 
according to specifications in the planned menu, however subjects were allowed to eat ad libitum 
between meals. Foods were weighed before each meal, and any unconsumed portions were also 
weighed to determine the amount of food consumed. Subjects were instructed to only eat the foods 
provided or prepared within their housing ward during the 7 day trial period. Dietary intakes were 
calculated using Australia specific dietary analysis software (Foodworks, Xyris Software, Highgate 
Hill, Australia).  
 
2.3.4 Calculation of dietary GI and glycaemic load 
The dietary GI and glycaemic load were calculated using the following equations: dietary GI= (GI 
for food item  proportion of total carbohydrate contributed by item), and dietary glycaemic load = 
(GI for food item  its carbohydrate content in grams  100). The GI values used had glucose as the 
reference food and were taken from reference tables (Foster-Powell et al., 2002), and Sydney 
University‘s GI website (Sydney University, date unknown). 
 
2.3.5 Diurnal measurement of capillary blood glucose 
On day 3, blood glucose was measured every hour between 09:00-21:00 to verify differences in 
glycaemic load. Subjects were allowed to engage in light activities (eg. slow walking, easy physical 
work and sitting) during the day of testing, but were restricted from doing any moderate-high intensity 
activities. Capillary blood glucose was measured using the glucose dehydrogenase method (HemoCue 
201+ glucose analyser, Sweden; intra-assay CV = 1.6%). The postprandial glucose responses were 
assessed using the incremental (iAUC) and total (tAUC) area under the glucose curve. iAUC and 
tAUC were geometrically calculated using the trapezoidal method (Wolever and Jenkins, 1986). 
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2.3.6 Acne scoring 
Scaling of acne was performed by a dermatology registrar on day 0 of the study to provide information 
on subject characteristics at baseline. The registrar assessed facial acne occurrence and severity only, 
using the Cunliffe-Leeds lesion count technique (Burke and Cunliffe, 1984). Changes in acne severity 
were not reported as at study outcome due to the short duration of the study and as treatment response 
usually takes several weeks (Gollnick et al., 2003). 
 
2.3.7 Laboratory analyses 
Code labelled serum samples were stored at -20 C for analysis post-study by an independent 
laboratory. Day 0 and day 7 samples for each subject were included in the same assay run to avoid 
inter-assay variability. Serum insulin was measured using a commercially available microparticle 
enzyme immunoassay (Abbott Laboratories, Tokyo, Japan; intra-assay CV: 4.0%). SHBG 
concentrations were assayed with a commercially available radioimmunoassay (Orion Diagnostica, 
Espoo, Finland; intra-assay CV = 2.5%). Total testosterone was measured using solid-phase 
radioimmunoassay (Diagnostic Products, Los Angeles, USA; intra-assay CV: 2.7%). The Free 
Androgen Index (FAI) was calculated as testosterone concentration (nmol/L)  100  SHBG 
concentration (nmol/L). Total IGF-I (intra-assay CV: 2.9 %) and dehydroepidandrosterone sulphate 
(DHEAS, intra-assay CV: 8.1%) were measured using semi-automated Immulite technology 
(Diagnostic Products, Los Angeles, USA). IGFBP-1 and IGFBP-3 were assayed with a non-
commercial radioimmunoassay as previously described (Baxter and Martin, 1986; Baxter et al., 1987). 
An automated Olympus analyser (Melville, USA) was used to measure total cholesterol, high density 
lipoprotein cholesterol and triglyceride levels (intra-assay CV were 1-2% for all tests). Low-density 
lipoprotein cholesterol was calculated by the Friedewald formula (Friedewald et al., 1972). 
 
2.3.8 Insulin sensitivity 
The homeostasis model assessment of insulin resistance (HOMA-IR) was used as a surrogate measure 
of insulin sensitivity. HOMA-IR was calculated as fasting glucose (mmol/L)  insulin ( U/mL)  22.5 
(Matthews et al., 1985).  
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2.3.9 Statistical analysis 
All statistical analyses were performed using SPSS 11.0 for Windows (SPSS Inc., Chicago, Illinois). 
Baseline data and nutritional characteristics were compared between groups using a Mann-Whitney U 
test or an independent-sample t test, depending upon whether or not the data was normally distributed. 
For the primary endpoints, general linear models were used to test for overall treatment differences 
with adjustments made for baseline data. Within group comparisons were performed using the paired t 
test. Changes from baseline are reported as adjusted means and percentages, with statistical analyses 
done for absolute values. P-values less than 0.05 were considered significant. 
 
2.4 RESULTS 
2.4.1 Subjects 
Table 2.1 shows the baseline characteristics according to group allocation. The groups had similar 
baseline characteristics with the exception of acne lesion counts. The LGL group had a greater mean 
number of acne lesions than subjects on the HGL diet. 
 
2.4.2 Dietary composition 
Table 2.2 shows the composition of the mean baseline diet of all subjects and the LGL and HGL diets 
during the trial period. No significant group differences were observed for any dietary variables at 
baseline. During the trial, both diets were significantly different with regards to the dietary glycaemic 
load and dietary glycaemic index. Both diets were also consistent with their target macronutrient 
composition and the composition of dietary fats was comparable. Although subjects were permitted to 
eat ad libitum between meals, energy intake did not differ significantly between the groups. 
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Table 2.1: Baseline characteristics of subjects by dietary group  
Variable LGL group   (n=7) HGL group  (n=5) P
1
 
Age (yr) 16.6  0.5 17.6  0.5 0.18 
Acne lesion count 34.7  5.0 7.2  2.5 0.001 
Weight (kg) 65.4  3.5 75.1  9.3 0.37 
Body Mass Index (kg/m
2
) 20.5  0.6 24.6  2.2 0.15 
Waist circumference (cm) 71.8  2.4 81.5  6.1 0.13 
Fasting glucose (mmol/L) 4.66  0.38 4.68  0.24 0.94 
Fasting insulin (mU/L) 7.91  1.70 8.84  2.01 0.73 
HOMA-IR index 1.67  0.39 1.82  0.40 0.80 
IGF-I (nmol/L) 42.4  4.3 40.6  5.1 0.80 
Testosterone (nmol/L) 20.6  2.1 16.6  2.3 0.23 
SHBG (nmol/L) 26.0  4.0 19.4  3.7 0.27 
Data is expressed as means ± SEM 
1
P value corresponds with an independent-sample t test or Mann-Whitney U test for means  
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Table 2.2: Dietary composition of the LGL and HGL diets at baseline and during the controlled 
feeding period 
Nutrient  
Baseline
1
 Trial period 
(n=13) LGL (n=7) HGL (n=5) P
2
 
Energy, kJ/day 9814  542 10278  912 11574  425
c
 0.30 
Dietary glycaemic index 58.1  1.0 36.0  0.3
c
 71.0  1.4
c
 <0.001 
Dietary glycaemic load 175.7  11.1 93.5  9.2
c
 254.9  10.6
d
 <0.001 
Carbohydrate, % of total kJ 52.1  1.8 44.0  1.0
c
 54.0  2.4 0.001 
Protein, % of total kJ 16.4  1.0 24.1  0.9
c
 15.6  0.4 <0.001 
Total fat, % of total kJ 31.4  1.2 31.0  1.4 30.6  1.8 0.85 
 Fat subgroups, % of total kJ    
 Saturated 13.2  0.6 8.0  0.3
d
 7.7  0.4
d
 0.50 
 Polyunsaturated 4.1  0.3 6.7  0.7
c
 6.7  0.4
e
 0.94 
 Monounsaturated 11.5  0.6 13.6  0.7 13.6  0.9 0.96 
Cholesterol, mg/day 296  28 391  17
c
 200  9 <0.001 
Dietary fibre, g/day 19.3  1.3 31.6  3.9 22.5  2.1 0.16 
Data is expressed as means ± SEM 
1
An independent-sample t test revealed no significant group differences at baseline. 
2
P value corresponds with independent-sample t test  
Significant difference from baseline 
c
(P<0.05), 
d
(P<0.01), 
e
(P<0.001) 
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2.4.3 In vivo verification of dietary glycaemic load 
Figure 2.1 shows the postprandial blood glucose response to meals on day 3. Blood glucose rose to a 
higher peak in the HGL group after each meal. The calculated incremental area under the blood 
glucose curve (iAUC) was significantly greater for the HGL group compared to the LGL group 
(P=0.02; Table 2.3). However, the total calculated area under the curve was not significantly different 
between groups. 
 
Tables 2.3 and 2.4 show the nutritional characteristics and foods consumed on the day of blood 
glucose monitoring. The diets were significantly different with regards to glycaemic load (P<0.001), 
dietary GI (P=0.001), percentage energy from carbohydrate (P=0.01) and percentage energy from 
protein (P=0.02). With regards to relationship of dietary variables and blood glucose profile, the iAUC 
correlated with dietary GI (r=0.60, P= 0.04), but not glycaemic load (P=0.08). 
  
 
Figure 2.1: Capillary blood glucose profile for participants on the HGL or LGL diet 
Values are mean  SEM. (—) LGL group (n=6); (---) HGL group (n=5).  
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Table 2.3: Nutritional characteristics and the area under the glucose curve for the day of 
diurnal blood glucose monitoring 
Variable LGL group   (n=7) HGL group   (n=5) P 
Nutritional characteristics, Day 3   
Energy, kJ 9817  660 10400  568 0.54 
Dietary glycaemic load 88.7  6.7 248.7  20.5 <0.001 
Dietary glycaemic index 33.1  0.5 71.4  1.4 0.001 
Carbohydrate, % of total kJ 45.0  2.5 56.9  2.8 0.01 
Protein, % of total kJ 22.8  0.9 18.4  1.5 0.02 
Fat, % of total kJ 31.8  3.0 24.2  2.4 0.09 
Glycaemic profile, Day 3   
iAUC, mmol·hr/L 10.3  1.5
†
 16.9  1.9 0.02 
tAUC, mmol·hr/L 66.4  2.0
†
 70.9  2.4 0.18 
†
n=6 due to an outlier of more than 3 standard deviations from the mean; subject has an 
undiagnosed myopathy. 
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Table 2.4: Experimental meals during the day of blood glucose monitoring 
 LGL group (n=6) HGL group(n=5) 
   
 Meal 1 Bran based cereal or muesli 40g 
Milk, low-fat 160g 
Bacon, fat removed, fried 35g 
Egg, whole, fried 35g 
Bread, mixed-grain 2 slice 
Margarine, canola 7g 
Honey 1tsp 
Apple juice 225ml 
 
Corn or rice based cereal 50g 
Milk, skinny 200g 
Bread, white, increased fibre 1 slice 
Honey/Jam 1tsp 
Margarine, polyunsaturated 7g 
Fruit juice 225ml 
 
 Snack 1 Yoghurt, low-fat 200g 
 
Yoghurt, low fat 200g 
Lamington 1 piece 
 
 Meal 2 Bread, mixed grain 4 slice 
Beef, silverside, lean 150g 
Salad, mixed 60g 
Water 500ml 
  
 
Bread, white, increased fibre 4 slice 
Ham, lean 42g 
Cheese, low-fat 45g 
Salad, mixed 110g 
Water 500ml 
 
 Snack 2 Milk, low-fat  200ml 
Chocolate beverage base 2 tsp 
Dried fruit and nuts 100g 
 
Cordial beverage 225ml 
Cereal bar 30g 
 
 Meal 3 Beef, rump, lean, fried 195g 
Vegetables, raw 170g 
Honey ½ tsp 
Soy sauce, light 1 ½ tsp 
Noodles, mung bean, cooked 75g 
Frozen fruit dessert 85g 
  
 
Fish, poached 150g 
Potato chips, baked 225g 
Salad, raw 80g 
Fruit 1 piece 
Ice cream, low-fat 100g 
Orange-flavoured soft drink 225ml 
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2.4.4 Study outcomes 
Table 2.5 shows the mean change in hormonal variables and plasma lipids at day 7 according to 
dietary group. The mean change in fasting insulin levels (P = 0.05) and HOMA-IR (P = 0.03) was 
significantly different between groups with the LGL group showing a trend for improved insulin 
sensitivity and the HGL group showing a trend for increasing insulin resistance. At day 7, SHBG 
levels decreased by 9% (P=0.03) from baseline in the HGL group and the FAI increased by 19% 
(P=0.03). In contrast, no change in androgen levels or the FAI were observed in the LGL group. 
However, the LGL group demonstrated a 28% increase in IGFBP-1 levels (P=0.03) and a 27% 
increase in IGFBP-3 concentrations (P=0.03) when contrasted to the pre-treatment values. Both 
groups also demonstrated significant decreases from baseline in plasma total cholesterol (P=0.004 for 
LGL group and P=0.03 for HGL group) and LDL-cholesterol (P=0.002 for LGL group and P=0.04 for 
HGL group). In addition, the HGL group demonstrated a 10% decrease in HDL cholesterol (P=0.01), 
while the LGL group showed a 32% decrease in plasma triglycerides (P<0.001). 
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Table 2.5: Mean change in study endpoints after 7 days on experimental diets 
 Adjusted means
a
 
 LGL group (n=7) HGL group (n=5) P
b
 
Fasting glucose (mmol/L) -0.12  0.11 0.10  0.13 0.22 
Fasting insulin (mU/L)
 
 -2.58  0.88 -0.59  1.04 0.05 
HOMA-IR index -0.57  0.18 0.14  0.22 0.03 
Testosterone (nmol/L) -1.21  0.76 1.00  0.92 0.11 
SHBG (nmol/L) -1.18  0.75 -2.14  0.89
c
 0.44 
FAI (nmol/L) -2.37  5.91 19.39  7.03
c
 0.04 
DHEA-S ( mol/L) 0.32  0.39 -0.11  0.46 0.50 
IGF-I (nmol/L) -4.51  1.95 -7.23  2.31 0.39 
IGFBP-1 (ng/L) 8.65  3.23
c
 0.38  3.85 0.14 
IGFBP-3 (mg/L) 0.73  0.28
c
 0.23  0.34 0.30 
T-Chol (mmol/L) -0.81  0.15
d
 -0.63  0.17
c
 0.45 
LDL-Chol (mmol/L) -0.85  0.14
d
 -0.51  0.16
c
 0.16 
HDL-Chol (mmol/L) 0.03  0.04 -0.10  0.05
d
 0.06 
Triglycerides (mmol/L) -0.24  0.34
e
 0.46  0.41 0.25 
a Means are adjusted for baseline values 
b 
General linear models were used to test for overall treatment differences  
Significant difference from baseline 
c
(P<0.05), 
d
(P<0.01), 
e
(P<0.001) 
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2.5 DISCUSSION 
This study showed that altering the dietary glycaemic load may have important effects on insulin 
sensitivity and factors related to acne. In a well-controlled feeding environment, subjects on the LGL 
diet demonstrated improvements in insulin sensitivity when compared to the HGL group. In addition, 
this study found that the HGL diet significantly increased androgen bioavailability; while increases in 
IGF-I binding proteins in the LGL group suggest a reduction in IGF-I activity. These results are 
concordant with the known relationship of insulin and the actions of androgens and IGF-I, and 
suggests that HGL diets may promote underlying causal factors associated with acne development. 
 
The acute physiologic responses to feeding were also demonstrated in the marked between diet 
differences in day-long blood glucose responses. By maximising differences in glycaemic load, this 
study demonstrated a ~60% higher iAUC for glucose with the HGL diet when compared to the LGL 
diet. However, iAUC for glucose did not correlate with dietary glycaemic load possibly due to the 
small number of subjects and the frequency of blood glucose sampling in the early postprandial phase 
(<1hr). Instead, this study found that the calculated dietary GI predicted the day-long iAUC for 
glucose, suggesting that the GI of relative carbohydrate foods was an important determinant in 
postprandial glycaemia. This is consistent with previous mixed meal studies which found that blood 
glucose responses can be predicted from the weighted GI of constituent foods (Wolever and Jenkins, 
1986; Chew et al., 1988). Although the coingestion of protein and fat can reduce postprandial 
glycaemia (Nuttall et al., 1984; Nuttall and Gannon, 1990), Wolever and Bolognesi (1996) observed 
that the amount and type of carbohydrate in mixed meals accounts for 90% of the variability in the 
blood glucose response. As seen in our study and others (Wolever and Jenkins, 1986; Chew et al., 
1988), variations in the protein and fat content of mixed meals did not appear to obscure the 
accumulative effect of component carbohydrates. This is supported by the observation that the 
glycaemic load can be used to predict day-long blood glucose and insulin responses for whole diets, 
independent of increases in protein consumption (Atkinson et al., 2004). 
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One of the important findings of the present study was the rapid and significant effect of dietary 
intervention on fasting insulin and HOMA-IR. These findings are consistent with previous 
intervention studies which suggest that LGL diets can improve insulin sensitivity, independently of 
changes in caloric intake (Frost et al., 1996; Frost et al., 1998). However, clamping for total energy 
may limit the full benefit of LGL diets because of the influence of low GI foods on satiety and 
decreasing food intake (Ludwig et al., 1999; Ball et al., 2003). Accumulating evidence suggests that 
LGL interventions may facilitate weight loss in overweight and obese adolescents, without the need 
for an imposed energy restriction (Spieth et al., 2000; Ebbeling et al., 2003). Although both diets in 
the present study were essentially designed to prevent changes in body weight, the voluntary intake of 
food between meals allowed some degree of variability in energy consumption. However, we suspect 
that the difference in energy of the two diets was not sufficient in magnitude and/or duration to 
significantly impact on insulin resistance via changes in body fat distribution. Although the underlying 
mechanisms are yet to be fully defined, HGL diets may influence insulin sensitivity, independently of 
changes in weight or caloric intake, through elevations in: 1) plasma insulin (Del Prato et al., 1994; 
Zammit et al., 2001);  2) free fatty acids (Ludwig, 2002);  3) counterregulatory hormones (eg. cortisol 
and growth hormone);(Jenkins et al., 1990) and 4) adipocyte diameter (Kabir et al., 1997). 
The results of the present study suggest that HGL diets may be associated with increases in androgen 
activity. This study found that the HGL diet increased androgen bioavailability by 19% and decreased 
SHBG levels by 9% when compared to pretreatment values. These changes may be partly explained 
by the ability of insulin to suppress SHBG synthesis at the hepatic level (Plymate et al., 1998), thereby 
increasing the bioavailability of circulating androgens to tissues. In addition, insulin can further 
promote androgen bioavailability, by acting at the pituitary (Adashi et al., 1981) and gonads (Barbieri 
et al., 1988; Bebakar et al., 1990) to increase androgen synthesis. These findings suggest that dietary 
glycaemic load may have important implications for acne and other clinical manifestation of androgen 
activity (eg. hirsuitism, alopecia). Indirect support for this notion comes from evidence of the 
therapeutic effect of pharmacotherapies aimed at slowing the rate of carbohydrate absorption. Ciotta et 
al (2001) recently demonstrated a 46% reduction in the acne/seborrhoea score in PCOS patients 
treated with an -glucosidase inhibitor. The clinical improvement was associated with a significant 
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reduction in the insulin response to an oral glucose load, a decrease in androgen concentrations, with a 
significant rise in SHBG levels (Ciotta et al., 2001). This suggests that reducing the postprandial rise 
in blood glucose concentrations per se may have a therapeutic effect on clinical and endocrine 
assessments of acne. 
 
This study also suggests that LGL diets can influence IGF-I activity via changes in the level of  IGF-
binding proteins (IGFBPs). The LGL diet increased concentrations of IGFBP-1 by 28% and IGFBP-3 
by 27% when compared to the pre-treatment values. These changes may be explained by the changes 
in the metabolic milieu associated with the consumption of a LGL diet. Insulin is the principle 
determinant of plasma IGFBP-1 levels and low basal IGFBP-1 levels have been observed in insulin 
resistant individuals, possibly due to increased portal insulin overnight (Attia et al., 1998).  IGFBP-3, 
on the other hand, may be affected by postprandial hyperglycemia as demonstrated by the significant 
reduction in IGFBP-3 concentrations after the consumption of a high GI meal when compared to a low 
GI meal (Brand-Miller et al., 2005). Given that IGF-I is a potent stimulator of sebocyte (Deplewski 
and Rosenfield, 1999) and keratinocyte (Hodak et al., 1996) proliferation, it is possible that LGL diets 
may induce changes to the IGF-I system which may be clinically relevant to acne development.  
 
Several methodological issues pertaining to this study warrant further consideration. Firstly, as 
participants were not formally randomised to groups (for reasons previously outlined), we cannot 
underestimate the influence of selection bias. Nevertheless, our results are consistent with other 
randomised trials which report that LGL diets reduce androgen bioavailability and increase SHBG 
levels, while improving insulin metabolism (Berrino et al., 2001; Smith et al., 2007). The use of 
HOMA-IR as a surrogate measure of insulin sensitivity also warrants consideration. This index 
reflects hepatic insulin sensitivity and is based on the assumption that insulin sensitivity of the liver 
and peripheral tissues are equivalent (Monzillo and Hamdy, 2003). Although this index has been 
found to correlate with clamp-derived insulin sensitivity in large studies, its utility in small 
intervention trials remains uncertain. Furthermore, given the nature of the dietary intervention in this 
study, it is possible that the compensatory changes in other nutrients (eg. increased meat intake, 
micronutrients etc) may have influenced study endpoint measurements.   
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On the other hand, this study also had several strengths, including the precise control in the 
composition of foods provided and the accurate recording of dietary intakes. As participants were 
absolved from outside influences, dietary compliance could be achieved with minimal deviation from 
the dietary protocol. In nutrition research, knowledge of the level of dietary adherence is crucial when 
assessing the impact of dietary manipulations on physiologic processes (Hall and Most, 2005). By 
eliminating the variability associated with food selection and discrepancies in dietary compliance, this 
study was able to be performed with fewer numbers and under a shorter time frame. 
  
In summary, these results suggest that LGL diets may have a therapeutic potential in the treatment of 
acne because of the beneficial endocrine effects of these diets. When compared to a typical HGL 
Western diet, a LGL diet was shown to reduce postprandial glycemia, while improving insulin 
sensitivity and decreasing androgen bioavailability. However, as this study only evaluated the short 
term effects of dietary intervention under ideal conditions, these suggestive findings will need to be 
substantiated by larger-scale experiments carried out under real life conditions. 
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3.1 ABSTRACT 
Background: Although the pathogenesis of acne is currently unknown, recent epidemiologic studies 
of non-Westernised populations suggest that dietary factors, including the glycaemic load, may be 
involved. 
Objective: The objective was to determine whether a low glycaemic load diet improves acne lesion 
counts in young males. 
Design: Forty-three male acne patients aged 15-25yr were recruited for a 12-week, parallel design, 
dietary intervention incorporating investigator-blinded dermatology assessments. The experimental 
treatment was a low glycaemic load diet, comprised of 25% energy from protein and 45% from low 
glycaemic index carbohydrates. In contrast, the control situation emphasised carbohydrate-dense foods 
without reference to the glycaemic index. Acne lesion counts and severity were assessed during 
monthly visits and insulin sensitivity (using the homeostasis model assessment) was measured at 
baseline and 12 weeks. 
Results: At 12 weeks, mean (  SEM) total lesion counts had decreased more (P=0.03) in the low 
glycaemic load group (-23.5  3.9) than in the control group (-12.0  3.5). The experimental diet also 
resulted in a greater reduction in weight (-2.9  0.8 compared with 0.5  0.3kg; P<0.001), and body 
mass index (in kg/m
2
; -0.92  0.25 compared with 0.01  0.11 kg/m
2
, P=0.001) and a greater 
improvement in insulin sensitivity (-0.22  0.12 compared with 0.47  0.31, P=0.02) than did the 
control diet. 
Conclusion: The improvement in acne and insulin sensitivity after a low glycaemic load diet suggests 
that nutrition-related lifestyle factors may play a role in the pathogenesis of acne. However, further 
studies are needed to isolate the independent effects of weight loss and dietary intervention and to 
further elucidate the underlying pathophysiologic mechanisms. 
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3.2 INTRODUCTION 
Acne is a common and complex skin disease that affects individuals of all ages. In Western 
populations, it is estimated to affect 79% to 95% of the adolescent population, 40 to 54% of 
individuals older than 25 yr and 12% of women and 3% of men by middle age (Cordain et al., 2002). 
In contrast, acne remains rare in non-Westernised societies such as the Inuit (Schaefer, 1971), 
Okinawan Islanders (Steiner, 1946), Ache hunter gatherers and Kitavan Islanders (Cordain et al., 
2002). Although familial and ethnic factors are implicated in acne prevalence, this observation is 
complicated by findings that acne incidence rates have increased with the adoption of Western 
lifestyles (Schaefer, 1971). These observations suggest that lifestyle factors, including diet, may be 
involved in acne pathogenesis. 
 
Historically, much debate has surrounded the subject of diet in the management of acne. In the 1930s, 
acne was considered to be a disease of disturbed carbohydrate metabolism as early work suggested 
impaired glucose tolerance occurred in acne patients (Campbell, 1931). On the basis of these 
observations and the anecdotal impressions of physicians, patients were often discouraged from eating 
excessive amounts of carbohydrates and high-sugar foods (Sulzberger and Baer, 1948; Belsario, 
1951). The diet and acne connection finally fell from favour in 1969 when a clinical study found no 
exacerbation of acne lesions in a group that ingested a chocolate bar compared with a group that 
ingested a placebo bar (Fulton et al., 1969). Although it is the most widely cited reference dissociating 
diet and acne, this study has been criticised for a number of design flaws, including the similar nutrient 
composition of the placebo (Mackie and Mackie, 1974; Rasmussen, 1977; Cordain, 2005). 
 
Recently, there has been a reappraisal of the diet and acne connection because of a greater 
understanding of how diet may affect endocrine factors involved in acne (Cordain et al., 2002; 
Cordain, 2005). Of interest is the concept of the glycaemic index (GI) - a system of classifying the 
glycaemic response of carbohydrates. Because the GI can only be used to compare foods of equal 
carbohydrate content, the glycaemic load was later developed to characterise the glycaemic effect of 
whole meals or diets (GI  available dietary carbohydrate). Cordain et al (2002) postulated that high 
glycaemic load diets may be a significant contributor to the high prevalence of acne seen in Western 
CHAPTER THREE 78 
 
  
countries. The authors speculate that the frequent consumption of high-GI carbohydrates may 
repeatedly expose adolescents to acute hyperinsulinaemia. Hyperinsulinaemia has been implicated in 
acne pathophysiology because of its association with increased androgen bioavailability and free 
levels of insulin-like growth factor I (IGF-I) (Cordain et al., 2003; Cordain, 2005). Therefore, we 
hypothesised that low glycaemic load dietary interventions may have a therapeutic effect on acne 
based on the beneficial endocrine effects of these diets. Consequently, the aim of this preliminary 
study was to investigate the efficacy of a low glycaemic load diet in reducing the severity of acne 
symptoms. 
 
3.3 SUBJECTS 
Males with facial acne were recruited through posted fliers at the RMIT University (Melbourne, 
Australia) and newspaper advertisements. Informed consent was obtained from each participant or 
guardian (if aged <18yr), and the study was conducted at RMIT University after obtaining approval 
from the RMIT Human Ethics committee. This study included only male participants, aged 15-25yr 
with mild to moderate facial acne. Participants were required to have had acne for longer than 6 
months prior to recruitment. Individuals were excluded if they were currently taking medications 
known to affect acne or glucose metabolism. Additionally, a wash-out period of 6 months was 
required for subjects who had previously taken oral retinoids or 2 months for subjects who had taken 
oral antibiotics or topical antibacterial or retinoid agents. 
 
3.4 METHODS 
3.4.1 Study Design  
It was calculated that 19 subjects per group would provide 80% power (at the 2-sided 5% level) to 
detect a difference of 20% in the reduction of acne lesions between groups, assuming a standard 
deviation of 22%. To compensate for subject withdrawal, 54 subjects were enrolled in the study. 
 
Eligible participants were recruited between June 2003 and June 2004. Approximately 2-3 weeks after 
recruitment, participants attended their baseline appointment and were randomly assigned to either the 
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low glycaemic load (LGL) or control group (Figure 3.1). Randomisation was carried out by computer 
generated random numbers and allocation to groups was performed by a third party.  
 
This study was designed as a parallel dietary intervention study with investigator-blinded dermatology 
assessments. Topical therapy, in the form of a noncomedogenic cleanser, was standardised for both 
groups and facial acne was scored at monthly visits (weeks 0, 4, 8, and 12) at the academic research 
clinic. On all visits, height and weight were measured. All subjects were weighed in light clothes and 
body mass index (BMI) was calculated as weight (kg)/height (m) squared. At baseline and 12 weeks, a 
venous blood sample was taken after an overnight fast and an oral glucose insulin sensitivity test was 
performed on a subgroup of participants from the LGL and control groups. 
 
The primary endpoints of the study were changes in inflammatory lesion counts (papules, pustules and 
nodules) and total lesion counts (inflammatory lesions and non-inflammatory lesions) after 12 weeks. 
Secondary endpoints include changes in anthropometric measures and insulin sensitivity indexes.  
 
3.4.2 Dietary intervention 
Participants were informed that the study‘s intent was to compare the dietary carbohydrate to protein 
ratio and were not informed of the study‘s true intent. The LGL diet was achieved through 
modifications of the amount and type of carbohydrate. The LGL group was instructed to substitute 
high GI foods with foods higher in protein (e.g. lean meat, poultry or fish) or lower in GI (e.g. whole 
grain bread, pasta, fruit). Some staple foods were supplied and participants were urged to consume 
these or similar foods daily. Each participant received individualised dietary plans that were 
isocalorically matched with their baseline diet as determined from 7-day weighed/measured food 
records. The recommended LGL diet consisted of 25% energy from protein, 45% from low GI 
carbohydrates and 30% energy from fats. In contrast, the control group received carbohydrate-dense 
staples and were instructed to eat these or similar foods daily. The foods provided had moderate-to-
high GI values and were typical of their normal diet as evidenced from 7-day weighed and measured 
food records. The control group were not informed about the GI, but were urged to include 
carbohydrates as a regular part of their diet. All participants received initial education on use of foods 
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scales and keeping of foods records. During the study period, nutrient intakes were calculated from 3-
day weighed and measured food records each month using Australia specific dietary analysis software 
(Foodworks, Xyris Software, Highgate Hill, Australia). Dietary compliance was monitored by regular 
telephone interviews, assessments of GL /day and 24-hr urine samples (weeks 0 and 12) for an 
assessment of urea excretion relative to urinary creatinine as a marker of protein intake. 
 
3.4.3 Calculation of dietary glycaemic index and glycaemic load 
Daily dietary glycaemic index and glycaemic load were calculated from diet records. The dietary GI 
and glycaemic load were calculated using the following equations: dietary GI= (GI for food item  
proportion of total carbohydrate contributed by item), and dietary glycaemic load = (GI for food item 
 its carbohydrate content in grams  100). The GI values used had glucose as the reference food and 
were taken from reference tables (Foster-Powell et al., 2002) and Sydney University‘s GI website 
(Sydney University, date unknown). If a food from Australia was not available, the GI was estimated 
by using similar foods of known value. 
 
3.4.4 Standardised topical lotion 
All participants were provided with a topical cleanser (Cetaphil gentle skin cleanser, Galderma, 
Frenchs Forrest, Australia) and advised to use it in place of their normal wash, soap or cleanser. 
Subjects began using the topical wash 2 weeks prior to baseline and were asked to maintain a standard 
level of usage during the trial. 
 
3.4.5 Dermatology assessment 
Scaling of the acne was performed by a dermatology registrar who was blinded to the group 
assignment of the participants. The registrar assessed facial acne occurrence and severity only, using a 
modified Cunliffe-Leeds lesion count technique (Burke and Cunliffe, 1984). To ensure all acne lesions 
were counted, located and graded by size and severity, lesions were mapped by placing a transparent 
plastic film with a laser-printed grid gently against the skin. Facial anatomical landmarks, such as the 
ear, chin and tip of nose, were used to ensure consistency between assessments. Each side of the face 
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was assessed separately. Where necessary, the registrar palpated the skin to determine the lesion type. 
To maintain reproducibility of this procedure, one physician performed all the dermatology 
assessments. A small group of volunteers (n=4) was counted one-week apart to evaluate the 
reproducibility by the same physician [9.5% coefficient of variation (CV)].  
 
3.4.5 Laboratory analyses 
Code labelled serum samples were stored at -80 C for analysis post-study by an independent 
laboratory. Baseline and 12-week samples for each participant were included in the same assay run to 
avoid inter-assay variability. Serum insulin was measured using a commercially available 
microparticle enzyme immunoassay (Abbott Laboratories, Tokyo, Japan; intra-assay CV: 4.0%). 
Capillary blood glucose was measured on the day of testing using a Glucose 201+ analyser 
(HemoCue, Sweden; intra-assay CV = 1.6%).  
 
3.4.6 Insulin sensitivity measures 
The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as: fasting 
glucose (mmol/L)  fasting insulin ( U/mL)  22.5 (Matthews et al., 1985). We also used the model-
derived formula proposed by Mari et al (Mari et al., 2001) to calculate the oral glucose insulin 
sensitivity (OGIS) index from a 2hr oral glucose tolerance test. This formula was calculated using six 
fixed rate constants, the oral glucose dose (75g); body surface area; glucose concentrations (mg/dL) at 
0, 90, and 120 min; and insulin concentrations ( U/mL) at 0 and 90min. In the present study, some 
participants were unable to sit the 2hr test due to scheduling interference (eg. school, work 
commitments). Consequently, the OGIS data presented are for only 18 subjects in the LGL group and 
17 subjects in the control group. 
 
3.4.7 Statistical analysis 
All statistical analyses were performed with the use of SPSS 11.0 for Windows (SPSS Inc., Chicago, 
Illinois). Baseline characteristics were analysed for between group significance using Mann-Whitney 
U test or an independent-sample t test, depending upon whether or not the data was normally 
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distributed. Repeated-measures analysis of variance was used to analyse dietary and acne (lesion 
count) data and to explore the effects of time, treatment and an interaction of these two factors. We 
compared changes in lesion counts using repeated measures analysis of log-transformed data at each 
follow up visit with baseline lesion counts as the covariate. P-values less than 0.05 were considered 
significant. Analysis of covariance (ANCOVA) was used to test for overall treatment differences at 
12-weeks, with baseline data as the covariate. Secondary analyses were performed with adjustment for 
changes in BMI. 
 
The primary clinical outcome (changes in lesion counts at 12 weeks) was analysed using an intention-
to-treat model for all randomised subjects using the last measurement carried forward for all missing 
data.  
 
Bivariate linear regression analysis was also conducted, pooling data from both groups, to explore 
relationships between dietary variables and acne improvement.  
 
3.5 RESULTS 
3.5.1 Subjects 
Forty-three subjects completed the study per protocol (Figure 3.1). Seven participants did not 
complete the study (five in control and two in LGL) and four were removed from data set (two began 
acne medications and two were non-compliant). Baseline characteristics are shown in Table 3.1.  
   
 
 
Figure 3.1: Recruitment to completion of participants after 12 weeks (T0 =baseline, T12=12 weeks)
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Table 3.1: Subject characteristics at baseline by dietary group 
Variable LGL group 
(n = 23) 
CO group  (n 
= 20) 
P
1
 
Ethnicity (n) 
Caucasian  
Asian 
 
20 
3 
 
17 
3 
 
0.60 
Age (yr) 18.2  0.5
2
 18.5  0.5 0.76 
Body weight (kg) 73.5  2.5 73.3  3.3 0.90 
Body Mass Index (kg/m
2
) 22.9  0.6 22.5  0.7 0.34 
Total lesion count 40.6  5.0 34.9  4.3 0.40 
Inflammatory lesion count  31.9  3.9 28.4  3.6 0.72 
OGIS (mL·m
-2
·min
-1
)
3
 481  9 503  9 0.12 
HOMA-IR 1.6  0.2 1.5  0.2 0.88 
1
 Corresponds with an independent-sample t test or Mann-Whitney U test 
for means and the Fisher‘s exact test for ethnicity 
2
 Data is expressed as means  SEM (for all such values).  
3 
n=18 for the LGL group and n=17 for the control group  
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3.5.2 Diet composition 
Dietary intakes of the LGL and control groups at baseline and during the trial is shown in Table 3.2. 
No significant group differences were observed in any of the dietary variables at baseline. During the 
trial period, dietary glycaemic load decreased significantly in the LGL group compared with the 
control group, and this change was achieved by a reduction in carbohydrate intake and by inclusion of 
low-GI foods (as indicated by a reduction in the calculated dietary GI). Protein intake increased in the 
LGL and decreased slightly in the control group, indicating that some carbohydrates were replaced 
with foods higher in protein. This observation was substantiated by a 15.4% increase in urinary urea to 
creatinine ratio at 12 weeks for the LGL group compared with a 12.3% decrease for the control group 
(P=0.009), which indicated good dietary compliance.  
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Table 3.2: Dietary intakes of low glycaemic load (LGL) and control groups at baseline and during 
the trial period 
 
LGL group 
(n=23) 
Control group 
(n=20) 
P
1
 
Variable Group Time Group  time 
interaction 
Energy (kJ/day)  0.15 0.09 0.100 
 Baseline
2
 
Trial period
4
  
10625  572
3
 
9320  460 
10540  546 
10620  494 
   
Dietary glycaemic index  <0.001 <0.001 <0.001 
 Baseline 
Trial period 
57.5  1.0 
43.2  0.8 
57.2  0.8 
56.4  0.8 
   
Dietary glycaemic load  <0.001 <0.001 <0.001 
 Baseline 
Trial period 
174.7  9.1 
101.5  6.1 
181.5  11.5 
174.3  10.7 
   
Carbohydrate, % of total kJ  0.013 0.195 0.001 
 Baseline 
Trial period 
50.2  1.1 
44.1  1.3 
48.2  1.2 
50.1  1.2 
   
Protein, % total kJ  0.001 <0.001 <0.001 
 Baseline 
Trial period 
16.3  0.6 
22.7  0.8 
17.5  0.9 
17.4  0.8 
   
Total fat, % total kJ  0.84 0.74 0.45 
 Baseline 
Trial period 
32.5  1.1 
31.5  0.9 
31.8  1.2 
31.4  1.2 
   
Saturated fat, % total kJ  0.002 <0.001 <0.001 
 Baseline 
Trial period 
13.5  0.6 
9.0  0.4 
12.9  0.7 
13.0  0.9 
   
Fibre, g/day   0.002 <0.001 <0.001 
 Baseline 
Trial period 
25.3  1.8 
36.9  2.0 
25.2  2.1 
25.2  2.0 
   
1
 Repeated measures ANOVA was done to incorporate data from all time points and to evaluate the 
differences between the LGL and control groups (main effect of group), the change over time (main 
effect of time) and the differences in the time course between the two groups (group  time 
interaction). 
2
 An independent-sample t test revealed no significant differences between the LGL and control 
groups for any of the listed dietary variables at baseline. 
3
 All data is expressed as mean  SEM 
4
 Means of data collected at 4, 8 and 12 weeks 
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3.5.3 Study outcomes 
As shown in Figure 3.2, both the LGL and control groups showed reductions in inflammatory and 
total lesion counts from 0 to 12 weeks. Repeated-measures analysis that used baseline counts as the 
covariate indicated an overall difference between the LGL and control groups (main effect of group), 
but no significant change over time (main effect of time), or difference in the time course between the 
groups (group  time interaction) was observed. At 12 weeks, the LGL group had a greater reduction 
in the mean number of total and inflammatory lesions than did the control group (Table 3.3). 
Examples of acne improvement in the LGL group are shown in Figure 3.3. The mean number of total 
lesions fell by 23.5 (51%) in the LGL group and by 12.0 (31%) in the CO group (P=0.03). 
Inflammatory lesions counts fell by 17.0 (45%) in the LGL group and by 7.4 (23%) in the control 
group (P=0.02). The results at 12 weeks were also materially unchanged by intention-to-treat analysis.  
 
The LGL group also showed significant reductions in weight (P<0.001), BMI (P=0.001) and HOMA-
IR (P=0.026) when compared to the control group. The change in HOMA-IR correlated with the 
change in OGIS index (r=-0.36, P=0.035), with both models suggesting a trend for improved insulin 
sensitivity in the LGL group and a trend for increasing insulin resistance in the control group. 
Statistical adjustment of study endpoints for the change in BMI was found to alter the outcome for 
HOMA-IR (P=0.10) and total lesion counts (P=0.07), but not inflammatory counts (P=0.04). 
However, we found no significant interaction effect of dietary treatment and the change in BMI on 
acne lesion counts.  
 
3.5.4 Dietary variables as predictors of acne improvement 
Dietary correlates with acne improvement include reductions in glycaemic load (r = 0.49, P = 0.001), 
dietary GI (r = 0.30, P = 0.05), carbohydrate intake (r = 0.46, P = 0.002), percentage saturated fat (r = 
0.36, P = 0.02) and total energy intake (r = 0.40, P = 0.01). These relationships are shown in Figures 
3.4.  
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Figure 3.2: Mean (  SEM) percentage changes from baseline in inflammatory acne lesion counts 
and in total acne lesion counts for the low glycaemic load group (solid line; n=23) and the control 
group (dashed line; n=20) at each visit. Repeated-measures ANOVA was performed incorporating 
the absolute data (log transformed) from each follow up visit, with baseline counts as the covariate. 
(i) 
(ii) 
CHAPTER THREE 89 
 
 
 
 
Table 3.3: Absolute mean differences from baseline to 12 weeks in outcome variables by 
dietary group 
Variable LGL group CO group P
1
 
 Difference n Difference  n  
Per-protocol analysis      
Total count -23.5  3.92
2
 23 -12.0  3.5 20 0.03 
Inflammatory count -17.0  3.1 23 -7.4  2.5 20 0.02 
Weight (kg) -2.9  0.8 23 0.5  0.3 20 <0.001 
BMI (kg/m
2
) -0.92   0.25 23 0.01  0.11 20 0.001 
HOMA-IR
3
 -0.22  0.12 23 0.47  0.31 20 0.03 
OGIS (mL·m
-2
·min
-1
) 12.7  7.9 16 -18.3  9.9 17 0.08 
Intention-to-treat analysis     
Total count -22.0  3.5 27 -10.9  2.9 27 0.02 
Inflammatory count -16.2  2.9 27 -5.6  2.5 27 0.01 
1
 Testing using ANCOVA for between group comparison with baseline as a covariate  
2 
All data is expressed as absolute mean difference (12 weeks minus baseline)  SEM  
3
 Mean change in HOMA-IR is non-parametrically distributed. ANCOVA was performed on log 
transformed data. 
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Figures 3.3: Photographs of acne improvement in the low glycaemic load group. (i) and (ii): 
Subject A at baseline and 12 weeks respectively; (iii) and (iv): Subject B at baseline and 12 weeks 
respectively; and (v) and (vi): Subject C at baseline and 12 weeks respectively 
 
(i) (ii) 
(iii) (iv) 
(v) (vi) 
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Figure 3.4: Relationships between acne improvement and changes in dietary glycaemic index, 
dietary glycaemic load, energy intake, carbohydrate intake, and percentage saturated fat.     
Bivariate analysis was performed with a 2-tailed Pearson‘s correlation (n=43) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(i) 
(ii) 
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(vi) 
(iii) 
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(v) 
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3.6 DISCUSSION 
This study represents the first randomised controlled intervention to examine the influence of dietary 
glycaemic load on the clinical assessment of acne. After adjusting for differences in acne severity at 
baseline, we found that the LGL group showed a greater overall reduction in total and inflammatory 
lesion counts than did the control group. Analysis of the primary endpoint data also showed that the 
differences between groups remained significant after using an intention-to-treat model. However, we 
found no significant effect of time on acne possibly due to the fact that acne is a dynamic condition in 
which both spontaneous improvements and flares may occur over time.  
 
Few well-controlled dietary studies have examined the effect of diet on acne. Fulton et al (1969), in a 
crossover single-blind study, found no effect of chocolate on acne when compared to a placebo bar. 
However, a later examination of the ingredients in the placebo bar indicated that the fatty acid 
composition and sugar contents were virtually identical to that found in the chocolate (Mackie and 
Mackie, 1974). Anderson (1971) examined the effect of the daily consumption of chocolate, milk or 
nuts and found no effect on acne. However, this study has also been criticised for its small sample 
size, the short follow-up and lack of controls (Margin et al., 2005). Chiu et al (2003) showed, in 
university students, an association between worsening diet quality and exacerbation of acne during a 
preexamination period. However, stress was found to be the main contributing factor, and diet was 
assessed using a non-quantitative, self-assessed measure of diet quality. Recently, a retrospective 
evaluation of dietary intake revealed a positive association between milk intake and physician-
diagnosed severe acne (Adebamowo et al., 2005). However, the authors admit that this association 
may have been affected by the imprecision inherent in the measurement of dietary intakes via distant 
recall. 
 
High glycaemic load diets have recently been implicated in acne aetiology because of their ability to 
increase insulin demand and other factors associated with insulin resistance (eg. hyperphagia, elevated 
nonesterified fatty acids and obesity) (Cordain et al., 2003). Clinical and experimental evidence 
suggests that insulin may increase androgen production and affect, through its influence upon 
steroidogenic enzymes (Kristiansen et al., 1997), gonadotrophin releasing hormone secretion (Willis et 
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al., 1996) and sex hormone binding globulin production (Plymate et al., 1995; Haffner, 1996; 
Goodman-Gruen and Barret-Connor, 1997). Additionally, insulin has been shown to decrease a 
binding protein for IGF-I, which may facilitate the effect of IGF-I on cell proliferation (Powell et al., 
1991). Overall, these events may influence one or more of the four underlying causes of acne: 1) 
increased proliferation of basal keratinocytes within the pilosebaceous duct, 2) abnormal 
desquamation of follicular corneocytes, 3) androgen-mediated increases in sebum production, and 4) 
colonisation and inflammation of the comedo by Propionibacterium acnes (Cordain et al., 2003). 
 
The role of insulin in acne development is also supported by the high prevalence of acne in women 
with polycystic ovary syndrome (PCOS), a condition associated with insulin resistance, 
hyperinsulinaemia and hyperandogenism (Franks, 2003). Insulin resistance is believed to be the 
underlying disturbance in PCOS, as it generally precedes and gives rise to the cluster of endocrine 
abnormalities that characterise PCOS (elevated androgen and IGF-I  concentrations and low sex 
hormone binding globulin) (Dunaif et al., 1989). Treatments for PCOS now include oral 
hypoglycaemic agents which improve insulin sensitivity, restore fertility and alleviate acne (Bourne 
and Jacobs, 1956). 
 
Our study also suggests that changes in acne may be closely related to changes in insulin sensitivity, as 
we observed a positive effect of the LGL diet on insulin sensitivity when compared to the control diet. 
However, the improvement in insulin sensitivity may be attributable not only to the reduction in 
glycaemic load (Frost et al., 1996), but also to the reduction in body mass. The participants in the LGL 
group lost weight despite receiving dietary advice to maintain their baseline energy intake. This may 
be due to the dual effect of added protein and low-GI foods, as both influence hunger and satiety. 
Feeding studies have shown that low-GI foods increase satiety, delay hunger and decrease food intake 
when compared with high-GI foods (Ludwig, 2000; Ball et al., 2003). Similar effects upon satiety 
have been reported for high-protein meals compared to isocaloric high-carbohydrate or high-fat meals 
(Poppitt et al., 1998). Therefore, the combined effect of low-GI foods and added protein may 
synergistically reduce ad libitum food intake, which made it difficult for our participants to maintain 
the energy density of their baseline diets. This observation is supported by previous studies that 
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showed ad libitum LGL diets to reduce energy intake without the need for an externally imposed 
energy restriction (Spieth et al., 2000; Ebbeling et al., 2003). 
 
Because the participants on the LGL diet lost weight, we cannot preclude a role of the change in BMI 
in the overall treatment effect. When we statistically adjusted the data for changes in BMI, the effect 
of the LGL diet on total lesion counts and HOMA-IR was lost. This suggests that the therapeutic effect 
may be a factor of the weight loss, or simply that weight loss is another manifestation of a LGL diet. 
Apart from women with PCOS, there is little evidence to suggest an association between acne severity 
and body weight. Aizawa and Niimura (1996) demonstrated mild peripheral insulin resistance in 
female acne sufferers that was not associated with obesity or menstrual irregularities. In contrast, 
Bourne and Jacobs (1956) demonstrated that adult men with acne were significantly heavier (5.6kg) 
than men without acne. However, the authors demonstrated that this association was dependent on 
age, as weight was not associated with acne in adolescents aged 15-19yr. Our data also showed a 
significant correlation between acne lesion counts and BMI in males aged 18-25yr, but this was not 
true for the subjects aged <18yr (data not shown). The reason for this observation is unknown, but it is 
possible that the transient decline in insulin sensitivity that occurs with the progression through 
puberty (Bloch et al., 1987; Caprio et al., 1989) may influence acne in the younger population. 
 
A few limitations of the study should be addressed. First, it is possible that the topical application of 
the mild skin cleanser may have contributed to the acne improvement through effects on the epidermal 
barrier function (Draelos, 2006). Because acne improved in the control group without any significant 
changes to their diet, a possible direct effect of the cleanser should be considered. Second, because of 
the nature of LGL dietary intervention, we cannot solely attribute the treatment effects to changes in 
glycaemic load as other dietary factors (eg. zinc and vitamin A intake) may mediate or confound the 
relationship between diet and acne improvement. Last, this study relied upon self-reporting of dietary 
intakes. Underreporting of the quantity of food eaten is a known source of measurement error when 
assessing adolescent diets (Livingstone and Robson, 2000).  
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To our knowledge, this is the first study to demonstrate a therapeutic effect of dietary intervention on 
acne. After 12 weeks, a LGL diet was shown to significantly reduce acne lesion counts and improve 
insulin sensitivity when compared to a high-glycaemic-load diet. Although we could not isolate the 
effect of the LGL diet from that of weight loss, these findings are consistent with earlier suggestions of 
the association between hyperinsulinaemia and acne. These observations will need to be substantiated 
and the underlying mechanisms determined in larger-scale studies. 
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4.1 ABSTRACT 
Background:  No previous study has sought to examine the influence of dietary composition on acne 
vulgaris. 
Objective:  We sought to compare the effect of an experimental low glycaemic load diet with a 
conventional high glycaemic load diet on clinical and endocrine aspects of acne vulgaris. 
Methods:  A total of 43 male patients with acne completed a 12 week, parallel, dietary intervention 
study with investigator-masked dermatology assessments. Primary outcomes measures were changes 
in lesion counts, sex hormone binding globulin, free androgen index, insulin-like growth factor-I and 
insulin-like growth factor binding proteins.  
Results:  At 12 weeks, total lesion counts had decreased more in the experimental group [-21.9 (95% 
confidence interval, -26.8 to -19.0)] compared to the control group [-13.8 (-19.1 to -8.5), P=0.01]. The 
experimental diet also reduced weight (P=0.001), reduced the free androgen index (P=0.04) and 
increased IGF binding protein-1 (P=0.001) when compared with a high glycaemic load diet. 
Limitations:  We could not preclude the role of weight loss in the overall treatment effect. 
Conclusion:  This suggests nutrition-related lifestyle factors play a role in acne pathogenesis. 
However, these preliminary findings should be confirmed by similar studies. 
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4.2 INTRODUCTION 
The pathogenesis of acne is complex, with strong evidence supporting the involvement of sebaceous 
hyperplasia, follicular hyperkeratinisation, bacterial and yeast intrafollicular colonisation and 
inflammation (Deplewski and Rosenfield, 2000). Although androgens play an essential role in the 
development of acne, few studies have demonstrated a direct correlation between acne severity and 
plasma androgen levels (Shaw, 2002). Variations in the clinical response to androgens suggests that 
the endocrine control of acne is complex (Levell et al., 1989). Some studies suggest that acne severity 
correlates better with sex hormone binding globulin (SHBG) than circulating testosterone levels 
(Odlind et al., 1982; Lawrence, 1986; Slayden et al., 2001). Elevated dehydroepiandrosterone sulphate 
(DHEA-S), the major adrenal androgen, has also been shown to correlate with acne severity in 
adolescent girls and with lesion counts in adults (Lucky et al., 1983; Cappel et al., 2005).  Other 
biological factors, such as insulin and insulin-like growth factor (IGF)-I, may also augment sebum 
production, one of the four proximate causes of acne. Clinically, IGF-I has been shown to correlate 
with acne lesion counts in adult women and significantly higher IGF-I levels have been described in 
women with acne compared with controls (Aizawa and Niimura, 1995; Deplewski and Rosenfield, 
1999; Cappel et al., 2005). 
 
Acne is also a common feature of women with polycystic ovary syndrome (PCOS), a condition 
characterised by hyperandrogenism and hyperinsulinaemia (Franks, 2003). Clinical and experimental 
evidence suggests that insulin resistance and its compensatory hyperinsulinaemia are the underlying 
disturbance in PCOS, as insulin resistance generally precedes and gives rise to hyperandrogenism 
(Dunaif et al., 1989). Insulin has been shown to stimulate ovarian androgen production through effects 
on steroidogenic enzymes and by amplifying gonadotrophin releasing hormone secretion (Willis et al., 
1996). Insulin and IGF-I stimulate adrenal androgen synthesis (Kristiansen et al., 1997) and inhibit 
hepatic SHBG production (Singh et al., 1990), allowing for an increase in androgen bioavailability. 
Furthermore, insulin has been shown to decrease IGF-binding protein 1 (IGFBP-1), allowing free IGF-
I concentrations to act on target tissues (Powell et al., 1991). Treatments aimed at reducing insulin 
secretion and/or increasing insulin sensitivity, such as metformin or acarbose, have been shown to 
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improve clinical symptoms of acne in patients with PCOS (Kolodziejczyk et al., 2000; Ciotta et al., 
2001; Kazerooni and Dehghan-Kooshkghazi, 2003). 
 
Expression of acne during adolescence may also be affected by endocrine changes, which are closely 
related to changes in insulin sensitivity. During normal puberty and adolescence, there is a transient 
decline in insulin sensitivity (Caprio et al., 1989; Smith et al., 1989), which is accompanied by a 
reciprocal decrease in levels of SHBG and IGFBP-1 (Holly et al., 1989). According to cross-sectional 
observations, acne begins about the same time as the gradual increase in plasma insulin (Smith et al., 
1989), the preadolescent rise in body mass index (BMI) (Rolland-Cachera, 1993), and the increase in 
IGF-I concentrations (Caprio et al., 1989; Smith et al., 1989). Acne incidence more closely 
corresponds to the changing course of insulin and IGF-I levels than to changes in plasma androgens. 
This is because insulin and IGF-I levels peak during late puberty and gradually decline until the third 
decade (Smith et al., 1989). Acne generally resolves by this time despite circulating androgens 
remaining unchanged.  
 
Hyperinsulinaemia may provide an important link between nutrition-related lifestyle factors and the 
incidence of acne. Accumulating evidence suggests that low glycaemic load (LGL) diets may play a 
dual role in the prevention of hyperinsulinaemia by lowering the postprandial insulin demand and 
improving insulin sensitivity (Jenkins et al., 2002; Willett et al., 2002; Carnethon et al., 2004; 
McKeown et al., 2004). Dietary glycaemic load may be interpreted as a measure of the blood glucose 
and insulin-raising potential, as it represents the rate of carbohydrate absorption (indicated by the 
glycaemic index [GI]) and the quantity of carbohydrate consumed (Brand-Miller et al., 2003). It has 
recently been postulated that high intakes of refined, high-GI carbohydrates may be a significant 
contributor to the high incidence of acne in Western countries (Cordain et al., 2002). However, the 
impact of such a dietary change on acne and hormone levels has not been previously investigated. 
Therefore, the aim of the present study was to investigate the effect of a LGL diet, compared with a 
typical high-glycaemic-load diet, on acne severity and metabolic and endocrine variables associated 
with insulin resistance.  
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4.3 SUBJECTS AND METHODS 
4.3.1 Study population 
Male acne sufferers were recruited using flyers posted around RMIT University (Melbourne, 
Australia) and newspaper advertisements. Informed consent was obtained from participants and 
guardians (if aged <18 yr) and the study was conducted at RMIT University with the approval of the 
RMIT Human Ethics committee. This study included only male participants, aged 15-25 with mild-
moderate facial acne. Eligible participants were required to have acne for more than 6 months and a 
severity grade of >0.25 but <2.0 as defined by the Leeds acne grading technique (Burke and Cunliffe, 
1984). Volunteers were excluded if they were taking medications known to affect acne or glucose 
metabolism. A wash-out period of 6-months was required for oral retinoids or 2-months for oral 
antibiotics or topical agents. 
 
4.3.2 Study Design 
It was calculated that 20 subjects per group would provide 80% power (at the two-sided 5% level) to 
detect a difference of 20% in acne lesion counts, 2.7 U/L in fasting insulin, 5.5nmol/L in SHBG and 
8.3ng/mL in IGFBP-1. To compensate for expected subject withdrawal, 54 subjects were enrolled. 
 
Eligible participants were recruited between June 2003 and June 2004. Approximately 2-3 weeks 
following recruitment, participants attended their baseline appointment and were randomly assigned 
(1:1) to either the low glycaemic load (LGL) or control group (see Figure 4.1). Randomisation was 
carried out by computer generated random numbers and allocation to groups was performed by a third 
party.  
 
This study was designed as a parallel dietary intervention study with investigator-masked dermatology 
assessments. Topical therapy, in the form of a non-comedogenic cleanser, was standardised for both 
groups and facial acne was scored at monthly visits (weeks 0, 4, 8, and 12) at the academic research 
clinic. On all visits, height, weight, percentage body fat and hip and waist circumference were 
measured. All subjects were weighed in light clothes and body mass index (BMI) was calculated as: 
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weight (kg)/height (m)
2
. Percentage body fat was measured using a bio-electrical impedance analyser 
(TBF-521, Tanita, Illinois, USA).  At baseline and 12 weeks, a venous blood sample was taken after 
an overnight fast.  
 
4.3.3 Dietary intervention 
Participants were informed that the study was comparing the carbohydrate to protein ratio in the diet 
and were not informed of the study‘s hypothesis. The LGL diet was low in glycaemic load, achieved 
through modifications to the amount and type of carbohydrate. The LGL group were educated on how 
to substitute high-GI foods with foods higher in protein (eg. lean meat, poultry or fish) and lower in GI 
(eg. whole grain bread, pasta, fruits). Some staple foods were supplied and participants were urged to 
consume these or similar foods on a daily basis. Each participant‘s dietary directions were 
isocalorically matched with their baseline diet as determined from 7-day weighed/measured food 
records. The recommended LGL diet consisted of 25% energy from protein, 45% from low-GI 
carbohydrates and 30% energy from fats. In contrast, the control group received carbohydrate-dense 
staples and were instructed to eat these or similar foods daily. The foods provided had moderate to 
high-GI values and were typical of their normal diet as evidenced from 7-day weighed/measured food 
records. The control group were not informed about the GI, but were urged to include carbohydrates as 
a regular part of their diet. All participants received initial education on how to use foods scales and 
keep foods records. During the study period, nutrient intakes were calculated from 3-day 
weighed/measured food records each month using Australia specific dietary analysis software 
(Foodworks, Xyris Software, Highgate Hill, Australia). Dietary compliance was monitored by regular 
telephone interviews, assessments of GL /day and 24-hr urine samples (wks 0 and 12) for an 
assessment of urea excretion relative to urinary creatinine. 
 
4.3.4 Standardised topical cleanser 
All subjects were provided with a topical cleanser (Cetaphil  gentle skin cleanser, Galderma, Forrests 
Hill, Australia) and were advised to use it in place of their normal wash, soap or cleanser. The cleanser 
provided contained no active agents for acne and its formulation is identical to that which is currently 
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available overseas. Subjects began using the topical cleanser 2 weeks prior to baseline and were asked 
to maintain a standard level of usage during the trial. Compliance was determined from self-report at 
each visit. 
 
4.3.5 Dermatology assessment 
Scaling of the acne was performed by a dermatology registrar who was masked to the group 
assignment of the participants. The registrar assessed facial acne occurrence and severity using a 
modified Burke and Cunliffe (Leeds) lesion count technique (Burke and Cunliffe, 1984). To ensure all 
acne lesions were counted, located and graded by size and severity, lesions were mapped by placing a 
transparent plastic film with a laser-printed grid gently against the skin. Facial anatomical landmarks, 
such as the ear, chin and tip of nose, were used to ensure consistency between assessments. Each side 
of the face was assessed separately. Where necessary, the registrar palpated the skin to determine the 
lesion type. All assessments were performed under fluorescent background lighting and with a halogen 
lamp, which could be easily moved to illuminate both sides of the subject‘s face. To maintain 
reproducibility of the above method, one physician performed all the dermatology assessments. A 
small group of volunteers (n=4) was counted one-week apart to evaluate the reproducibility by the 
same physician [9.5% coefficient of variation (CV)].  
 
4.3.6 Biochemical measurements 
Code labelled samples were stored at -80 C for analysis post-study by an independent laboratory. 
Baseline and 12 week samples for each participant were included in the same assay run to avoid inter-
assay variability. Serum insulin was measured using a commercially available microparticle enzyme 
immunoassay (Abbott Laboratories, Tokyo, Japan; intra-assay CV: 4.0%). Capillary blood glucose 
was measured using a Glucose 201+ analyser (HemoCue, Sweden; intra-assay CV = 1.6%). The 
homeostasis model assessment of insulin resistance (HOMA-IR) was used as a surrogate measure of 
insulin sensitivity, calculated as fasting glucose (mmol/L)  insulin ( U/mL)  22.5 (Matthews et al., 
1985). SHBG concentrations were assayed with a commercially available radioimmunoassay (Orion 
Diagnostica, Espoo, Finland; intra-assay CV = 2.5%). Total testosterone was measured using solid-
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phase radioimmunoassay (Diagnostic Products, Los Angeles, USA; intra-assay CV: 2.7%). The Free 
Androgen Index (FAI) was calculated as testosterone concentration (nmol/L)  100  SHBG 
concentration (nmol/L). IGF-I (intra-assay CV: 2.9 %) and DHEA-S (intra-assay CV: 8.1%) were 
measured using semi-automated Immulite technology (Diagnostic Products, Los Angeles, USA). 
IGFBP-1 and IGFBP-3 were assayed with a non-commercial radioimmunoassay as previously 
described (Baxter and Martin, 1986; Baxter et al., 1987). An automated Olympus analyser (Melville, 
USA) was used to measure total cholesterol, high density lipoprotein cholesterol and triglyceride 
levels (intra-assay CV were 1-2% for all tests). Low-density lipoprotein cholesterol was calculated by 
the Friedewald formula (Friedewald et al., 1972). 
 
4.3.7 Statistical analysis 
All statistical analyses were performed for the per protocol population using statistical software (SPSS 
11.0 for Windows, SPSS Inc, Chicago, Ill) and significance was set at P less than 0.05. Baseline 
variables were analysed for between group significance using Mann-Whitney U test or one-way 
ANOVA, depending on whether the data was normally distributed. General linear regression models 
were used to test for overall treatment differences, with adjustments made for potential cofounders, 
including age, ethnicity and baseline data. Secondary analyses of acne end points and hormone 
variables were performed adjusting for changes in BMI. All covariates were individually entered into 
the models to determine whether there was an interaction between the covariate and the treatment. 
Bivariate linear regression analysis was also conducted, pooling data from both groups, to explore 
relationships between endocrine variables and the change in lesion counts.  
 
4.4 RESULTS 
4.4.1 Subjects 
In all, forty-three subjects completed the study per protocol (Figure 4.1). Seven participants did not 
complete the study (five in control and two in LGL groups) and four were removed from data set (two 
were non-compliant; two began medications known to affect acne, an exclusion criterion). Baseline 
characteristics are shown in Table 4.1.  
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Figure 4.1: Recruitment to completion of participants in trial. 
Assessed for eligibility 
(n=135) 
Randomised 
(n=54) 
Control group 
 
Received dietary advice (n=27) 
Didn’t meet 
inclusion criteria 
(n=81) 
LGL group 
 
Received dietary advice (n=27) 
Control group 
 
Followed up at 12 weeks (n=22) 
LGL group 
 
Followed up at 12 weeks (n=25) 
Control group 
Withdrawn  
    Lost to follow-up (n=5) 
    Began acne medications (n=2) 
LGL group 
Withdrawn  
     Lost to follow up (n=2) 
     Non-compliant (n=2) 
Control group 
 
Completed trial (n=20) 
LGL group 
 
Completed trial (n=23) 
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Table 4.1: Baseline characteristics of the participants by dietary group for the per protocol 
population 
Variable LGL (n=23) Control (n=20) P 
Age (yr) 18.2  0.5 18.5  0.5 0.76 
Body Mass Index (kg/m
2
) 22.9  0.6 22.5  0.7 0.34 
Weight (kg) 73.5  2.5 73.3  3.3 0.90 
Waist circumference (cm) 79.2  1.7 79.0  2.2 0.81 
Total count average 40.6  5.0 34.9  4.3 0.40 
Inflammatory count average 31.9  3.9 28.4  3.6 0.72 
Non-inflammatory count average 8.8  2.2 6.5  1.6 0.62 
Fasting glucose (mmol/L) 4.76  0.07 4.47  0.09 0.02 
Fasting insulin (mU/L) 7.37  0.66 7.35  0.74 0.99 
Testosterone (nmol/L) 20.97  1.19 20.36  1.48 0.75 
SHBG (nmol/L) 25.39  1.27 24.75  1.92 0.78 
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4.4.2 Diet composition 
Table 4.2 lists the diet composition of the LGL and control groups before randomisation and during 
the trial. No significant group differences were observed in any of the dietary variables at baseline. 
During the trial period, dietary glycaemic load was significantly lower in the LGL group compared 
with the control group and this was achieved by a reduction in carbohydrate intake and by means of 
low-GI foods (as indicated by a reduction in the calculated dietary GI; see Table 4.2). Protein intake 
increased in the LGL compared with the control group (P<0.001), indicating that some carbohydrates 
were replaced with foods higher in protein. This was substantiated by a 15.4% increase in urinary 
urea/creatinine ratio at 12 weeks for the LGL group compared with a 12.3% decrease for the control 
group (P=0.009), indicating good dietary compliance. Although the LGL group received isocaloric 
dietary advice, energy intake decreased relative to their baseline diet (P=0.02). 
4.4.3 Compliance with topical non-acne cleanser 
There was no discontinuation of the topical non-acne therapy amongst the study completers. 
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Table 4.2: Dietary composition of the LGL and control diets before randomisation and during the trial 
period. 
Nutrient  
Before randomisation Trial period 
(n=43) LGL (n=23) Control (n=20) P 
Energy (kJ/day) 10585 9320
a
 10620 0.06 
Dietary glycaemic index
†
 57 43
a
 54 <0.001 
Dietary glycaemic load
‡
 178 101
a
 174 <0.001 
Carbohydrate, % total kJ 49 44
a
 50 <0.001 
Protein, % total kJ 17 23
a
 17 <0.001 
Total fat, % total kJ 32 31 32 0.74 
 Fat subgroups, % total kJ     
 Saturated 13.2 9.0
a
 12.6 <0.001 
 Polyunsaturated 4.5 6.8
a
 4.8 0.001 
 Monounsaturated 11.7 12.4 11.9 0.51 
Cholesterol, mg/d 296 309 304 0.93 
Dietary fibre, g/day 25.3 36.9
a
 26.2 <0.001 
P value corresponds with one-way ANOVA or Mann-Whitney. 
a 
Significantly different from baseline (P<0.05) 
† 
Calculated as the weighted average glycaemic index of all carbohydrate-containing foods in the diet. 
‡
 Calculated as the food‘s carbohydrate amount (grams)  the respective glycaemic index value and 
divided by 100, then totalled for all foods each day.
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4.4.4 Study outcomes 
Table 4.3 shows the mean change in lesion counts and anthropometric measures at 12 weeks 
according to dietary group. After adjusting for age, ethnicity and baseline counts, the reduction in total 
lesion counts was significantly greater in the LGL group compared to the control group (P=0.01). 
Similar results were observed for the mean decrease in inflammatory counts (P=0.02). Figure 4.3 
shows examples of acne improvement in the LGL group. The LGL group also showed significantly 
greater reductions in weight (P<0.001), BMI (P=0.001), body fat percentage (P=0.006) and waist 
circumference (P=0.04) when compared to the control group. Statistical adjustment of the mean 
change in acne scores for changes in BMI altered the outcome for total lesion counts [-21.6 (95% CI, -
28.9 to 14.4) vs -14.1 (-21.9 to -6.2), P=0.07], but not inflammatory counts [-16.0 (95% CI, -20.6 to -
11.4) vs -8.5 (-13.4 to -3.5), P=0.04]. However, we found no significant interaction effect of dietary 
treatment and the change in BMI on acne end-points.  
 
Table 4.4 shows the mean change in hormonal variables and plasma lipids at 12 weeks according to 
dietary group. The mean change in fasting insulin levels (P = 0.03) and logHOMA-IR (P = 0.02) was 
significantly different between groups with the LGL group showing a trend for improved insulin 
sensitivity and the control group showing a trend for increasing insulin resistance. SHBG levels 
decreased in the control group compared with the LGL group (P = 0.031). The effect of dietary 
treatment on FAI (P = 0.041) was marginally significant, with the LGL group showing a decrease in 
testosterone bioavailability compared to the control group. IGFBP-1 increased significantly in the 
LGL group relative to baseline (P = 0.001) and this was significantly different from the mean change 
in the control group. Statistical adjustment for changes in BMI was found to affect the results for 
HOMA-IR (-0.04 for the LGL group vs 0.08 for the control group, P=0.08), SHBG (-0.04 for the LGL 
group vs -2.35 for the control group, P=0.13), and FAI (-8.8 for the LGL group vs 4.6 for the control 
group, P=0.07) but not IGFBP-1 (0.14 for the LGL group vs -0.09 for the control group, P=0.003). 
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Table 4.3: Mean change in outcome variables for the per protocol population at 12 weeks according 
to dietary group 
 Adjusted means (95% CI)
 †
  
Variable LGL group (n=23) Control group (n=20) P 
Total lesion counts -21.9 (-26.8, -19.0) -13.8 (-19.1, -8.5) 0.01 
Inflammatory lesion counts -16.0 (-20.3, -11.8) -8.4 (-13.0, -3.8) 0.02 
Weight (kg) -2.9 (-4.0, -1.7) 0.4 (-0.8, 1.7) <0.001 
BMI (kg/m
2
) -0.89 (-1.25, -0.54) -0.02 (-0.41, 0.36) 0.002 
Percentage body fat (%) -2.2 (-3.0, -1.4) -0.5 (-1.3, 0.4) 0.006 
Waist circumference (cm) -2.2 (-3.6, -0.9) -0.2 (-1.6, 1.2) 0.04 
† 
Means are adjusted for differences in baseline values, age and ethnicity 
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Figures 4.2(i)-(iv): Photographs of acne improvement in the low-glycemic-load group. Patient A at 
baseline (i) and 12 weeks (ii). Patient B at baseline (iii) and 12 weeks (iv). 
(i) (ii) 
(iii) (iv) 
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Table 4.4: Mean change in hormone concentrations and plasma lipids for the per protocol 
population at 12 weeks according to dietary group 
 Adjusted means
† 
(95% CI)  
 LGL (n=23) Control (n=20) P 
Fasting insulin ( U/L)
 ‡ 
 -0.90 (-2.59, 0.79) 1.96 (0.15, 3.77) 0.03 
Log(HOMA-IR)  -0.05 (-0.13, 0.03) 0.09 (0.01, 0.18) 0.02 
Testosterone (nmol/L) -1.32 (-2.75, 0.12) -1.20 (2.74, 0.34) 0.91 
SHBG (nmol/L) 0.27 (-1.56, 2.09) -2.71 (-4.67, -0.74)
a
 0.03 
FAI (nmol/L) -8.73 (-17.34, -0.12)
a
 4.51 (-4.74, 13.75) 0.04 
DHEA-S ( mol/L) -0.68 (-1.30, -0.06)
a
 -0.12 (-0.79, 0.55) 0.22 
IGF-I (nmol/L) -2.93 (-6.21, 0.35) -2.79 (-6.31, 0.73) 0.95 
Log(IGFBP-1) (ng/mL) 0.14 (0.05, 0.22)
a
 -0.09 (-0.18, 0.03) 0.001 
IGFBP-3 (mg/mL) 0.11 (-0.10, 0.32) 0.16 (-0.06, 0.38) 0.75  
T-Chol (mmol/L) -0.42 (-0.63, -0.21)
a
 -0.05 (-0.27, 0.17) 0.02 
LDL-Chol (mmol/L) -0.32 (-0.51,-0.13)
a
 -0.04 (-0.25, 0.16) 0.06 
HDL-Chol (mmol/L) -0.04 (-0.10, 0.10) -0.05 (-0.11, 0.01) 0.92 
Log(triglycerides) (mmol/L) -0.06 (-0.13, 0.08) 0.03 (-0.05, 0.10) 0.10 
† 
Means are adjusted for differences in baseline values, age and ethnicity 
‡ 
n=42 due to an outlier of more than 3 SD from the mean 
a 
Significant difference from baseline to 12 weeks (P<0.05) 
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4.4.5 Hormonal variables as predictors of acne improvement 
Figure 4.2 depicts the results from bivariate linear regression analysis. A positive relationship was 
observed between the change in total lesion counts and the change in insulin sensitivity as determined 
by HOMA-IR (r = 0.38, P = 0.01). A change in SHBG levels was also shown to correlate negatively 
with a change in lesion counts (r = -0.38, P = 0.01). In contrast, a change in FAI was not significantly 
associated with the change in lesion counts (r=0.10, P=0.50).  
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Figures 4.3: Relationships between acne improvement and hormone variables. (i) HOMA-IR 
and (ii) SHBG. 
(i) 
(ii) 
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4.5 DISCUSSION 
This pilot study investigated the independent effects of an experimental LGL diet versus a 
conventional high-glycaemic-load diet, combined with a standardised non-acne cleanser. Although 
both groups showed improvements in acne, the LGL group showed significantly greater reductions in 
the clinical and endocrine assessments of acne. In addition, participants in the LGL group showed 
reductions in weight and measures of adiposity, despite receiving dietary advice that was isocalorically 
matched with diets at baseline. In contrast, participants on the conventional, high-glycaemic-load diet 
showed no change in weight or body composition.  
 
This study found a positive effect of a LGL diet on insulin sensitivity when compared with a 
conventional high-glycaemic-load diet. The improvement in insulin sensitivity may be attributable not 
only to the decrease in glycaemic load (Frost et al., 1996), but also to the decrease in total energy 
intake and subsequent body weight loss (Hannah and Howard, 1994). It has been hypothesised that a 
decrease in insulin may mediate a reduction in underlying pathological aspects of acne (Cordain et al., 
2002). In accordance with this hypothesis, we observed a moderate relationship between the change in 
insulin sensitivity and the change in acne lesion counts. This suggests that the therapeutic effect may 
be a factor of the change in insulin sensitivity, or simply that improved insulin sensitivity is another 
manifestation of a LGL diet. An association between acne and mild peripheral insulin resistance has 
been previously described in healthy eumenorrheic women (Aizawa and Niimura, 1996).  The authors 
found that acne sufferers exhibited significant hyperinsulinaemia during an oral glucose tolerance test 
compared to age-matched controls. This relationship was also found to be independent of obesity, as 
BMI was similar in both groups.  
 
Our results suggest that the improvement in insulin sensitivity may be linked to reductions in 
androgenicity. We observed a reduction in testosterone bioavailability and DHEA-S concentrations in 
the LGL group and this may help to explain the lessening of acne severity. The observed reduction in 
free testosterone was probably related to the dual effect of insulin on androgen production in testicular 
tissues (Bebakar et al., 1990) and the hepatic production of SHBG (Singh et al., 1990). Plasma 
concentrations of DHEA-S, the major adrenal androgen, also decreased in the LGL group, possibly 
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owing to insulin‘s effect on the expression of adrenal steroidogenic enzymes (Kristiansen et al., 1997). 
In contrast, the control group showed a decline in insulin sensitivity and SHBG concentrations. Why 
acne improved in the control group despite no significant change in androgen levels remains 
unanswered, but the possible direct effect of the topical cleansing agent should be considered (Draelos, 
2006). As SHBG correlates inversely with insulin, it wasn‘t surprising to find that acne also correlated 
with the change in SHBG. Our results also corroborate previous evidence that SHBG may be a marker 
of acne (Odlind et al., 1982; Marynick et al., 1983; Lawrence). However, we observed no relationship 
between acne severity and free testosterone levels, an association which has been demonstrated in 
some (Lucky et al., 1983; Schiavone et al., 1983), but not all studies (Levell et al., 1989; Cibula et al., 
2000). 
 
Normal sebaceous gland growth is also influenced by factors other than androgens, such as IGF-I 
(Deplewski and Rosenfield, 1999). Therefore, increased expression of IGF-I or a reduction in the level 
of its carrier proteins could influence acne. In the present study, IGFBP-1 levels increased 
significantly in the LGL group compared with the control group and we speculate that this is a 
compensatory adaptation to the improvement in insulin sensitivity and the reduction in basal insulin. 
Insulin is the principle determinant of plasma IGFBP-1 levels and low basal IGFBP-1 levels have been 
observed in insulin resistant individuals, possibly due to increased portal insulin overnight (Attia et al., 
1998). Therefore, it is possible that the LGL diet may also induce changes to the IGF system that may 
be clinically relevant to events involved in acne pathogenesis.  
 
There are some limitations regarding the study design and intervention that should be addressed. 
Firstly, as subjects in the LGL group lost weight, we cannot preclude the change in BMI to the overall 
treatment effect. When we statistically adjusted the data for changes in BMI, the effect of the LGL diet 
on several clinical and endocrine parameters was lost. However, this does not necessarily imply that 
acne is influenced by weight loss per se. Weight loss trials, involving PCOS women, have consistently 
shown increased SHBG levels(Kiddy et al., 1989; Guzick et al., 1994) and decreased FAI (Kiddy et 
al., 1989; Guzick et al., 1994). However, low-fat dietary interventions in nonobese women have 
shown no change in SHBG levels following weight loss (Prentice et al., 1990; Rose et al., 1992). At 
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present, there is a paucity of evidence to indicate that acne is more prevalent or severe in overweight 
adolescents. One study revealed a relationship between weight and acne in men aged 20-40, but this 
was not true for adolescents aged 15-19 (Bourne and Jacobs, 1956). Although we cannot determine an 
aspecific effect of weight loss on acne, one could speculate that a reduction in hyperinsulinaemia, 
either through weight loss or dietary composition, may reduce precipitating factors involved in acne. 
Another limitation of the present study was the use of a fasting index to quantitatively estimate 
hyperinsulinaemia and insulin resistance. Although this index correlates with the euglycaemic clamp 
technique and has proven to be useful in large studies, its applicability to small intervention trials 
remains uncertain (Daly, 2003). Furthermore, this test reflects insulin action in a basal state, whereas 
in life much of insulin action in postprandial. Therefore, it is possible that this index may provide an 
underestimation or overestimation of the relationship between acne and the extent of 
hyperinsulinaemia.  
 
To our knowledge, this is the first study to demonstrate a therapeutic effect of dietary intervention on 
acne. The results of the present study open the prospect that nutrition-related lifestyle factors may 
affect the pathogenesis of acne. After 12 weeks, a LGL diet was shown to reduce weight, acne severity 
and hormonal aspects of acne (eg. testosterone bioavailability, IGFBP-1 and HOMA-IR) when 
compared to a conventional high-glycaemic-load diet. Although we could not determine an aspecific 
effect of diet from that of weight loss, the finding that insulin sensitivity correlated with acne suggests 
that both may be involved. Therefore, these results should be considered preliminary and larger-scale 
studies are needed to confirm the effect of dietary intervention on acne.  
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5.1 ABSTRACT 
Background:  Dietary factors have long been implicated in acne pathogenesis. It has recently been 
hypothesised that low glycaemic load diets may influence sebum production based on the beneficial 
endocrine effects of these diets. 
Objective:  To determine the effect of a low glycaemic load diet on acne and the fatty acid 
composition of skin surface triglycerides 
Methods:  Thirty-one male acne patients (aged 15-25 years) completed sebum sampling tests as part 
of a larger 12 week, parallel design, dietary trial. The experimental treatment was a low glycaemic 
load diet, comprised of 25% energy from protein and 45% from low glycaemic index carbohydrates. 
In contrast, the control situation emphasised carbohydrate-dense foods without reference to the 
glycaemic index. Acne lesion counts were assessed during monthly visits. At baseline and 12 weeks, 
the follicular sebum outflow and composition of skin surface triglycerides were assessed using lipid 
absorbent tapes. 
Results:  At 12 weeks, subjects on the experimental diet demonstrated increases in the ratio of 
saturated to monounsaturated fatty acids of skin surface triglycerides when compared with controls [-
5.3 ± 2.0% (mean ± SEM) vs -2.7 ± 1.7%, P=0.007]. The increase in the saturated/monounsaturated 
ratio correlated with improvements in acne lesion counts (r=-0.39, P=0.03). Increased follicular sebum 
outflow was also associated with an increase in the proportion of monounsaturated fatty acids in 
sebum (r=0.49, P=0.006). 
Conclusion:  This suggests a possible role of desaturase enzymes in sebaceous lipogenesis and the 
clinical manifestation of acne. However, further work is needed to clarify the underlying role of diet in 
sebum gland physiology.  
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5.2 INTRODUCTION  
Dietary factors have long been implicated in the pathogenesis of acne (Rasmussen, 1977; 
Michaëlsson, 1981). It is well known that increased sebum production plays a fundamental role in 
acne (Harris et al., 1983) and evidence suggests that dietary manipulation alters sebaceous gland 
output. Extreme caloric restriction dramatically decreases the sebum excretion rate and these changes 
can be reversed when a normal diet is resumed (Pochi et al., 1970; Downing et al., 1972). Other 
studies have demonstrated that increased consumption of dietary fat or carbohydrate increases sebum 
production (Llewellyn, 1967), and modifications to the type of carbohydrate can also alter sebum 
composition (MacDonald, 1964; MacDonald, 1967). Altogether, these studies suggest that the quantity 
and composition of foods, when changed significantly, may affect underlying mechanisms involved in 
sebum production.  
 
Evidence suggests that diet may be an important source of substrate for the synthesis of sebaceous 
lipids (Rasmussen, 1977). Human sebum is comprised mainly of triglycerides (40-60%), wax esters 
(19-26%) and squalene (11-15%), with some cholesterol and cholesterol esters (Kellum, 1967; 
Downing et al., 1969; Greene et al., 1970). These lipids can be synthesised from a variety of sources 
(eg. glucose, acetate, and fatty acids) which serve to donate two carbon fragments (Cassidy et al., 
1986; Middleton et al., 1988). However, some dietary lipids (especially fatty acids) can also pass 
unchanged from the circulation to the sebaceous cells. It is presumed that undifferentiated cells of the 
sebaceous gland acquire the dietary lipids whilst in the basal layer exposed to the circulation 
(Downing et al., 1986). This notion is supported by the observation that sebum contains linoleic acid, 
an essential fatty acid that cannot be synthesised in vivo and therefore must be obtained from the diet.  
 
The triglyceride fraction of sebum is presumably responsible for acne development (Nicolaides, 1974; 
Katsuda et al., 2005). Bacteria can hydrolyse sebaceous triglycerides (Shalita, 1974), liberating the 
fatty acids which can penetrate the follicular wall and become incorporated into the metabolism of the 
surrounding epidermis. The application of free fatty acids on rabbit ears or hairless mice has been 
shown to induce hyperkeratinisation and epidermal hyperplasia similar to that seen in comedo 
formation (Maeda, 1991; Katsuda et al., 2005). However, the hyperkeratotic effect may not be a 
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feature of all fatty acids, as recent evidence suggests that only monounsaturated fatty acids (MUFAs) 
stimulated the morphological changes whereas the saturated fatty acids (SFAs) have little effect 
(Katsuda et al., 2005). Human sebum is known to contain a high proportion of MUFAs, with a 
characteristic double bond at the Δ6 position rather than at the standard Δ9 position (Nicolaides, 
1974). The most abundant of these is sapienic acid (16:1Δ6), which is formed by the Δ6 desaturation 
of palmitic acid (16:0) (Stewart et al., 1986). Sapienic acid is unique to human sebum and has not 
been identified in other human tissues or in sebaceous gland secretions of other animals (Nicolaides, 
1974). It is presumed that this fatty acid may play a role in acne pathogenesis, however its role is not 
well defined (Ge et al., 2003). 
  
In the present study, we examined the influence of diet on the fatty acid composition of skin surface 
triglycerides. Recent evidence suggests that low glycaemic load diets may affect sebum production 
based on the beneficial hormonal effects of these diets (Cordain et al., 2002). The glycaemic load may 
be interpreted as a measure of the blood glucose and insulin-raising potential of the diet, as it 
represents the rate of carbohydrate absorption (indicated by the glycaemic index) and the quantity of 
carbohydrate consumed (Brand-Miller et al., 2003). Previous studies indicate that the dietary 
manipulation of the quality and quantity of carbohydrates can affect the composition of fatty acids in 
sebum (MacDonald, 1964; MacDonald, 1967). A relative excess of dietary carbohydrate (500g/day) 
can increase the proportion of 16:1 in sebum, however the effect on the other fatty acids of sebum is 
varied depending on the type of carbohydrate used (MacDonald, 1964; MacDonald, 1967). Based on 
these observations, one can speculate that the composition of fatty acids in sebum may vary with 
alterations in the dietary glycaemic load. Therefore, the objective of the present study was to 
determine the effect of a low glycaemic load diet on acne and the fatty acid composition of skin 
surface triglycerides.  
 
5.3 MATERIALS AND METHODS 
5.3.1 Study population 
Male volunteers with acne were recruited for a dietary intervention study that was conducted at RMIT 
University (Melbourne, Australia). Informed consent was obtained from participants and guardians (if 
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aged <18years) and the study had the approval of the RMIT Human Ethics committee. This study 
included only male participants, aged 15-25 with mild-moderate facial acne. Participants were 
required to have had acne for longer than 6 months prior to recruitment. Volunteers were excluded if 
they were taking medications known to affect acne or glucose metabolism. A wash-out period of 6-
months was required for oral retinoids or 2-months for oral antibiotics or topical therapy. 
 
5.3.2 Study design 
Eligible participants were recruited between June 2003 and June 2004. Participants were randomly 
assigned to either the low glycaemic load (LGL) or control group (see Figure 5.1) at the time of their 
baseline appointment. Randomisation was carried out by computer generated random numbers and 
allocation to groups was performed by a third party.  
 
The experimental protocol followed a parallel, dietary intervention with monthly visits at an academic 
research clinic (weeks 0, 4, 8, and 12). At baseline and 12 weeks, participants also sat a 1-hour sebum 
sampling test. Due to scheduling interferences (eg. school, work commitments), not all of the study 
participants were available to sit the 1-hour sebum sampling test. Figure 5.1 shows the proportion of 
participants who completed the sebum test as per protocol. 
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Figure 5.1: Recruitment to completion of participants in trial. 
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5.3.3 Dietary intervention 
Participants were informed that the study‘s intent was to compare the dietary carbohydrate to protein 
ratio and were not informed of the study‘s true hypothesis.  The LGL diet was low in glycaemic load, 
achieved through a reduction in carbohydrate intake and by reducing the dietary glycaemic index. The 
LGL group were educated on how to substitute high glycaemic index foods with foods higher in 
protein (eg. lean meat, poultry or fish) and lower in glycaemic index (eg. whole grain bread, pasta, 
fruits). Some staple foods were supplied and participants were urged to consume these or similar foods 
on a daily basis. Each participant‘s dietary directions were isocalorically matched with their baseline 
diet as determined from 7-day weighed/measured food records. The recommended LGL diet consisted 
of 25% energy from protein, 45% from low GI carbohydrates and 30% energy from fats. In contrast, 
the control group received carbohydrate-dense staples and were instructed to eat these or similar foods 
daily. The foods provided had moderate to high glycaemic index values and were typical of their 
normal diet as evidenced from 7-day weighed/measured food records. The control group were not 
informed about the glycaemic index, but were urged to include carbohydrates as a regular part of their 
diet. Actual dietary intakes, as assessed from weight/measured food records, have been reported 
elsewhere (Smith et al., 2007). 
 
5.3.4 Standardised topical cleanser 
All subjects were provided with a topical cleanser (Cetaphil  gentle skin cleanser, Galderma, Forrests 
Hill, Australia) and were advised to use it in place of their normal wash, soap or cleanser. The cleanser 
provided was non-comedogenic and contained no active agents for acne. Subjects began using the 
topical cleanser 2 weeks prior to baseline and were asked to maintain a standard level of usage during 
the trial.  
 
5.3.5 Dermatology assessment 
Scaling of the acne was performed by a dermatology registrar who was blinded to the group 
assignment of the participants. The registrar assessed facial acne occurrence and severity only, using a 
modified Cunliffe-Leeds lesion count technique (Burke and Cunliffe, 1984).  
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5.3.6 Sebutape sample collection method 
Skin surface lipids were collected using Sebutape
 
 test strips (CuDerm Corporation, Dallas, USA) at 
baseline and 12 weeks. Sebutape  is a lipid absorbent strip that has been shown to be a reproducible 
and non-invasive method for estimating the output of sebum from active follicles (Nordstrom et al., 
1986).  
 
Prior to the application of the Sebutape  adhesive strips, residual surface lipid was removed from the 
forehead using an isopropyl alcohol swab. For sampling, two lipid absorbing strips were applied to the 
forehead for a 1 hour collection, using disposable gloves and alcohol-rinsed forceps to prevent lipid-
contamination. The forehead was chosen as the site of collection as the contribution of epidermal 
lipids to the total composition of skin surface lipids has been shown to be minimal (less than 10 
g/cm
2
 compared with average recoveries of 150 – 300 g/cm2 for sebum) (Greene et al., 1970). 
During the sampling time, the room temperature was kept between 18-21ºC.  
 
Following collection, one test strip was applied to storage card (supplied by CuDerm) for photometric 
analysis and the second strip was placed in a chloroform-methanol rinsed, teflon-capped glass vial. 
The glass vial was flushed with nitrogen and then frozen at -80ºC for later compositional analysis.  
 
5.3.7 Photometric assessment of the follicular sebum outflow 
High resolution photographs were taken of the test strips against a black background using a digital 
camera. Photographs were converted to black and white binary images for quantitative analysis using 
Image Tool Software (Version 2 alpha, University of Texas Health Science Center, San Antonio, 
Texas). This software was used to quantify the total spot area (number of black pixels) as a percentage 
of the total test area (total pixelated area). Sebum outflow was determined as the percentage lipid area 
(percentage of black area of the whole test area) on Sebutape  strips following a 1 hour collection. 
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5.3.8 Patient’s assessment of skin oiliness 
At baseline and 12 weeks, each participant was asked to rate their facial skin oiliness using a 7-point 
scale. Reponses were reported using a scale from 0 (‗not at all‘) to 6 (‗extremely‘).This question was a 
component of an acne-specific questionnaire relating to acne symptoms and quality of life. Details 
regarding the questionnaire are described elsewhere (Martin et al., 2001). 
 
5.3.9 Analysis of the fatty acid composition of skin surface triglycerides 
Lipids from the test strip were extracted as previously described (Nordstrom et al., 1986). 
Triglycerides were isolated by preparative thin layer chromatography using silica 60G plates that had 
been heated in an oven at 100 C and cooled to room temperature in a desiccator. A reference standard 
of cholesterol, cholesterol oleate, oleate, methyl oleate, triolein, palmityl oleate and squalene (Nu 
Chek Prep Inc. Elysian, Minnesota and Sigma chemical Co Missouri) was used to identify the 
triglycerides and wax ester fractions. After spotting the samples, the plates were developed according 
to the method of Doran et al (1991). 
 
Lipids were visualised on the plates under ultraviolet light after spraying with a methanoic solution of 
2‘7‘-dichlorofluorescein. The bands containing wax esters and triglycerides were isolated and 
saponified according to the method of Sinclair et al (1987). The fatty acid methyl esters (FAME) were 
analysed by gas chromatography using a Shimadzu GC-17A chromatograph, equipped with a flame 
ionisation detector and integrated software. Each sample was injected onto a 60m BPX-70 (0.32mm 
internal diameter and 0.25mm film thickness) bonded phase, fused silica capillary column (SGE, 
Ringwood, Victoria, Australia) and samples were run according to Sinclair et al (1987) using a 
splitless injection technique. A commercial standard of C14:0, C16:0, C16:1 9, C18:0, C18:1 9, 
C18:2 9,12, C20:0 (Nu Chek Prep Inc. Elysian, Minnesota) was used for identification of sample 
FAMEs. Isolated sebaceous wax esters served as a source of identification of 16:1 6 (Nordstrom et 
al., 1986).  
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5.3.10 Statistical analysis 
All statistical analyses were performed using SPSS 11.0 for Windows (SPSS Inc., Chicago, Illinois). 
Data conforming to a normal distribution were analysed using an independent t test. We analysed 
ordinal and non-normally distributed data using Mann-Whitney U test for independent groups and the 
Wilcoxon signed rank test for paired data. Changes from baseline are reported in percentages, with 
statistical analyses done for absolute values. We compared changes in lesion counts using analysis of 
covariance of log-transformed data with baseline lesion counts as the covariate. Bivariate linear 
regression analysis was also conducted, pooling data from both groups, to explore relationships 
between outcome variables. P-values less than 0.05 were considered significant. As the primary 
endpoint for this paper was the fatty acid composition of skin surface triglycerides, the data was 
analysed per protocol. 
 
CHAPTER FIVE 137 
 
 
5.4 RESULTS 
5.4.1 Subjects 
Figure 5.1 shows the trial profile. Fifty-four subjects were recruited for the parallel, dietary 
intervention study. Seven participants did not complete the study (five in control and two in LGL), 
four were removed from data set (two began acne medications and two were non-compliant) and 12 
were unable to participate in the sebum test. Thirty-one subjects completed the trial and sebum test as 
per protocol. 
 
5.4.2 Study outcomes 
Table 5.1 shows the clinical characteristics of the subjects who completed the sebum test as per 
protocol. Baseline characteristics according to group allocation were not significantly different for 
total (P=0.15), inflammatory (P=0.44) and non-inflammatory (P=0.45) lesion counts. At 12 weeks, a 
greater improvement in total lesion counts was observed in the LGL group compared to controls after 
adjusting for baseline differences. Total acne lesion counts decreased by 59% in the LGL group and 
by 38% in the control group (P=0.046). However, there were no significant group differences with 
regards to changes in inflammatory lesions. The LGL group also showed reductions in weight 
(P<0.001) and BMI (P=0.001) when compared to the control group (Table 5.1). 
 
Figure 5.2 and Figure 5.3 illustrate the changing pattern of increasing sebum output and the follicular 
sebum outflow as determined from the percentage of the lipid impregnated area of test strips. The 
follicular sebum outflow did not differ between groups at baseline (P=0.07) and did not change 
following 12 weeks of dietary intervention. However, there was a significant decline in the reported 
oiliness of the skin at 12 weeks in the LGL group (Figure 5.4). The mean response score of skin 
oiliness decreased from baseline in the LGL group (P=0.013), whereas no significant change was 
observed in the control group.  
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Table 5.1: Clinical outcomes according to dietary group for subjects who completed sebum 
test as per protocol 
 Baseline n 12 weeks n Change from 
baseline
a
 
P 
Total acne lesions 
LGL 48.9  5.8
b
 16 18.9  2.8 16 -59.4  4.6% 0.046 
Control 38.7  5.1 15 24.9  4.9 15 -37.8  8.8%  
Inflammatory lesions  
LGL 38.1  4.7  16 16.7  2.7 16 -50.0  9.1% 0.10 
Control 32.1  4.3 15 22.6  4.3 15 -30.3  10.2%  
Weight (kg)      
LGL 74.1  2.9 16 70.5  2.4 16 -4.4  1.0% <0.001 
Control 72.6  4.0  15 73.4  4.1 15 1.0  0.5%  
BMI (kg/m
2
)       
LGL  23.0  0.5 16 21.9  0.4 16 -4.7  1.1% 0.001 
Control 22.2  0.8 15 22.3  0.8 15 0.5  0.6%  
a
 Changes from baseline are reported in percentages, with statistical analyses done for 
absolute values. Lesion count data was analysed using ANCOVA on log transformed data 
with baseline counts as the covariate. Body composition data was analysed using Mann-
Whitney 
b
 Results expressed as mean  SEM. Analysis of baseline data revealed no significant 
group differences for listed variables. 
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Figure 5.2: Pattern of sebum droplets from subjects exhibiting low (i), moderate (ii) and high (iii) 
levels of follicular sebum outflow. 
Figure 5.3: Percentage lipid impregnated area (95% CI) of sebutapes at baseline and follow up 
according to dietary group 
(i) (ii)  (iii) 
CHAPTER FIVE 140 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Mean response score of skin oiliness (95% CI) according to dietary group at baseline 
and follow-up.  
Note: a lower score reflects a decline in reported skin oiliness 
* Follow-up score significantly different from baseline P<0.05 
* 
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The relative amounts of the major fatty acids in the triglyceride fraction of sebum are summarised in 
Table 5.2. No significant group differences were observed for the change in the proportion of 
individual fatty acids in sebum. However, the two treatment groups demonstrated opposing trends for 
changes in the SFAs/MUFAs ratio. The SFAs/MUFAs ratio significantly increased in the LGL group 
(P=0.017) and the change at 12 weeks was significantly different from that of controls (5.3  7.8% for 
the LGL group vs -2.2  6.0% for the control group, P=0.006). Similarly, the 16:0/16:1Δ6 +Δ9  ratio 
increased in the LGL group compared to the control group (4.5  2.3% for the LGL group vs -5.5  
2.2% for the control group, P=0.004). 
 
5.4.3 Sebaceous fatty acids associated with acne improvement and sebum output 
We found that an increase in the SFAs/MUFAs ratio was predictive of the clinical improvement in 
acne (Figure 5.5). Furthermore, an increase in the SFAs/MUFAs was associated with a decline in the 
follicular sebum outflow (Figure 5.6). In light of this, we explored the improvement in acne in terms 
of changes in sebum output and found that the relationship was not significant (P=0.70). However, the 
sebum outflow was found to be a function of the increasing proportion of MUFAs in sebum (Figure 
5.6). 
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Table 5.2: Weights percent of the major fatty acids in the triglyceride fraction of sebum 
according to dietary group. 
Fatty acid Baseline n 12 weeks n Change from 
baseline
a
 
P
b
 
14:0 (%wt of total) 
LGL 9.22  0.49
c
16 9.34  0.35 16 2.9  2.9% 0.75 
Control 9.63  0.62 15 9.62  0.64 15 -0.07  2.4% 
14:1 (%wt of total) 
LGL 2.29  0.18 16 2.24  0.17 16 -3.9  6.2%  0.65 
Control 2.38  0.11 15 2.46  0.12 15 4.3  4.3% 
15:0 (%wt of total) 
LGL 6.20  0.32 16 6.49  0.31 16 5.4  2.6% 0.71 
Control 6.75  0.28 15 6.95  0.40 15 2.3  2.8% 
16:0 (%wt of total) 
LGL 23.3  0.5 16 23.9  0.5 16 2.9  2.1% 0.07 
Control 24.3  0.4 15 23.6  0.6 15 -2.4  1.7% 
16:1Δ6 + Δ9 (%wt of total) 
LGL 19.3  0.6 16 19.0  0.6 16 -0.7  3.3% 0.23 
Control 19.2  0.6 15 19.8  0.5 15 3.8  2.4% 
18:0 (%wt of total) 
LGL 2.85  0.21 16 2.63  0.13 16 -3.4  3.8% 0.34 
Control 2.65  0.15 15 2.62  0.21 15 -0.5  6.7%  
18:2 Δ9,12 (%wt of total) 
LGL 0.52  0.06 15 0.43  0.03 15 -8.9  6.9% 0.65 
Control 0.43  0.04 14 0.42  0.06 14 3.7  15.2% 
20:0 (%wt of total) 
LGL 0.53  0.05 16 0.51  0.04 16 -2.1  6.2%   0.22 
Control 0.46  0.05 15 0.47  0.05 15 4.5  6.3% 
Total saturated (%wt of total) 
LGL 44.8  0.9 16 45.6  0.6 16 2.2  1.4% 0.09 
Control 46.3  0.8 15 45.7  0.9 15 -1.4  1.1% 
Total monounsaturated (%wt of total)
d
 
LGL 32.8  1.2 16 31.8  1.0 16 -2.3  2.6% 0.15 
Control 32.0  1.0 15 32.4  0.9 15 1.7  1.6% 
a
 Changes from baseline are reported in percentages, with statistical analyses done for 
absolute values 
b
 P-value corresponds with an independent-sample t test or Mann-Whitney for changes in 
absolute data 
c
 Results are expressed as mean  SEM. An independent-sample t test revealed no significant 
group differences for listed fatty acids at baseline. 
d
 Includes 14:1, 16:1 and 18:1 monounsaturated series. 
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Figure 5.5: (i) Change in acne lesion count as a function of the change in the ratio of 
SFAs/MUFAs in sebaceous triglycerides. (ii) Change in acne lesion count as a function of the 
change in the ratio 16:0/16:1Δ6 +Δ9 in sebaceous triglycerides. 
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Figure 5.6: (i) Change in the quantity of skin surface lipid as a function of the change in the 
MUFAs in sebaceous triglycerides. (ii) Change in the quantity of skin surface lipid as a 
function of the change in the ratio of SFAs/MUFAs. 
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5.5 DISCUSSION 
Increased sebum production is an obligatory condition for developing acne. Support for an association 
between acne and sebum production comes from three lines of evidence: (i) acne patients have higher 
rates of sebum secretion than controls (Strauss and Pochi, 1961; Harris et al., 1983); (ii) children have 
low sebum output and do not get acne; and (iii) sebum-suppressive agents alleviate acne symptoms 
(Strauss et al., 1962; Farrell et al., 1980). Although the role of sebum in acne remains to be defined, 
there is suggestive evidence that compositional changes, which occur with increasing sebum 
production, may influence events involved in comedo formation (Downing et al., 1986). Therefore, 
profiling the fatty acids of sebum may contribute to our understanding of events involved in acne 
pathogenesis. 
 
In the present study, we examined the influence of a LGL diet on clinical assessments of acne and the 
composition of skin surface triglycerides. After 12 weeks, we found that the subjects on a LGL diet 
demonstrated significantly greater reductions in total lesion counts when compared with controls. 
Although we were unable to detect an effect of dietary intervention on sebum output or the 
composition of individual fatty acids, we did observe opposing trends in the SFAs/MUFAs ratio of 
skin surface triglycerides. Subjects on the LGL diet demonstrated an increase in the SFAs/MUFAs 
ratio compared to a decrease seen in the control group. The LGL group also demonstrated an increase 
in the 16:0/16:1Δ6+Δ9 ratio, thereby suggesting a decrease in the enzymatic desaturation of 16:0 with a 
LGL diet. Interestingly, these changes were found to correlate with the clinical improvement in acne, 
thereby suggesting that the desaturation of sebaceous fatty acids may play a role in acne development. 
 
The enzyme, Δ6-desaturase, is responsible for converting palmitic acid (16:0) into the 
monounsaturated fatty acid sapienic acid (16:1Δ6) in a unique type of reaction that is characteristic of 
human sebaceous glands. In sebaceous secretions of other species, the pattern of desaturation occurs at 
the Δ9 carbon rather than at the Δ6 position (Stewart, 1992). Human sebaceous glands do not express 
Δ9 desaturase (Ge et al., 2003), however accumulation of some Δ9 forms may occur in 
undifferentiated cells in the basal layer of the glands. As cells differentiate and move into the 
unvascularised interior of the gland, the Δ9 fatty acids initially acquired by cells may be diluted by the 
CHAPTER FIVE 146 
subsequent synthesis of Δ6 fatty acids. In adult sebum, sapienic acid accounts for around 25% of the 
total fatty acids of sebum and the contribution of fatty acid 16:1Δ9 is less than 0.5% (Nicolaides, 
1974). In the present study, we were unable to resolve the Δ6 and Δ9 isomers by gas chromatography, 
however we suspect that basal levels of 16:1Δ9 would be fairly constant and therefore any change in 
16:1Δ6+Δ9 is most likely to reflect a change in the endogenous production of 16:1Δ6. 
The expression of Δ6-desaturase and the resultant accumulation of sapienic acid in sebum may be an 
important factor in sebaceous lipogenesis. Support for this role comes from evidence of sebaceous 
gland hypoplasia in asebia mice which fail to express Δ9 desaturase (Zheng et al., 1999). Progenitor 
cells of the human sebaceous gland do not express Δ6-desaturase, however this enzyme is highly 
expressed in lipid-containing cells situated one cell layer away (Ge et al., 2003). This pattern of 
expression supports a role of Δ6-desaturase in sebaceous lipogenesis and it has recently been proposed 
that sapienic acid production may provide a functional marker of sebaceous gland activity (Ge et al., 
2003). Our study found that a higher follicular sebum outflow was associated with an increase in the 
proportion of MUFAs in sebum, which was largely explained by variations in 16:1Δ6+Δ9 (data not 
shown). This observation supports previous reports of high sapienic acid levels in conditions of 
increased sebum production (ie. puberty and acne) (Sansome-Bassano et al., 1980; Perisho et al., 
1988). We also observed that increased sebum outflow was associated with a decrease in the 
SFAs/MUFAs ratio, which supports the suggestion that desaturase activity plays a fundamental role in 
sebum production. 
Sebum composition has also been implicated in the abnormal follicular keratinisation which is 
associated with acne development. Katsuda et al (2005) recently demonstrated that  fatty acid subtypes 
can have discrete effects on skin surface morphology and epidermal proliferation. The authors showed 
that the topical application of MUFAs (oleic acid and palmitoleic acid) induced scaly skin, abnormal 
keratinisation and epidermal hyperplasia. In contrast, triglycerides (triolein) and SFAs (palmitic and 
stearic acid) had no affect on skin morphology. It is thought that the MUFAs of sebum interfere with 
the intracellular calcium dynamics of follicular keratinocytes and the intercellular lipid bilayer 
structure of the epidermal water barrier. Katsuda et al (2005) have postulated that reducing sebum 
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secretion and/or the production of free MUFAs may serve as potential targets for acne therapy. In 
support of this hypothesis, our study found that an increase in SFAs relative to MUFAs was predictive 
of the clinical improvement in acne. This relationship was largely explained by an increase in the 
16:0/16:1Δ6+Δ9 ratio. Given that the LGL group demonstrated an increase in the 16:0/16:1Δ6+Δ9 ratio 
when compared to controls, this may serve to explain the greater acne improvement in the LGL group.  
 
The precise mechanism by which dietary glycaemic load influences the sebum composition is 
unknown. Given that sebaceous glands can synthesise lipids from a variety of precursors, one could 
assume that the supply of glucose is not a limiting factor. To synthesise lipids, sebaceous glands 
require energy, acetyl-coenzyme A and NADPH, which can be acquired through β-oxidation of fatty 
acids and/or the catabolism of glucose (Downie et al., 2004). However, to sustain the normal pattern 
of sebaceous lipids, Downie and Kealey (2004) have hypothesised that endogenous glycogen may be 
an important provider of NADPH, as well as substrates (eg. glycerophosphate and acetate), for the 
synthesis of triglycerides. Glycogen and glucose concentrations have been shown to decrease as cells 
accumulate lipid and move from the periphery to the centre of the glands (Im and Hoopes, 1974; 
Downie and Kealey, 1998). The glycogen content of undifferentiated sebaceous cells is also 6.3 times 
that of the epidermal keratinocytes (Im and Hoopes, 1974). Furthermore, glycogen stores are greatly 
reduced in isolated sebaceous glands, even in the presence of acetate, lactate and amino acid 
substrates, thereby suggesting that endogenous glycogen is essential for sebaceous lipogenesis 
(Downie and Kealey, 1998). 
 
We have hypothesised that a LGL diet may affect sebum composition via metabolic effects (eg. fuel 
storage) and/or secondary effects on hormone levels (eg. free testosterone and adrenal androgens) (see 
Figure 5.7).  Accumulating evidence suggests that high glycaemic load diets can increase glycogen 
storage within body tissues (ie. muscle, liver) when compared to isoenergetic, low glycaemic load 
diets (Kiens and Richter, 1996; Brand-Miller et al., 2002). Therefore, it is possible that dietary 
manipulation of the glycaemic load may affect glycogen stores in sebaceous glands, which may be a 
limiting and directing factor in sebaceous lipogenesis. Furthermore, we have shown that a LGL diet 
can reduce testosterone bioavailability and dehydroepiandrosterone sulfate concentrations (Smith et 
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al., 2007), which may be explained by the insulin lowering effect of these diets (Cordain et al., 2002). 
As sebum production is largely under androgenic control, a reduction in circulating androgen levels 
may also account for the changes in sebum composition. This raises the possibility that nutritional 
intake may influence sebum production via the synchronised modulation of androgens and glycogen 
stores.  
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Figure 5.7: Schematic illustrating the hypothesised metabolic-endocrine pathway linking a low 
glycaemic load diet and the changes in the fatty acid profile of human sebum production.  
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There are some issues relating to this study that warrant further consideration. Firstly, it is possible 
that the relative changes in sebum composition could also be related to the change in body mass in the 
LGL group (Tsai et al., 2006). This weight loss occurred despite dietary instructions being given to 
maintain the subject‘s baseline kilojoule intake. There is increasing evidence to indicate that LGL 
diets enhance weight loss via increases in satiety and fat oxidation (Kiens and Richter, 1996; Brand-
Miller et al., 2002), and studies suggest that obese adolescents lose weight on LGL diets without the 
need for an imposed energy restriction (Spieth et al., 2000; Ebbeling et al., 2003). This study found 
that the weight loss in the LGL group correlated with starting BMI, indicating that extent of obesity at 
baseline was a significant predictor of the overall weight loss (data not shown). Secondly, it is possible 
that use of the mild non-comedogenic skin cleanser may have assisted in the management of acne-
associated symptoms (Draelos, 2006). Although the participants were stabilised on the mild cleanser 
two weeks prior to baseline, the acne improvement seen in controls suggests a possible therapeutic 
effect of the cleanser use. However, as the cleanser was standardised for both groups, this would not 
explain the differences observed between groups. 
 
In conclusion, this study is the first to report the effect of a LGL diet on follicular sebum outflow and 
composition of skin surface triglycerides. We observed that after 12 weeks a LGL diet reduced weight 
and total lesion counts when compared to controls. The LGL group also demonstrated a significant 
increase in the ratio of SFAs/MUFAs, which was largely explained by alterations in the ratio of 
16:0/16:1Δ6+Δ9. These changes suggest either a decrease in desaturase activity or the levels of the 
desaturase enzyme. As changes in the ratio of 16:0/16:1Δ6+Δ9 correlated with the clinical improvement 
in acne, the desaturation of 16:0 may have practical implications for studying the disease process. 
However, as the participants in the LGL group lost weight we are unable to isolate the independent 
effects of dietary composition from that of weight loss. Therefore, the role of diet in sebum 
composition is yet to be fully clarified and further studies are required to isolate the underlying 
mechanistic factors. 
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CHAPTER SIX
Evaluating the effect of a low glycaemic load 
diet on Acne-Specific Quality of Life parameters 
The following section has not been submitted for publication to a peer-reviewed journal. 
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6.1 ABSTRACT 
Background:  Although knowledge concerning the negative psychological effects of acne has grown in 
recent years, relatively few studies have assessed the impact of treatment upon the emotional and 
functional status of a patient. The Acne-Specific Quality of Life (Acne-QoL) questionnaire was purposely 
developed to assess the impact of treatment in acne clinical trials. 
Objective:   To evaluate the effect of dietary treatment on Acne-QoL 
Methods:   Participants self-completed the Acne-QoL questionnaire at baseline and at study exit as part of 
a 12 week, dietary intervention trial comparing a low glycemic load diet with a conventional high 
glycemic load diet. The Acne-QoL instrument is designed to measure the impact of acne across four 
domains of patient QoL (self-perception, role emotional, role social, acne symptoms). Domain score 
changes with this instrument were used to report treatment advantages following dietary intervention. 
Higher scores reflect more favourable improvements in Acne-QoL.  
Results:   At 12 weeks, the total Acne-QoL score (mean ± SEM) increased significantly more (P=0.001) 
in the low glycaemic load group (16.8 ± 5.6) when compared with controls (-0.2 ± 3.2). The low glycemic 
load group showed greater improvements in the self-perception (5.4  1.2 compared with 0.9  0.9; 
P<0.01), role social (2.6  0.9 compared with -2.2  1.27; P<0.01), and role emotional (5.0  1.3 
compared with -0.3  0.9; P<0.01), domains. However, no significant group differences were observed for 
the change in the acne symptoms domain score. 
Conclusion: These results suggest that patient-assessed outcomes respond to diet-mediated improvements 
in acne, suggesting that the emotional, social and psychological disability of acne may be partially 
improved with a low glycemic load diet. 
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6.2 INTRODUCTION 
Although acne is not a life threatening condition, the physical and psychological morbidity associated 
with the disease is well recognised (Kilkenny et al., 1997; Niemeier et al., 2002; Yazici et al., 2004). 
Physical morbidity relates to acne type (comedomes, papules and pustules), distribution (face, chest, back) 
and extent (number of lesions). As acne often affects the face, significant psychological morbidity can 
arise from the perceived disfigurement of one‘s appearance (Henkel et al., 2002). It is estimated that 30-
50% of 12-20 year olds with facial acne show negative psychological symptoms, including anxiety, 
depression, self-consciousness, embarrassment, diminished self-esteem, as well as perceived social 
rejection (Gupta et al., 1990; Gupta and Gupta, 1998; Aktan et al., 2000; Smithard et al., 2001). These 
factors may contribute to lower academic performance, higher unemployment and problems in 
interpersonal relationships (Jowett and Ryan, 1985; Cunliffe, 1986; Girman et al., 1996). Therefore, if 
untreated, acne can impose a negative impact on the psychological development of adolescents and young 
adults and can significantly diminish an individual‘s quality of life.    
 
Effective treatment can potentially reverse some of the negative psychological effects of acne (Newton et 
al., 1997). Several studies indicate that amelioration of acne can decrease symptoms of depression and 
anxiety and improve other psychosocial parameters (Rubinow et al., 1987; Myhill et al., 1988; Newton et 
al., 1997; Weiss et al., 2003). In fact, one study found that patients who achieved the greatest clinical 
improvement in acne also experienced the greatest reduction in negative psychological symptoms 
(Rubinow et al., 1987). However, this is not always the case as some patients maintain the psychological 
response to the disease, even after successful treatment (Kellet and Gawkrodger, 1999). The negative 
psychological impact of acne is highly individualistic and emotional impairment does not always correlate 
with the objective severity of the disease (Niemeier et al., 1998). Therefore, patient care should focus on 
improving both the clinical symptoms and the experience of the disease (Newton et al., 1997).  
 
Over recent years, several quality of life tools have been developed to inform clinicians about the impact 
of disease on individuals. Generic instruments, such as the General Health Questionnaire (GHQ-28) and 
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the Short Form 36 (SF36), provide meaningful information on aspects of disability or well-being without 
reference to the cause. Using these scales, one study found that the social, psychological and emotional 
impact of acne was as great as that reported by patients with chronic disabling diseases such as asthma, 
epilepsy, diabetes, back pain or arthritis (Mallon et al., 1999). However, generic instruments often provide 
inconsistent results, in part because these scales are developed for assessing general health status, and do 
not address problems which are relevant to the disease of interest (Finlay, 2004). Disease-specific quality 
of life instruments, such as the Cardiff Acne Disability Index and the Acne-Specific Quality of Life 
Questionnaire, have a greater power to detect change following therapy as they focus on aspects that are 
most affected by the disease and tend to be of greatest importance to patients (Finlay, 2004). As disease-
specific quality of life tools are more sensitive to change than generic instruments, they can be utilised in 
clinical trials to discriminate between treatments.  
 
The following chapter describes the use of an Acne-Specific Quality of Life (Acne-QoL) tool to evaluate 
the efficacy of dietary treatment of acne from the patient‘s perspective. We have previously described that 
a low glycaemic load (LGL) diet significantly improved objective measures of acne when compared to 
controls; however, the patient‘s experience of the disease from a personal and social context has not been 
described. This chapter also describes the reliability, validity and responsiveness of the Acne-QoL 
instrument for psychometric evaluation. 
  
6.3 METHODS 
The Acne-Specific Quality of Life (Acne-QoL) tool was incorporated as part of the 12 week, parallel, 
dietary intervention study to evaluate participant satisfaction with dietary treatment. Subjects self-
completed the Acne-QoL questionnaire during visits to the academic research clinic at baseline and the 
study‘s termination. A discrete group of acne sufferers (n=4) also completed the questionnaire twice in 
one week to assess the reproducibility of the questionnaire. Details regarding the study design and 
population have been reported elsewhere (Smith et al., 2007a). 
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Table 1 provides a summary of the content areas of the Acne-QoL questionnaire and a full description is 
provided by Martin et al (2001). Although the Acne-QoL tool was initially validated within a usual care 
setting, a subsequent study demonstrated that the questionnaire is capable of detecting treatment 
differences in randomised clinical trials (Fehnel et al., 2002). The Acne-QoL questionnaire is composed 
of 19 items, each referring to the past week, which may be organised into four domains: self-perception, 
role-emotional, role social and acne symptoms. Responses to each item are scored using a 7-point likert 
scale from 0 (‗extremely‘ or ‗extensive‘) to 6 (‗not at all‘ or ‗none‘). For each domain, scores are 
calculated by summing the responses within each category to yield four domain scores, and higher scores 
indicate more favourable QoL.  
 
This study evaluated the Acne-QoL instrument to ensure that items are answered consistently by 
respondents (instrument reliability) and to confirm that Acne-QoL scores are sensitive to clinical 
parameters (instrument validity). The instrument reliability of the Acne-QoL instrument was assessed 
according to the internal consistency of items and by the test-retest method. Internal consistency was 
assessed using Cronbach‘s alpha coefficient, which examines the consistency of responses to items within 
each domain. Cronbach‘s alpha values between 0.70 and 0.95 suggest that scores are reliable (Streiner, 
1993). The test-retest reliability coefficient was determined by administering the same questionnaire one 
week later to the small group of volunteers (n=4) and correlating the two sets of scores. A test-retest 
correlation coefficient value greater than 0.75 is considered acceptable (Martin et al., 2001). Convergent 
and divergent validity was evaluated by correlating each of the four Acne-QoL domains scores with 
clinical measures that were presumed to be related (acne severity) and unrelated to Acne-QoL (height and 
HDL cholesterol). A priori assumption was that height and HDL cholesterol are not related to acne-
specific measures of QoL.   
 
The Acne-QoL instrument was assessed for internal responsiveness (‗ability to measure change over 
time‘) and external responsiveness (‗the extent to which changes in a measure over time relate to 
corresponding changes in a reference measure of health status‘) as previously described (Husted et al., 
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2000). Internal responsiveness was assessed using the paired t-test (separately for the LGL and control 
groups) and the Guyutt‘s internal responsiveness statistic, which is defined as the difference in average 
change scores between the two treatment groups, divided by the standard deviation of changes scores in 
the control group (Guyatt et al., 1987). External responsiveness was evaluated using Pearson‘s product-
moment coefficient for the relationship between the change in Acne-QoL and clinical improvement in 
acne. Treatment differences were determined by comparing the change in Acne-QoL scores at the end of 
the 12 week study using an independent t-test or the Mann-Whitney U test. P values less than 0.05 were 
considered significant. 
   
 
 
Table 6.1: Summary of Acne-QoL domains 
Self-perception Role-social Role-emotional Acne symptoms 
 Feeling unattractive 
 Feeling self-conscious 
 Diminished self-confidence 
 Feeling embarrassed 
 Dissatisfaction with self-
appearance 
 Concern about going out in 
public 
 Concern about meeting new 
people 
 Problems associated with 
interacting with the opposite 
sex  
 Problems associated with 
socialising with people 
 Annoyed about time spent 
cleansing/treating face 
 Concern about need to have 
medication/cover up 
available 
 Concern about not looking 
one‘s best 
 Feeling upset about having 
facial acne 
 Bumps on faceª 
 Bumps full of pusª 
 Scabbing from acneª 
 Concern about scarring 
 Oily skin 
 
All questions refer to the subject‘s experience with facial acne in the past week 
Responses to all but three questions are scaled: extremely, very much, quite a bit, a good bit, somewhat, a little bit, and not at all. 
ªThe response options for these questions includes: extensive, a whole lot, a lot, a moderate amount, some, very few, and none. 
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6.4 RESULTS 
6.4.1 Instrument reliability 
Table 6.2 shows the reliability coefficients for the Acne-QoL instrument. The internal consistency of 
items within Acne-QoL domains was high, suggesting good agreement among items within each 
domain. Although the coefficient of test-retest reliability was computed on a smaller than ideal sample 
(n=4), the correlation was high for the self-perception, role emotional and role social domains. 
However, the repeated test scores for the acne symptoms domain only achieved a satisfactory 
correlation (see Table 6.2).  
 
6.4.2 Instrument validity 
The strong correlation of worsening acne symptoms scores with increasing acne severity (total lesion 
count and severity rating) supports the convergent validity of the Acne-QoL construct, demonstrating 
that objective clinical assessments of acne correlated with the respondent‘s rating of physical 
symptoms. A somewhat weaker association was shown for the role emotional and self perception 
domains (r = 0.17-24) and no relationship was observed with the role social domain. However, the 
latter scales measure the emotional and social impact from all sources and are therefore less specific to 
the disease. Discriminant validity was also supported by the very low correlations obtained between 
the Acne-QoL domain scores and clinical measures assumed to be unrelated to acne-specific QoL 
(height and HDL cholesterol). 
 
6.4.3 Internal and external responsiveness of the Acne-QoL tool 
Figure 6.1 illustrates the mean change over time in Acne-QoL domain scores for the LGL and control 
groups.  The LGL group demonstrated significant increases across all four domain scores at 12 weeks, 
suggesting improvements in acne-specific QoL for subjects on the LGL diet. In contrast, Acne-QoL 
domain scores did not significantly change over time in the control group. The Guyatt‘s responsivness 
statistic (see Table 6.4) was moderate-high for all domains, suggesting that the Acne-QoL tool was 
adequately responsive to measure treatment advantages (ie. the degree of variability in the general 
population was low compared to the difference in the mean change scores between the LGL and 
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control groups). Taken together, these results provide strong evidence for the instrument‘s internal 
responsiveness or ability to detect change. 
Table 6.3 demonstrates how changes in Acne-QoL domain scores and clinical assessments of acne 
relate. Acne improvement, defined as either a reduction in lesion counts or global severity, 
appropriately correlated with improvements in the Acne-QoL acne symptoms score, indicating that the 
respondent‘s subjective rating of acne improved proportionally to the physician‘s assessment of acne 
improvement. Although similar trends were observed for the other domains, their relationship with the 
physician‘s clinical assessments did not meet statistical significance. However, a reduction in total 
lesion counts was found to correlate with the improvement in the overall Acne-QoL domain score. 
6.4.4 Treatment differences in Acne-QoL 
Statistically significant ‗between group‘ differences were observed for changes in the self-perception, 
role social and role emotional domains, with greater improvements in average Acne-QoL domain 
scores for the LGL group compared to controls (see Table 6.4). However, no significant group 
differences were observed for the change in the acne symptoms domain score. 
    
 
 
 
Table 6.2: Reliability and validity of the Acne-QoL instrument 
Domain 
Reliability  Validity
3
 
Internal 
consistency
1
 
Test-retest
2
 
 Total lesion 
count 
Severity rating Height HDL cholesterol 
Self perception 0.91 0.93  -0.17 -0.17 -0.04 -0.15 
Role social 0.89 0.94  0.05 0.02 0.05 0.00 
Role emotional 0.83 0.82  -0.24 -0.23 0.04 -0.08 
Acne symptoms 0.70 0.53  -0.54 -0.52 0.06 0.02 
1
 Cronbach‘s alpha coefficient for internal consistency of items within a domain, n=43 
2
 Pearson‘s correlation coefficient using the test-retest method obtained within one week, n=4 
3
 Pearson‘s correlation coefficients of clinical measures that are assumed to be both related (lesion counts, severity rating) and unrelated (height 
and HDL) to Acne-QoL, n=43  
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: Mean domain scores (+/- SEM) according to dietary group at baseline and 12 weeks 
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Table 6.3: Correlation of Acne-QoL change scores against the objectively 
assessed improvement in clinical symptoms 
 Domain  Total lesion count Severity rating
1
 
 Self-perception -0.21
2
 -0.20 
 Role-emotional -0.27 -0.15 
 Role-social -0.16 -0.22 
 Acne symptoms -0.41
**
 -0.38
*
 
 Total score -0.31
*
 -0.28 
1 
Severity rating according to Cunliffe-Burke global method 
2
 Pearson‘s correlation coefficient 
*
P<0.05, 
**
P<0.01 
 
 
Table 6.4: Mean change in domain scores from baseline
1 
according to dietary group allocation 
Domain 
LGL group (n=23)  Control group (n=20) Guyatt‘s 
effect size
2
 
P
3
 
Mean SEM  Mean SEM 
Self-perception 5.35 1.23  0.90 0.94 1.06
4
 0.007 
Role-emotional 4.96 1.33  -0.30 0.87 1.35 0.003 
Role-social 2.57 0.92  -2.15 1.27 0.83 0.004 
Acne symptoms 3.89 0.95  1.35 0.99 0.57 0.07 
Total score 16.76 3.56  -0.20 3.2 1.18 0.001 
1
A higher domain scores reflects improved QoL 
2 Guyatt‘s index defined as the difference in average change scores between the two treatment groups, 
divided by the standard deviation of change scores in the control group.
 
3 
Between group differences for the change in domain scores 
4 
Effect sizes near 0.20 represent small effects, those near 0.50 represent moderate effects and those 
near 0.80 represent large effects (Cohen, 1977). 
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6.5 DISCUSSION 
In the past, studies comparing therapeutic interventions for acne have focused on clinical outcomes, 
with little attention given to the impact of treatment on the individual‘s health-related QoL. This is 
because laboratory and clinical measures tend to perform better in terms of sensitivity and reliability 
than QoL measures (Newton et al., 1997). However, the advent of validated disease-specific tools, 
such as the Acne-QoL instrument, has made these measures more reliable and more sensitive to 
treatment when compared to instruments which are not specific to the disease (Girman et al., 1996). 
The results of the present study confirmed that the Acne-QoL tool is both a reliable (as assessed from 
internal consistency and test retest methods) and valid tool (as determined from convergent/divergent 
validity tests) for psychometric evaluation.  
 
This study found that not all Acne-QoL domains cross-sectionally correlated with clinical parameters, 
presumably because the Acne-QoL tool is designed to measure health-related QoL, rather than disease 
severity. In the present study, Acne-QoL domains were found to strongly correlate with clinical 
parameters if they contained questions which explicitly relate to symptoms of acne (such as the acne 
symptoms domain). In contrast, weak relationships were observed between disease severity and 
domains that measure the psychosocial impact of acne (such as the role social and role emotional 
domains). This is likely to be because the latter scales are less specific to the disease and may relate 
more to the individual and their environment. The impact of acne on a given individual can be 
influenced by several factors, including age and gender, baseline self esteem, response and support of 
family and friends, personality and coping mechanisms (Baldwin, 2002; Fried and Wechsler, 2006). 
Furthermore, Acne-QoL can also be influenced by underlying psychiatric disorders that may predate 
the onset of acne (Baldwin, 2002).  
 
This study demonstrated that the Acne-QoL tool is sensitive to change and is capable of detecting 
treatment differences. We have previously described that a low glycaemic load diet significantly 
improved clinical parameters of acne when compared to controls (Smith et al., 2007a). In addition to 
these clinical improvements, subjects on the LGL diet demonstrated statistically significant treatment 
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advantages across all four aspects of health-related QoL (self-perception, role social, role emotional 
and acne symptoms). Of the four domains, a clear relationship was observed between the change in the 
Acne-QoL acne symptoms score and the improvement in measured clinical parameters (eg. total lesion 
counts and acne severity), indicating that the respondent‘s subjective rating of acne symptoms 
improved proportionally to the objective clinical measurement of the physician (Table 6.3). However, 
changes in the other three domains, self-perception, role social and role emotional, did not correlate 
with the clinical improvement, possibly because the psychological impact is highly individualistic and 
can relate to factors other than disease severity (Niemeier et al., 1998). For instance, some individuals 
with mild acne may report highly negative on QoL scales, while others with severe acne may not. 
Previous studies have found little correlation between acne severity and psychological measures 
(Motley and Finlay, 1989; Chee-Chong et al., 1991; Krowchuk et al., 1991), while others found that 
QoL correlates more closely with patient-reported disease severity than with physician-reported 
severity (Martin et al., 2001). Similarly, our study found that an improvement in the acne symptom 
domain score (a measure of self reported disease severity) was significantly associated with 
improvements in the role emotional, role social and self perception domains (results not shown). These 
findings suggest that the psychosocial impact of the disease may be more sensitive to self-image, than 
to the objective clinical measurements. 
Although subjects on the LGL diet demonstrated greater improvements in Acne-QoL domains when 
compared to controls (Table 6.4), it is difficult to determine whether these treatment differences are 
clinically meaningful. Because Acne-QoL measures aren‘t as familiar as common clinical measures 
(ie blood pressure), the minimally reported clinical difference (MCID) was established to help 
interpret QoL change scores (McLeod et al., 2003; Terwee et al., 2003). In general, MCID refers to 
the ‗smallest difference in QoL domains that can be judged as worthwhile when assessing the effect of 
treatment‘ (Terwee et al., 2003). McLeod et al (2003) previously demonstrated that Acne-QoL score 
changes of 5.2, 4.7, 3.1 and 4.6 or more for the self-perception, role-emotional, role-social and acne 
symptoms domains, respectively, corresponded with a change in acne which was considered important 
to patients. According to these estimates, this would suggest that participants on the LGL diet 
demonstrated clinically meaningful improvements in the self-perception (5.4) and role-emotional (5.0) 
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domains, but not the role-social (2.6) and acne symptoms (3.9) domains (Table 6.4). However, the 
preferred methodology for defining MCID has not yet been established, as MCID estimates may be 
inflated when using a patient‘s assessment of the improvement as opposed to the physician‘s. 
Furthermore, it can be concluded that the definition of an important change depends on the study-
specific judgement of participants (Terwee et al., 2003). Therefore, the MCID estimates suggested by 
McLeod et al (2003) are only to be used as a guide and further research is needed to determine Acne-
QoL change scores that are clinically meaningful. 
 
These results provide further support for a role of low glycaemic load diets in the management of acne 
vulgaris. However, the generalisability of these results should be considered, as this study only 
included males with mild-moderate acne. Females may psychologically respond differently to dietary 
interventions as the psychological impact of acne can be greater in females than in males (Krowchuk 
et al., 1991; Kellet and Gawkrodger, 1999). Furthermore, certain patients that are designated as having 
severe acne or being at ―high risk‖ of depressive symptoms may warrant a more aggressive therapeutic 
plan in order to avert negative outcomes (Baldwin, 2002). Dietary measures may have limited 
potential in this regard and in these cases therapeutic agents may be required.  
  
There were a small number of limitations of this study that should be discussed. Firstly, as the Acne-
QoL questionnaires were administered in the research clinic, participant‘s responses may be biased by 
what participants think staff might expect them to say. However, we chose this option because 
response rates are generally low with a silent mail system. In addition, this study only assessed 
negative components of acne-specific QoL and did not assess negative experiences with following a 
diet. Diet is an especially difficult aspect of any treatment regimen and lower adherence rates are 
generally found with diets when compared with pharmaceutical agents (Ahlgren et al., 2001). 
However, this study found good compliance according to self-report and objective physiological 
measures (Smith et al., 2007a; Smith et al., 2007b), suggesting that the diets were well tolerated.  
 
The results reported here suggest that patient-assessed outcomes respond to diet-mediated 
improvements in acne, suggesting that the emotional, social and psychological disability of acne at 
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least be partially alleviated with a LGL diet. The World Health Organisation currently defines health 
as not merely the absence of disease or infirmity, but the ability of a person to lead a productive and 
enjoyable life (World Health Organisation, 1997). This definition, which has been instrumental in 
defining health-related QoL, acknowledges the potential discordance between clinical severity and the 
impact of the disease. Although our study found that patient outcomes improved with a LGL diet, the 
objective severity of acne did not predict the improvement in psychosocial factors. We suspect that 
LGL dietary interventions may affect Acne-QoL primarily in terms of physical symptoms and this, in 
turn, may have patient-specific effects on social functioning and general psychological distress. These 
results further support a role of diet in the management of acne, as patient preferences and health-
related QoL are important considerations in clinical decision making.  
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During the past century, much controversy has surrounded the subject of diet in acne management. In 
the 1930s, major dermatology textbooks advocated dietary restrictions for acne patients based upon 
―clinical experience.. that [suggests] a diet high in carbohydrates and sweets seems to make some acne 
cases worse‖ (Wise and Sulzberger, 1933). However, apart from the individual impressions of 
physicians, there was little evidence to support dietary practices for the control of acne. Forty years 
later, dietary advice was removed from standard texts and the consensus has since been that ―diet 
plays no role in acne treatment in most patients‖ (Kaminester, 1978). Nonetheless, many acne patients 
continue to believe that acne is exacerbated by diet (Rasmussen and Smith, 1983; Tan et al., 2001) and 
a recent survey found that 41% of final year medical students at Melbourne University regarded diet as 
an aggravating factor (Green and Sinclair, 2001).  
 
Few studies have examined the diet and acne connection and those that have, have design faults. 
Fulton et al (1969) in a crossover single-blind study found no effect of chocolate on acne when 
compared to a placebo bar. However, a later examination of the ingredients in the placebo bar 
indicated that the fatty acid composition and sugar contents were virtually identical to that found in the 
experimental treatment (Mackie and Mackie, 1974). Anderson (1971) examined the effect of the daily 
consumption of chocolate, milk or nuts and found no effect on acne. However, the present study has 
been criticised for its small sample size (minimum of 3 subjects for each food), the short follow-up 
and its lack of controls (Treloar, 2003). Although the experiments of Fulton et al (1969) and Anderson 
(1971) are frequently cited as evidence that diet plays no role in acne development, a major limitation 
of both studies was that they concentrated on single foods with no background dietary analysis. 
 
Variations in acne prevalence worldwide have prompted researchers to question the natural 
development of the disease. For instance, rates of acne in Kenya (Verhagen et al., 1968), Zambia 
(Ratnam and Jayaraju, 1979) and Peru (Freyre et al., 1998) are reportedly lower than in the black 
(Wilkins and Voorhees, 1970; Taylor et al., 2002) and Hispanic (Taylor et al., 2002) populations of 
Western countries. In a recent observational report, Cordain et al (2002) attributed that the absence of 
acne in two non-Westernised societies to environmental factors, mainly local diets, which are devoid 
of high-GI (glycaemic index) carbohydrates. This concept is an extension of an earlier hypothesis put 
CHAPTER SEVEN 176 
 
   
forward by Schaefer (1971), who reported the emergence of acne in the Eskimos of North America 
following the adoption of a Western lifestyle. Schaefer proposed that the increase in acne prevalence 
in Eskimo groups was the result of the ―shift to refined,.. rapidly absorbable carbohydrates‖. This is in 
stark contrast to their earlier diet which was comprised primarily of meat and fish (Nestle, 1999). 
Although Russian settlers introduced the Eskimos to basic agriculture and carbohydrate foods (eg. 
barely, buckwheat, cabbage, and potatoes) some 70 to 100 years ago, these carbohydrates were 
generally low in GI and did not replace animal protein as the main source of energy (Smith, 2004). 
The emergence of acne to varying degrees in Eskimo groups appeared to coincide with the increase in 
the annual per capita consumption of refined sugar and flour, while the per capita consumption of 
protein derived from animal sources showed an inverse relationship (Schaefer, 1970; Schaefer, 1971). 
Since the relatively recent introduction of refined carbohydrates to the diet, the Eskimos have 
demonstrated faster growth (increased final height), earlier puberty and dramatic increases in the 
incidence of obesity, diabetes and heart disease (Schaefer, 1970; Schaefer, 1971; Bendiner, 1974).  
 
A unifying feature of traditional diets is that they are naturally low in glycaemic load. As the GI can 
only be used to compare foods of equal carbohydrate content, the glycaemic load was later developed 
to characterise the glycaemic effect of whole meals or diets (GI  available dietary carbohydrate). The 
glycaemic load may be interpreted as a measure of the blood glucose and insulin-raising potential, as it 
represents the rate of carbohydrate absorption and the quantity of carbohydrate consumed (Brand-
Miller et al., 2003). The glycaemic load may be modulated by altering the absolute amount of 
carbohydrate consumed or by selecting foods using the GI concept. Accumulating evidence suggests 
that the glycaemic load of Western diets has increased over recent years due to an; (1) increase in 
carbohydrate consumption as a consequence of dietary recommendations to decrease dietary fat and 
(2) as dietary trends appear to favour high GI foods (Slyper, 2004).  
 
High glycaemic load diets have recently been implicated in acne aetiology due to their ability to 
increase insulin demand and other factors associated with insulin resistance (eg. hyperphagia, elevated 
NEFA, obesity) (Cordain et al., 2002). Clinical and experimental evidence suggests that insulin may 
increase androgen production and effect, through its influence upon steroidogenic enzymes 
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(Kristiansen et al., 1997), gonadotrophin releasing hormone secretion (Willis et al., 1996) and sex 
hormone binding globulin (SHBG) production (Haffner, 1996; Goodman-Gruen and Barret-Connor, 
1997; Plymate et al., 1998). Furthermore, insulin has been shown to decrease a binding protein for 
insulin-like growth factor-I (IGF-I), which may facilitate the effect of IGF-I on cell proliferation 
(Powell et al., 1991). Altogether, these events may influence one or more of the four underlying 
causes of acne: 1) increased proliferation of basal keratinocytes within the pilosebaceous duct, 2) 
abnormal desquamation of follicular corneocytes, 3) androgen-mediated increases in sebum 
production, and 4) colonization and inflammation of the comedo by Propionibacterium acnes 
(Cordain et al., 2002). 
Support for a role of insulin in acne development can also be found in the high prevalence of acne in 
women with polycystic ovary syndrome (PCOS), a condition associated with insulin resistance, 
hyperinsulinemia and hyperandogenism (Franks, 2003). Insulin resistance is believed to be the 
underlying disturbance in PCOS, as it generally precedes and gives rise to the cluster of endocrine 
abnormalities that characterise PCOS (increased androgens, increased IGF-I and decreased SHBG) 
(Dunaif et al., 1989). Treatments for PCOS now include oral hypoglycaemic agents which improve 
insulin sensitivity, restore fertility and alleviate acne (Ciotta et al., 2001; Kazerooni and Dehghan-
Kooshkghazi, 2003). 
The extent to which acne is related to the typical Western diet is controversial, but the future holds 
promise of a shift in paradigm. A recent study by authors (Smith et al., 2007), has found that a low 
glycaemic load diet, which mimics the diets of acne-free populations, significantly reduced acne lesion 
counts when compared with a conventional high glycaemic load Western diet. The lessening of acne 
severity may be explained by improvements in metabolic-endocrine parameters following dietary 
intervention. The experimental diet reduced insulin resistance and androgen bioavailability, and 
increased levels of SHBG and IGF-binding protein-1, when compared to controls. However, these 
changes may also relate to modest weight loss which concurred with the increase in protein and 
reduction in glycaemic load. Post hoc analysis revealed that the effect of the low glycaemic load diet 
on acne and certain endocrine variables (insulin sensitivity, SHBG and androgen bioavailability) was 
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lost after statistically adjusting for weight loss. Although this study could not determine an aspecific 
effect of a low glycaemic load diet from that of weight loss, these findings are consistent with earlier 
suggestions of the association between hyperinsulinemia and acne. 
Although confirmation of the diet-acne hypothesis will require larger-scale experiments, the present 
study suggests that the institution of a non-Westernised diet, adapted for modern times, may have a 
therapeutic effect on acne. As a basic principal, this type of diet should contain minimally 
carbohydrate-based foods, including a wide variety of fresh fruits, vegetables, wholegrains, lean 
meats, fish and seafood. 
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